Scientists Identify Gene Associated with Development of Spoken Language

A recent study suggests a specific gene variant may have played a crucial role in the development of spoken language in humans, enhancing communication and survival.

A new study has established a link between a specific gene and the origins of spoken language, proposing that a unique protein variant found only in humans may have facilitated our ability to communicate. This advancement in speech allowed early humans to share information, coordinate activities, and pass down knowledge, providing a significant advantage over extinct relatives such as Neanderthals and Denisovans.

The research is described as “a good first step to start looking at the specific genes” that may impact speech and language development, according to Liza Finestack, a researcher at the University of Minnesota who was not involved in the study.

Dr. Robert Darnell, an author of the study published in the journal Nature Communications, explained that the genetic variant under investigation is one of several genes that contributed to the emergence of Homo sapiens as the dominant species. Darnell has been studying the protein known as NOVA1, which is essential for brain development, since the early 1990s.

In their latest research, scientists at New York’s Rockefeller University utilized CRISPR gene editing to replace the NOVA1 protein found in mice with the human variant. The results were surprising; the modified mice exhibited changes in their vocalizations. For instance, baby mice with the human variant emitted different squeaks compared to their normal littermates when their mother approached. Similarly, adult male mice with the variant chirped differently than their typical counterparts when they encountered a female in heat.

Dr. Darnell noted that both scenarios are instances where mice are motivated to vocalize, and the differences in their calls illustrate the role of the NOVA1 variant in communication.

This study builds on previous research linking genetics to speech. In 2001, British scientists identified the FOXP2 gene, which was associated with a language and speech disorder and dubbed the “human language gene.” However, while FOXP2 is involved in language, it was later discovered that the variant present in modern humans is not unique to our species, as it is also found in Neanderthals. In contrast, the NOVA1 variant identified in this study is exclusive to modern humans, according to Dr. Darnell.

It is important to note that the presence of a gene variant alone does not account for the ability to speak. Factors such as anatomical features of the human throat and the coordinated functioning of specific brain areas also play crucial roles in enabling speech and language comprehension.

Dr. Darnell expressed hope that this research not only sheds light on the origins of human communication but may also lead to innovative treatments for speech-related disorders. Liza Finestack from the University of Minnesota emphasized that these genetic findings could potentially allow scientists to identify individuals who may require early speech and language interventions.

As research in this field progresses, the implications for understanding human evolution and addressing speech challenges could be profound, paving the way for future discoveries.

According to Fox News, the findings underscore the intricate relationship between genetics and the development of one of humanity’s most defining traits: the ability to communicate through spoken language.

Common Vitamin May Alleviate Long COVID Symptoms, Study Finds

Vitamin D supplements may reduce the risk of long COVID symptoms, such as fatigue and brain fog, according to a recent study conducted by researchers at Mass General Brigham.

A new study suggests that vitamin D supplements could play a role in alleviating long COVID symptoms, which persist after the initial infection. Researchers at Mass General Brigham investigated whether high doses of vitamin D could affect COVID-19 outcomes, particularly the risk of developing long COVID, a condition characterized by lingering symptoms such as fatigue, shortness of breath, and brain fog. The findings were published in The Journal of Nutrition.

The randomized clinical trial involved 1,747 adults who had recently tested positive for COVID-19, along with 277 members of their households. Participants were assigned to receive either vitamin D3 supplements or a placebo for a duration of four weeks.

Dr. JoAnn Manson, the senior author of the study and a physician at Mass General Brigham, highlighted the potential benefits of vitamin D supplementation for long-term symptoms. “A key takeaway is that vitamin D supplementation looks promising for reducing the risk of developing long COVID but does not appear to affect the severity of the acute infection,” Manson stated.

While the study found that vitamin D supplementation did not significantly alter short-term outcomes, such as symptom severity or the need for hospital visits, a closer examination of participants who adhered to the supplement regimen revealed a noteworthy difference in lingering symptoms. Approximately 21% of those who took vitamin D reported at least one ongoing symptom eight weeks after infection, compared to 25% of participants who received a placebo.

“There’s been tremendous interest in whether vitamin D supplements can be of benefit in COVID, and this is one of the largest and most rigorous randomized trials on the subject,” Manson remarked in a press release. “While we didn’t find that high-dose vitamin D reduced COVID severity or hospitalizations, we observed a promising signal for long COVID that merits additional research,” she added.

Manson explained that vitamin D may influence longer-term complications due to its role in regulating inflammation within the body. However, the researchers acknowledged several limitations in the trial. The study had to be conducted remotely during the pandemic, and participants began taking vitamin D several days after their COVID diagnosis.

Ideally, Manson noted, supplementation should commence before infection or immediately following diagnosis. She emphasized the need for larger studies to confirm whether vitamin D could effectively reduce the risk or severity of long COVID symptoms.

Researchers are planning additional trials to further explore the potential of vitamin D supplementation in treating individuals already experiencing long COVID.

These findings provide a promising avenue for future research and may offer hope for those grappling with the long-term effects of COVID-19, according to Fox News.

Yale’s Ranjit Bindra Elected to Connecticut Academy of Science and Engineering

Dr. Ranjit Bindra, a physician-scientist at Yale, has been elected to the Connecticut Academy of Science and Engineering for his significant contributions to cancer research and treatment.

Dr. Ranjit Bindra, an Indian American physician-scientist at the Yale School of Medicine, has been elected to the Connecticut Academy of Science and Engineering (CASE) for 2026. This prestigious recognition highlights his contributions to the fields of science, technology, engineering, mathematics, and medicine.

As the Co-Director of the Yale Brain Tumor Center at Smilow Cancer Hospital, Bindra is among eight faculty members selected for this year’s cohort of leading experts. The election to CASE is open to scientists and engineers who reside or work in Connecticut, with consideration based on significant original contributions to theory or applications, as well as pioneering accomplishments in emerging fields of applied science and technology.

The new members will be formally inducted during the academy’s 51st annual dinner, scheduled for May 19.

In his research, Dr. Bindra’s laboratory recently led a collaborative effort involving four major laboratories at Yale, resulting in a groundbreaking discovery. The team found that tumors with IDH1/2 mutations exhibit a significant DNA repair defect, making them particularly sensitive to PARP inhibitors. This pivotal work was published in esteemed journals, including Science Translational Medicine and Nature, and has garnered international attention due to its major clinical implications.

Currently, Dr. Bindra is translating these findings into clinical practice through four phase I/II clinical trials. One of these trials is an innovative, biomarker-driven study specifically targeting the Adolescent and Young Adult (AYA) cancer patient population. Additionally, he serves as the lead co-principal investigator for a 35-site, National Cancer Institute-sponsored Phase II trial that tests the PARP inhibitor olaparib in adult patients with IDH1/2-mutant solid tumors.

Beyond his academic and clinical work, Dr. Bindra is also a biotech entrepreneur. He recently co-founded Cybrexa Therapeutics, a company focused on developing a novel class of small molecule DNA repair inhibitors that specifically target the tumor microenvironment. This initiative reflects his commitment to advancing cancer treatment through innovative research and development.

Dr. Bindra’s academic journey began at Yale University, where he earned his undergraduate degree in Molecular Biophysics and Biochemistry in 1998. He continued his education at the Yale School of Medicine, obtaining both his MD and PhD in 2007. Following his education, he completed his medical internship, radiation oncology residency, and post-doctoral research at the Memorial Sloan-Kettering Cancer Center, finishing in 2012.

Dr. Bindra’s election to the Connecticut Academy of Science and Engineering underscores his significant impact on cancer research and treatment, as well as his ongoing commitment to improving patient outcomes through innovative therapies. According to The American Bazaar, his work continues to inspire and lead advancements in the medical field.

Cigarette Smoking in America Falls to Historic Single-Digit Low

U.S. adult smoking rates have reached a historic low of 9.9% in 2024, marking the first time cigarette use has dropped to single digits, although 25.2 million Americans still smoke.

The percentage of American adults who smoke cigarettes has fallen to a record low of 9.9% in 2024, according to a recent study. This marks a decrease from 10.8% in 2023 and represents the first time that adult smoking rates in the United States have dipped into single digits. The analysis, published in the journal NEJM Evidence, utilized data from the National Health Interview Survey.

This milestone is significant for public health officials, who have long aimed to reduce smoking rates. The findings indicate that the U.S. may be progressing toward the Healthy People 2030 goal of lowering adult smoking rates to 6.1%. Researchers, led by Israel Agaku, a public health expert based in Atlanta, expressed optimism about the trend. “If this decline continues, the target might be met or exceeded by 2030,” they noted in their paper.

Despite the encouraging statistics, tobacco use remains prevalent. Approximately 25.2 million adults in the U.S. still smoke cigarettes, which continue to be the most commonly used tobacco product. Furthermore, nearly 47.7 million adults, or 18.8% of the population, use at least one form of tobacco, including cigars and e-cigarettes.

The study analyzed responses from over 29,500 adults in 2023 and 32,600 adults in 2024, making it a comprehensive assessment of current tobacco use trends. The decline in cigarette smoking has also contributed to a reduction in overall combustible tobacco use, which includes both cigarettes and cigars. In 2024, about 12.6% of adults reported using combustible tobacco, down from 13.5% the previous year.

However, the prevalence of other tobacco products, such as e-cigarettes and cigars, did not show significant changes between 2023 and 2024. The researchers emphasized the need for more robust tobacco control policies that address all types of tobacco products, given the stagnant rates of e-cigarette and cigar use.

The study also highlighted disparities in tobacco use across different demographics. Men reported significantly higher tobacco use than women, with over 24% of men using at least one tobacco product compared to nearly 14% of women. Additionally, tobacco use was more common among certain occupational groups, particularly those in agriculture, construction, and manufacturing.

Among educational demographics, individuals with a general educational development certificate exhibited the highest tobacco use at 42.8%. Rural residents, low-income individuals, and people with disabilities also reported higher rates of tobacco consumption.

Young adults showed a preference for e-cigarettes over traditional cigarettes. Nearly 15% of adults aged 18 to 24 reported using e-cigarettes, while only 3.4% smoked cigarettes. This trend raises concerns among experts, who suggest that the shift in nicotine consumption reflects a change in habits rather than a reduction in addiction.

John Puls, a psychotherapist and addiction specialist in Boca Raton, Florida, noted that many of his patients prefer e-cigarettes and vaping products. “They’re easier to conceal, can be used almost anywhere, and deliver a much more powerful nicotine dose,” he explained. Puls, who was not involved in the study, pointed out that the social stigma surrounding cigarette smoking has increased, leading many to seek alternative nicotine sources.

He also expressed concern about the perception that e-cigarettes are a safer option, which may contribute to the decline in traditional cigarette smoking. “Cigarettes typically deliver about 1 to 2 milligrams of nicotine, while some vape products can contain 20 to 60 milligrams,” he said, highlighting the potential risks associated with vaping.

Health officials maintain that no tobacco product is safe, including e-cigarettes. The Centers for Disease Control and Prevention (CDC) emphasizes that cigarette smoking is the leading cause of preventable disease and death in the U.S., accounting for approximately one in three cancer deaths.

To further reduce tobacco use, sustained public health measures remain essential. These include smoke-free laws, tobacco taxes, and access to cessation support. Researchers noted that while progress has been made, ongoing efforts are critical to achieving lower smoking rates.

The study does have limitations, including variations in how smokeless tobacco has been defined over the years, reliance on self-reported data, and less reliable estimates for certain smaller subgroups. For further insights, Fox News Digital has reached out to Agaku for additional comments.

According to Fox News, the findings underscore the importance of continued vigilance in tobacco control efforts as the landscape of nicotine use evolves.

Parents Should Not Rely on Children for Elder Care in Modern Society

In today’s society, the expectation that children will care for their aging parents is being challenged by evolving cultural, economic, and social dynamics.

The notion that parents should not rely on their children for care in old age reflects a significant shift in societal norms. This change is underpinned by a complex interplay of biological, cultural, and economic factors that are reshaping intergenerational expectations in real time.

Historically, families operated as multi-generational alliances. Parents invested substantial resources—time, protection, and education—into their children, who, in turn, were expected to support their parents as they aged. This cycle of care is evident in anthropological studies of tribal societies, where the survival of elders often depended on the support of younger family members. Disrupting this cycle can lead to societal instability and increased loneliness.

Religious and moral traditions have long reinforced these familial obligations. In the biblical context, honoring one’s parents includes providing practical care, as outlined in the Book of Exodus and the Book of Deuteronomy. The early church further emphasized this responsibility, with teachings in the First Epistle to Timothy highlighting the importance of family care. Jesus Christ’s admonitions against neglecting parental support underscore the idea that spiritual commitments are meaningless if one abandons their family.

However, the modern world has fundamentally altered this paradigm. For much of history, individuals relied on family for support in their later years, as retirement systems were virtually nonexistent. Today, many people benefit from pensions, Social Security, retirement savings, medical insurance, and professional elder care. Economists refer to this transition as a shift from family-based welfare to institutional welfare, where governments and markets now play a significant role in elder support.

Increased mobility has further complicated these dynamics. Two centuries ago, children typically lived in close proximity to their parents. In contrast, modern families are often scattered across the globe, with children residing in different states or even countries. This geographical separation makes physical caregiving more challenging.

Individualism also shapes contemporary expectations. Modern culture places a premium on personal independence and self-direction, leading to a shift from the assumption that children will care for their parents to the belief that individuals must create their own retirement plans. Financial advisors increasingly encourage parents to prepare for a future where they are self-sufficient.

Yet, this shift raises philosophical concerns. Completely removing the expectation of care can result in a new issue: aging isolation. Wealthy societies are grappling with a growing number of elderly individuals who, while financially secure, face social abandonment. Loneliness, depression, and neglect among seniors have emerged as significant public health challenges. Humans require more than financial support; they need meaningful relationships.

There is also a moral aspect to consider. Parents often dedicate decades to nurturing their children—providing for their needs, supporting their education, and sacrificing personal comfort. The notion that children owe nothing in return can feel ethically unsatisfying to many. While it may be legally permissible, it conflicts with deep-seated human instincts of gratitude and loyalty.

A more balanced perspective suggests that parents in the modern world should not depend solely on their children for financial or physical support in their later years. Planning for independence is both prudent and responsible. Simultaneously, children should recognize their moral obligation to care for their parents’ well-being and offer assistance when necessary.

In essence, the traditional system of intergenerational support has been adapted rather than entirely dismantled. One can liken civilization to a long relay race, where parents run the first leg, guiding their children through childhood and into adulthood. Eventually, the baton of care, respect, and support is passed back to the parents. When this exchange functions effectively, families remain strong, and societies flourish.

Conversely, when this system collapses, the result is a technologically advanced society filled with isolated elderly individuals and fragmented families. Historical patterns suggest that such a system may appear efficient on paper but leads to profound dissatisfaction in practice.

As society continues to evolve, it is essential to navigate these changes thoughtfully, ensuring that the bonds between generations remain intact and that the needs of both parents and children are met.

According to GlobalNetNews, understanding these dynamics is crucial for fostering healthy family relationships in the modern age.

Sleep Remedy Called ‘Nature’s Valium’ Raises Expert Debate

Experts are debating the efficacy of an ancient herb dubbed “nature’s Valium,” which is claimed to improve sleep and reduce anxiety.

This week in health news, a variety of topics have captured attention, from ancient remedies to modern medical concerns. Among these, an ancient herb known as “nature’s Valium” has emerged as a focal point of discussion among health experts.

The herb, which has been used for centuries in traditional medicine, is touted for its potential to enhance sleep quality and alleviate anxiety. Proponents argue that its natural properties make it a safer alternative to pharmaceutical options, which often come with a range of side effects. However, this claim has sparked a debate within the medical community regarding its effectiveness and safety.

While some experts advocate for the herb’s use, citing anecdotal evidence and preliminary studies, others urge caution. They emphasize the need for more rigorous scientific research to substantiate the claims surrounding its benefits. The divergence of opinions highlights the ongoing conversation about natural remedies versus conventional medicine.

In addition to the discussions about herbal remedies, other health-related topics have also gained traction. Recent studies suggest that certain cannabis compounds may have the potential to reverse diseases affecting a significant portion of the adult population. This revelation has prompted further investigation into the therapeutic applications of cannabis in treating various health conditions.

Meanwhile, a highly contagious virus has been reported spreading rapidly through a western state, raising concerns among health officials. The lack of effective treatments for this virus underscores the importance of public health measures and awareness in preventing its spread.

In another area of concern, recent findings indicate that GLP-1 drugs, commonly used for weight management, may be linked to an increased risk of fractures, osteoporosis, and gout. This has prompted healthcare providers to reassess the long-term implications of these medications for patients.

Additionally, a report has shed light on the alarming rise in cancer rates among young adults, prompting discussions about potential environmental and lifestyle factors contributing to this trend. Experts are calling for more research to understand the underlying causes and to develop effective prevention strategies.

On a different note, a disturbing trend known as “fire-breathing” has been associated with severe burns in teenagers. This practice, often seen as a form of performance art, poses significant risks and has led to calls for increased awareness and safety measures among young performers.

Moreover, the impact of toxic relationships on health is gaining recognition, with studies suggesting that negative social interactions can have hidden health consequences. This has prompted individuals to reflect on the importance of surrounding themselves with supportive and positive influences.

Interestingly, nearly half of seniors report feeling better as they age, with researchers suggesting that various factors contribute to this phenomenon. Understanding the reasons behind this improvement could provide valuable insights into healthy aging.

Lastly, a debate has emerged regarding the health benefits of drinking cold versus hot water. Experts are weighing in on the topic, offering insights into how temperature may affect hydration and overall well-being.

As these diverse health topics continue to unfold, it is clear that ongoing research and dialogue are essential for understanding the complexities of health and wellness in today’s world. The conversation surrounding “nature’s Valium” and other health remedies will likely persist as experts seek to provide clarity and guidance.

For more information on these health stories, refer to Fox News.

Remote Robot Surgery Successfully Treats Cancer 1,500 Miles Away

U.K. surgeons have successfully performed remote robot-assisted surgery to remove prostate cancer from a patient located 1,500 miles away, marking a significant milestone in telesurgery.

Surgeons in the United Kingdom have achieved a groundbreaking milestone in medical technology by successfully conducting remote robot-assisted surgery to remove prostate cancer from a patient located 1,500 miles away. This pioneering operation, carried out at The London Clinic, represents the first instance of robot-assisted telesurgery in the U.K.

Traditionally, patients requiring specialized cancer surgery must travel to see a specialist. In this case, however, the specialist traveled to the patient. The procedure took place at St. Bernard’s Hospital in Gibraltar, where the patient remained in the operating room while Professor Prokar Dasgupta operated the robotic system from a control console at The London Clinic’s robotic center on Harley Street in London.

The advanced surgical robot used for this procedure is the Toumai robotic surgical system, developed by MicroPort MedBot. This platform is specifically designed for high-precision, minimally invasive surgeries. The operation was made possible through a secure fiber optic network that transmitted the surgeon’s movements to the robot in Gibraltar, with a latency of just 48 milliseconds—fast enough to create an almost real-time experience.

During the procedure, local urological surgeons James Allen and Paul Hughes were on standby in Gibraltar, ready to intervene if any complications arose or if the connection was interrupted. Fortunately, the operation proceeded without any issues.

The patient, 62-year-old Paul Buxton, has been a resident of Gibraltar for approximately four decades. He had initially planned to travel to London for his surgery, but was offered the opportunity to participate in a telesurgery trial earlier this year. This innovative approach allowed him to undergo the procedure in his local hospital, significantly reducing the disruption to his life. Reports indicate that he felt fantastic just days after the surgery.

The development of remote robotic surgery has been a long time in the making, with early examples dating back to the Lindbergh Operation, where surgeons in New York performed a gallbladder removal on a patient in Strasbourg, France. Since then, technology has advanced significantly, with cross-continental robotic surgeries being conducted between cities such as Rome and Beijing, as well as long-distance prostate operations in parts of Africa.

The successful procedure at The London Clinic signifies a shift in the landscape of remote robotic surgery, moving from experimental demonstrations to practical medical applications. To further showcase this technology, the hospitals plan to live-stream a telesurgery procedure to thousands of surgeons at the upcoming European Association of Urology Congress.

Several key technologies work in tandem to make remote surgery feasible. Surgeons need to see and react instantly during operations, as even minor delays can complicate precise movements. Modern fiber optic networks, along with backup 5G connections, help maintain extremely low latency. Robotic surgical systems translate a surgeon’s hand movements into smaller, more stable actions inside the patient’s body, which can enhance outcomes in delicate procedures like prostate cancer removal. High-definition 3D cameras provide surgeons with exceptional clarity, often surpassing the visibility offered by traditional open surgery.

Despite these advancements, remote robotic surgery still faces significant challenges. Infrastructure remains a critical issue, as hospitals must ensure that their networks are highly reliable with minimal downtime. The costs associated with robotic surgical systems and specialized networks can also be prohibitive, often running into millions of dollars. Additionally, regulatory concerns arise when surgeons operate across borders, introducing complexities related to legal and licensing requirements.

Every remote procedure necessitates contingency plans, with local surgical teams prepared to step in if technology fails. For now, hospitals view telesurgery as an emerging capability rather than a routine practice.

The long-term implications for patients could be profound. In the future, individuals may not need to travel to major medical centers for complex procedures. Instead, specialists could operate remotely, allowing patients to remain in hospitals closer to home. This evolution could particularly benefit those in rural areas or regions with limited access to specialized care, potentially reducing wait times for certain procedures.

Safety remains the paramount concern in this transition. Hospitals must demonstrate that remote procedures are as reliable as traditional surgeries before the technology can become widespread. The successful connection between London and Gibraltar illustrates the rapid advancements in surgical technology, with reliable networks and sophisticated robots enabling surgeons to guide delicate procedures from thousands of miles away.

While remote surgery may not become commonplace overnight, the trajectory is clear. As technology continues to improve, distance may no longer be a barrier to accessing world-class surgical care.

For further insights on this topic, please refer to Fox News.

A Common Daily Habit May Help Slow Aging and Improve Longevity

A recent study suggests that daily multivitamin use may slow biological aging by approximately four months, particularly benefiting older adults.

Aging is an inevitable part of life, but new research indicates that a daily multivitamin could potentially slow its progression. Conducted by Mass General Brigham in Boston, the study found that daily multivitamin use slowed biological aging by about four months over a two-year period among nearly 1,000 participants.

Biological aging refers to the pace of aging at a cellular level, which can differ from chronological age. The findings were published in the journal Nature Medicine and stemmed from a large randomized clinical trial involving healthy older adults with an average age of 70.

Participants in the study were divided into four groups: one group took a daily multivitamin-multimineral supplement along with a cocoa extract, another group received a daily cocoa extract and placebo, a third group took a placebo and multivitamin, and the final group received only a placebo.

The researchers analyzed blood samples collected from participants at three different points during the study, focusing on five biomarkers known as “epigenetic clocks.” These clocks measure age-related changes in DNA, providing insight into biological aging.

Dr. Marc Siegel, a senior medical analyst at Fox News, explained that biological aging can be marked by DNA methylation, which may increase in some cells while decreasing in others. This phenomenon is part of what is described as epigenetic changes or DNA expression.

The results indicated that those who took multivitamins experienced a slowdown in biological aging across all measured biomarkers, including two specifically linked to longevity. The most significant benefits were observed in participants whose biological age was older than their chronological age.

Howard Sesso, the senior author of the study and associate director of the Division of Preventive Medicine at Mass General Brigham, expressed enthusiasm about the findings. “There is a lot of interest today in identifying ways to not just live longer, but to live better,” he said. “It was exciting to see the benefits of a multivitamin linked with markers of biological aging. This study opens the door to learning more about accessible, safe interventions that contribute to healthier, higher-quality aging.”

Dr. Siegel, who was not involved in the study, described the results as “scientific and significant,” emphasizing the need for further investigation. However, he noted that it remains unclear which specific components of the multivitamin may be responsible for the observed slowdown in aging.

“There are so many possibilities, from biotin to calcium to zinc to vitamins B, C, or D, as well as niacin and metals like magnesium and copper,” he explained. “I am personally a believer in riboflavin, thiamine, and vitamin D, but further research is needed to parse this out and determine a cause-effect relationship.”

Despite the promising findings, the research does have limitations. The effects on aging were relatively small, and it is not yet known how these changes may influence actual medical outcomes. Additionally, the study population primarily consisted of older adults of European ancestry, which raises questions about the generalizability of the results to broader populations.

The researchers did not explore the relationship between changes in the epigenetic clock and actual health outcomes, such as reduced disease risk or increased lifespan. They are planning follow-up studies to determine whether the slowdown in biological aging persists after the trial and to assess the potential impact on clinical outcomes.

Future research will also investigate other possible benefits of daily multivitamins, including their effects on cognitive function and cancer risk. “A lot of people take a multivitamin without necessarily knowing any benefits from taking it, so the more we can learn about its potential health benefits, the better,” Sesso noted. “We are fortunate and excited to build upon a rich resource of biomarker data to test how two interventions may improve biological aging and reduce age-related clinical outcomes.”

This study was funded by the National Institutes of Health, highlighting the importance of ongoing research in understanding the potential health benefits of multivitamins.

Rishi Sharma Awarded SBB Research Group Scholarship for Cancer Research

Rishi Sharma, a University of Chicago student, has been awarded a $2,500 scholarship from the SBB Research Group Foundation for his innovative work in AI tools for cancer diagnosis and drug repurposing.

Rishi Sharma, an Indian American medical student at the University of Chicago, has been awarded a $2,500 STEM scholarship from the SBB Research Group Foundation. This scholarship supports students who are committed to creating societal value through interdisciplinary studies in Science, Technology, Engineering, and Mathematics (STEM).

Sharma is currently in his second year of medical school and is focused on developing artificial intelligence tools aimed at diagnosing rare cancers and facilitating low-cost drug repurposing. His research is pivotal in the field of oncology, where he explores both therapeutic and diagnostic applications of AI, as well as DNA-launched immunotherapies for cancer treatment.

“Sharma isn’t just committed to medicine; he’s committed to the future of medicine and ensuring it’s better for patients. I’m pleased we could support him in his endeavors,” said Matt Aven, co-founder and board member of the SBB Research Group Foundation.

Sharma’s contributions to the field are reflected in his research publications, which include titles such as “Digital Pathology: Deep Learning Can Differentiate Histological Subtypes of Thymic Epithelial Tumours” and “Cancer Treatment: Co-delivery of Bispecific Antibodies Targeting FSHR and Her2 Overcomes Treatment Resistance in Ovarian Cancer.” These works highlight his commitment to advancing cancer research through innovative methodologies.

In addition to his academic pursuits, Sharma has a wealth of practical experience. He previously served as Project Director at PBG Healthcare Consulting, where he led consulting projects for both a biopharma client and an academic spinout. His leadership extends to his role as Co-Director of the Seva Free Clinic, where he has developed a strong background in harm reduction and patient navigation.

Currently, Sharma is pursuing a dual MD/MBA degree at the University of Chicago, further enhancing his ability to integrate medical knowledge with business acumen. He also holds a Master of Engineering from the University of Pennsylvania, underscoring his commitment to interdisciplinary education.

The SBB Research Group Foundation is dedicated to philanthropic efforts that align with the mission of SBB Research Group LLC, a Chicago-based investment management firm. The Foundation not only sponsors the STEM scholarship but also provides grants to organizations that address unmet needs through thoughtful, long-term strategies.

Sharma’s work exemplifies the type of innovative thinking that the SBB Research Group Foundation aims to support, as he seeks to make a meaningful impact in the field of cancer research.

According to The American Bazaar, Sharma’s scholarship is a testament to his dedication and potential in the medical field.

Nearly Half of Seniors Show Improvement with Age, Researchers Find

New research from Yale University reveals that nearly half of seniors show cognitive or physical improvement over time, challenging the stereotype of inevitable decline in aging.

Aging is frequently portrayed as a period marked by decline, but recent research indicates that many older adults may actually experience improvements as they age. A study conducted by researchers at Yale University analyzed over a decade’s worth of data from a large, representative sample of older Americans, revealing that nearly half of adults aged 65 and older demonstrated enhancements in cognitive function, physical ability, or both.

The findings, published in the journal *Geriatrics*, suggest that these improvements are closely linked to the participants’ attitudes and beliefs about aging. Lead author Becca Levy, a professor of social and behavioral sciences at Yale, emphasized the significance of the study’s results. “In contrast to a predominant belief or stereotype that age is a time of continuous and inevitable decline, we found evidence that a meaningful number of older persons actually show improvement over 12 years in cognitive and/or physical health,” she stated.

The research utilized data from the Health and Retirement Study, a federally supported, long-term survey that tracks the health and economic well-being of older Americans. Researchers assessed changes in cognitive abilities through global performance tests and evaluated physical function based on walking speed, which is considered a crucial indicator due to its strong associations with disability, hospitalization, and mortality.

Over the 12-year study period, 45% of participants exhibited improvements in either cognitive or physical functions. Specifically, about 32% of participants showed cognitive gains, while 28% experienced enhancements in physical abilities.

<p”While the average results may indicate decline, examining individual trajectories reveals a different narrative,” Levy explained. “A meaningful percentage of the older participants … got better.” This highlights the importance of looking beyond general trends to understand the diverse experiences of aging individuals.

Interestingly, the study found that participants’ beliefs about aging significantly influenced their outcomes. Those who held more positive views about aging were notably more likely to show improvements in both cognitive performance and walking speed. This correlation persisted even after adjusting for variables such as age, sex, education, chronic disease, depression, and the duration of follow-up.

Improvements were observed even among participants who began with “normal” levels of function, not solely those recovering from injuries or illnesses. Levy noted, “Individuals who have taken in more positive age beliefs … tend to have a lower stress response and lower stress biomarkers.” Given that age beliefs can be modified, there is potential for fostering improvements later in life.

While the study presents compelling findings, the researchers acknowledged certain limitations. The research did not investigate how muscle or brain cell changes might contribute to the observed improvements. Future studies are encouraged to explore improvement patterns in other cognitive areas, such as spatial memory.

Additionally, although the study’s participants were drawn from a nationally representative sample, the researchers expressed a desire to examine improvement patterns in more diverse cohorts that better represent various ethnic minority groups.

The authors aim to challenge the prevailing notion that continuous physical and cognitive decline is an unavoidable aspect of aging. Levy remarked, “We found evidence that there could be psychological pathways, behavioral pathways, and physiological pathways [by which age beliefs impact health]. It’s common, and it should be included in our understanding of the aging process.”

As society continues to grapple with the implications of an aging population, this research offers a hopeful perspective on the potential for growth and improvement in later life, encouraging a shift in how aging is perceived and understood.

According to Fox News, these findings may help reshape conversations around aging and promote a more positive outlook on the later stages of life.

The Architecture of Resilience: Understanding Strength Through Vulnerability

The evolving understanding of resilience emphasizes emotional integration over stoic invulnerability, suggesting that true strength lies in the ability to embrace vulnerability and personal breakdowns.

Modern psychology is redefining resilience, moving away from the traditional notion of stoic invulnerability towards a more nuanced understanding that emphasizes emotional integration. True resilience is increasingly recognized not as the absence of breakdowns, but as the capacity to endure profound personal collapse without allowing that pain to permanently alter one’s identity.

For decades, cultural narratives have portrayed resilience as a form of psychological armor—an unyielding shield that enables individuals to withstand life’s challenges without revealing any signs of distress. Society has often celebrated the “stoic” figure: the executive who returns to work the day after a personal tragedy or the parent who maintains a composed exterior while facing internal turmoil. However, emerging psychological research and clinical observations indicate that this “powering through” mentality is not only unsustainable but can also lead to deeper psychological fragmentation.

The reality of human endurance is far more complex than our cultural myths suggest. For instance, last year, a woman experienced a complete emotional breakdown in the middle of a grocery store, collapsing between the cereal aisle and the frozen foods section. To an onlooker, this scene might have appeared as a sign of weakness or a failure of character. Yet, viewed through the lens of modern behavioral science, that moment of “crumbling” was not indicative of fragility; rather, it marked the beginning of a significant transformation into a more resilient and integrated version of herself.

The American Psychological Association defines resilience as the process of adapting well in the face of adversity, trauma, tragedy, threats, or significant sources of stress. Notably absent from this definition is any mention of invincibility, emotional suppression, or the maintenance of a “perfect facade.” Instead, the essence of resilience lies in the concept of process. It is a dynamic movement, not a static state of being.

The societal pressure to remain “unbreakable” often pushes individuals into a state of emotional dissociation. Many high-functioning professionals wear their ability to handle immense pressure without flinching as a badge of honor. However, this often comes at a significant cost. When we prioritize “handling everything,” we risk disconnecting from our true selves. In many instances, depression and anxiety can creep in so subtly that they remain unrecognized until a complete system failure occurs.

Consider the experience of navigating a significant life upheaval, such as a divorce or a career collapse. At the age of 34, one individual described feeling “completely shattered” after the end of a marriage. Their internal dialogue quickly shifted to identity-level labels: “I am a failure. I am broken. I am someone who cannot sustain a relationship.” This phenomenon, known as narrative fusion, occurs when the pain of the moment becomes the defining characteristic of the individual.

A breakthrough in modern therapy often arises from a subtle yet revolutionary distinction: the ability to experience devastation without adopting the identity of a “devastated person.” This shift from “I am sad” to “I am experiencing sadness” represents a fundamental pillar of psychological flexibility. It allows individuals to acknowledge their pain without allowing it to hijack their entire life narrative.

Most people instinctively respond to emotional distress in one of two ways: they either push the pain away through workaholism, substance use, or obsessive productivity, or they merge with the pain entirely, becoming consumed by it. Both approaches trap individuals in a cycle of reactivity.

The most resilient individuals have developed a third approach: the practice of sitting with discomfort. These are the people who cry, who have “bad days,” and who recognize when they need to cancel plans to prioritize their mental health. They do not perceive these moments as failures of strength; rather, they view them as essential maintenance for the human spirit. By allowing themselves to “break” in small, controlled ways, they prevent the catastrophic structural failure that can result from being overly rigid.

Research into family dynamics suggests that our methods for handling pain are often inherited. In families where “staying strong” is the only accepted norm, members frequently develop secondary pathologies—such as high-functioning anxiety or chronic stress-related physical ailments—due to a lack of tools for processing grief or fear. When an individual finally breaks this cycle by allowing themselves to be vulnerable, they not only heal themselves but also rewrite the emotional legacy of their lineage.

A cornerstone of long-term mental health is the realization that one is not defined by their pain. While struggles are significant and the pain is undeniably real, it does not encompass the entirety of a person’s value or identity. Accepting pain as a temporary (though potentially long-lasting) passenger rather than the driver of one’s life is a crucial factor in resilience, particularly for those facing chronic challenges.

This psychological shift requires a high degree of metacognition—the ability to reflect on one’s own thoughts. It involves observing feelings of being “shattered” with curiosity rather than judgment. When we stop resisting the fact that we are hurting, we free up the energy previously spent on suppression. That energy can then be redirected toward the “process of adapting” that the APA describes.

Ultimately, the most resilient individuals are often not those who appear to have it all together. Instead, they are the ones who have faced the depths of despair, who have sat amidst the ruins of their expectations, and who have learned that their worth is independent of their circumstances. They understand that true strength is not about never falling down; it is about having the courage to feel the impact of the fall and rising again with a deeper understanding of who they are.

According to GlobalNetNews.

UCLA Student Sohum Bhargava Promotes Kidney Health Awareness Through Origami

UCLA student Sohum Bhargava’s origami exhibition at the Cerritos Public Library aims to raise awareness about kidney health through art and education during Kidney Awareness Month.

CERRITOS, CA – Visitors to the Cerritos Public Library this month are experiencing a unique fusion of art, science, and public health. The exhibition, titled “Fold for Life,” features an array of paper cranes, geometric structures, and intricate folded forms, creating a space that serves as both gallery and classroom. Curated by UCLA student Sohum Bhargava, the exhibit runs through March 31 in honor of Kidney Awareness Month.

Bhargava’s exhibition explores a fascinating concept: the process of folding paper can reflect how organs develop within the human body. His inspiration stemmed from learning that three sets of kidneys form during early human development, with the first two existing only briefly before the final, permanent kidneys take shape.

While practicing origami, Bhargava recognized a compelling parallel. The creation of a finished origami model involves numerous folds that are crucial to its structure yet become invisible once the piece is complete. Similarly, the early stages of kidney development are hidden but essential in shaping the final organ.

This connection prompted Bhargava to ponder a broader question: if folding is integral to both art and biology, could origami provide a novel perspective for scientists studying organ formation? Researchers are already cultivating miniature kidney organoids from stem cells in laboratories. Bhargava believes that understanding the mechanics of folding in nature could enhance scientific approaches to organ development and potentially address the ongoing shortage of kidneys available for transplant.

However, the exhibition transcends mere scientific inquiry. Bhargava aims to foster discussions about a disease that often remains concealed until it reaches advanced stages. Kidney disease affects over 37 million Americans and is frequently characterized as a silent condition, with symptoms typically surfacing only after significant progression.

“Many people feel uncomfortable discussing disease,” Bhargava notes through the exhibition’s messaging. By presenting information through art, he hopes to create an environment where visitors feel more inclined to learn about kidney health and engage in conversations with family members.

One of the exhibition’s most impactful pieces is a large modular origami installation, collaboratively created with patients and caregivers from the Connie Frank Kidney Transplant Center at UCLA. Participants folded individual units, which Bhargava later assembled into a cohesive sculpture. This finished piece symbolizes the shared journey of illness, recovery, and support that characterizes organ transplantation.

In addition to the collaborative work, the exhibit showcases several single-sheet origami pieces that highlight the complexity and beauty achievable with simple materials. Accompanying the artwork are educational posters that detail the stages of kidney disease, early warning signs, and the medical tests used for detection.

The exhibition also features a wearable art piece: a scarf designed by Bhargava and hand-embroidered by artisans in India. The fabric incorporates subtle kidney motifs woven into a floral pattern, merging cultural craftsmanship with the exhibition’s health message.

Throughout the display, visitors will encounter accessible explanations of kidney structure and function, the stages of kidney disease, and the most common risk factors. Diabetes and hypertension, both increasingly prevalent among Indian Americans and other communities, remain leading causes of kidney failure. Medical professionals emphasize that two relatively simple tests can often detect kidney issues early, potentially preventing the need for dialysis if intervention occurs promptly.

Bhargava, who serves on the board of the Bruin Beans Health Club at UCLA, has organized a kidney health awareness exhibit at the Cerritos library for the past five years. Each March, the display aims to make medical education engaging for visitors of all ages.

The exhibit has garnered attention from community leaders and elected officials, with many already visiting and others planning to do so.

Ultimately, “Fold for Life” invites visitors to view both art and health through a new lens. Through the medium of folded paper, collaborative storytelling, and accessible information, Bhargava aspires to inspire conversations that could lead to a simple yet powerful outcome: earlier testing, increased awareness, and healthier lives.

According to India-West.

Neeraj Sood Connects Global Health Economics with Campus Civil Discourse

Neeraj Sood, an Indian American health policy expert, leads a new initiative at USC aimed at fostering civil discourse and open-minded engagement among students and faculty.

Neeraj Sood, an Indian American professor and health policy expert, is redefining the concept of the “marketplace of ideas” at the University of Southern California (USC). For Sood, this notion transcends academic metaphor; it embodies a space that demands rigorous evidence and respectful inquiry, principles he has long applied to global health policy.

As the founding director of the USC Open Dialogue Project, Sood is addressing one of the most pressing challenges in higher education today: the erosion of civil discourse. His multifaceted career includes appointments at the USC Price School of Public Policy, the Keck School of Medicine, and the Marshall School of Business, where he has consistently challenged conventional wisdom.

Whether he is investigating pharmaceutical markets or examining childhood illness in India, Sood’s hallmark is high-impact research that influences real-world decision-makers. Now, as a special advisor to the university president, he is helping faculty and students navigate the “know-do gap” in modern communication.

During the project’s inaugural event, Sood articulated his vision with three key expectations: “Let go of winning. Be curious and open-minded. Focus on the ideas, not the people.” These principles reflect his belief that intellectual courage is essential for the pursuit of truth.

Under Sood’s leadership, the Open Dialogue Project has launched a variety of programs, including “Speak Free USC” and “Difficult Conversations” workshops. These initiatives provide practical tools for instructors and students to engage with polarizing topics such as gun control and healthcare, fostering an environment where discussions can occur without fear of personal attack or reprisal.

Sood’s transition from a leading health economist to a champion of campus dialogue underscores his broader commitment to societal health. He believes that a community’s ability to disagree respectfully is a vital indicator of its institutional strength.

To further this mission, Sood has integrated a new Student Advisory Board into the project, ensuring that the next generation of leaders is actively involved in co-designing a culture where divergent viewpoints are seen as a strength rather than a threat. “I think [respectful disagreement] makes us a better kind of community,” he noted, emphasizing that the goal is not necessarily to reach a consensus but to restore the spirit of compromise.

In doing so, Sood is positioning USC as a global model for how universities can transform abstract principles of free expression into a daily practice. His work is a testament to the power of dialogue in fostering understanding and collaboration in an increasingly polarized world.

This initiative not only aims to enhance the educational experience at USC but also seeks to inspire other institutions to adopt similar approaches. By prioritizing civil discourse, Sood hopes to cultivate an environment where students and faculty can engage in meaningful conversations that contribute to their personal and intellectual growth.

As the Open Dialogue Project continues to evolve, it stands as a beacon for those who believe in the importance of open-minded engagement and the necessity of civil discourse in academia and beyond. According to The American Bazaar, Sood’s efforts are paving the way for a more inclusive and respectful dialogue within the university setting.

Breakthrough Test Identifies Dementia Risk Up to 25 Years Early

A groundbreaking blood test could identify dementia risk in women up to 25 years before symptoms appear, according to research from the University of California San Diego.

Researchers from the University of California San Diego have developed a blood test that may determine a woman’s risk of developing dementia as early as 25 years before any symptoms manifest. This promising finding centers on a specific biomarker protein associated with the early pathological processes of Alzheimer’s disease, known as phosphorylated tau 217 (p-tau217).

The study analyzed blood samples from 2,766 participants in the Women’s Health Initiative Memory Study, conducted in the late 1990s. The participants, aged between 65 and 79, exhibited no signs of cognitive decline at the study’s outset. Over a follow-up period of up to 25 years, researchers found a strong association between elevated levels of p-tau217 and future instances of mild cognitive impairment and dementia.

Women with higher levels of p-tau217 at the beginning of the study were significantly more likely to develop dementia later on. The findings were published in JAMA Network Open, highlighting the potential for early detection of dementia risk through a simple blood test.

“The key takeaway is that our study suggests it may be possible to detect risk of dementia two decades in advance using a simple blood test in older women,” said Aladdin H. Shadyab, the study’s first author and an associate professor of public health and medicine at UC San Diego. “Our findings show that the blood biomarker p-tau217 could help identify individuals at higher risk for dementia long before symptoms begin.”

This early detection could pave the way for preventive strategies and targeted monitoring, allowing for interventions before memory issues disrupt daily life. Shadyab emphasized that as research progresses, these biomarkers could help pinpoint individuals at the greatest risk and inform strategies to delay or prevent dementia.

However, the relationship between p-tau217 levels and dementia risk was not uniform across all demographics. The study indicated that women over 70 with elevated p-tau217 levels experienced poorer cognitive outcomes compared to their younger counterparts. Additionally, those with the APOE ε4 gene, a known risk factor for Alzheimer’s disease, also showed a stronger correlation between p-tau217 levels and cognitive decline.

Interestingly, the study revealed that p-tau217 was a more significant predictor of dementia in women who were randomly assigned to receive estrogen and progestin hormone therapy, compared to those who received a placebo. This finding suggests that hormonal factors may play a role in the relationship between p-tau217 levels and dementia risk.

Senior author Linda K. McEvoy, a senior investigator at Kaiser Permanente Washington Health Research Institute and professor emeritus at the Herbert Wertheim School of Public Health, noted the advantages of blood-based biomarkers like p-tau217. “Blood-based biomarkers like p-tau217 are especially promising because they are far less invasive and potentially more accessible than brain imaging or spinal fluid tests,” she explained. “This is important for accelerating research into the factors that affect the risk of dementia and for evaluating strategies that may reduce risk.”

Despite the promising nature of these findings, Shadyab cautioned that blood tests for Alzheimer’s disease are still under investigation and are not yet recommended for routine screening in asymptomatic individuals. Further research is necessary before this approach can be considered for clinical use prior to the onset of cognitive symptoms.

Future studies should explore how various factors, including genetics, hormone therapy, and age-related medical conditions, may interact with plasma p-tau217 levels. Shadyab also pointed out that the study focused exclusively on older women, indicating that the findings may not be applicable to men or younger populations. Additionally, the research examined overall dementia outcomes rather than specific subtypes, such as Alzheimer’s disease.

As the understanding of dementia risk factors evolves, the potential for early detection through blood tests like p-tau217 may revolutionize the approach to managing and preventing this debilitating condition.

According to Fox News Digital, the implications of this research could significantly impact future dementia prevention strategies.

Android Addresses 129 Security Vulnerabilities in Major Update

Google’s latest Android update addresses 129 security vulnerabilities, including a zero-day flaw linked to Qualcomm chips that has already been exploited in targeted attacks.

Google has rolled out a significant Android update that fixes a total of 129 vulnerabilities, including a critical zero-day flaw associated with Qualcomm chips that has already been exploited in attacks.

For many users, Android security updates often go unnoticed until a headline like this emerges. Suddenly, the device used for messaging, banking, and work becomes part of a broader cybersecurity narrative. This week, Google’s latest Android security updates have highlighted the importance of timely software maintenance.

Among the vulnerabilities addressed, one particular flaw has caught the attention of security researchers. Tracked as CVE-2026-21385, this zero-day vulnerability is concerning because it has already been utilized in targeted attacks. Attackers discovered this flaw before many devices had received a fix, which poses a significant risk to users.

The issue is linked to the graphics processing component in many Qualcomm chipsets. Specifically, it involves an integer overflow, a type of calculation error that can lead to memory corruption within the system. Once this occurs, attackers may gain unauthorized access to the device.

Qualcomm has indicated that this flaw affects 235 different chipsets, meaning a wide range of Android phones could potentially be impacted. Google’s Threat Analysis Group identified the issue and reported it through coordinated disclosure practices, prompting Qualcomm to collaborate with device manufacturers to implement necessary patches.

The implications of this Android security vulnerability are serious. Several of the patched vulnerabilities allow attackers to execute code remotely or gain elevated privileges on a device. One particular flaw within the Android System component is especially alarming, as it could enable remote code execution without any user interaction. This means an attacker could exploit the flaw without requiring the victim to click a link or install an app, making it one of the most dangerous types of vulnerabilities.

The March Android security bulletin addresses ten critical flaws across the System, Framework, and Kernel components. These core components are essential to Android’s functionality, so any weaknesses can have widespread repercussions across millions of devices.

Google has released two patch levels for this update. The second update encompasses everything in the first, in addition to fixes for extra hardware components and third-party software. Google Pixel devices typically receive updates immediately, while many other Android users may experience delays.

Phone manufacturers such as Samsung, Motorola, and OnePlus often need to test the patches before they are released for specific models. Additionally, carriers may delay updates to ensure compatibility. Consequently, some users receive security patches promptly, while others may have to wait weeks.

To protect your Android phone from security threats, there are several proactive steps you can take. First, install Android updates as soon as they become available. Regularly check for updates by navigating to Settings, tapping on Security and Privacy or Software Update, and selecting Check for Updates.

Second, avoid downloading apps from unknown sources. Stick to trusted stores like Google Play, as third-party app stores can pose a higher risk of malware.

Third, keep Google Play Protect enabled. This built-in malware protection scans apps for malicious behavior and alerts you to any suspicious activity. However, it is important to note that Google Play Protect is not infallible. Therefore, consider using robust antivirus software for an additional layer of protection.

Additionally, set a strong passcode on your phone and enable fingerprint or face unlock features if available. This helps safeguard your device in case it is lost or stolen. Lastly, exercise caution with suspicious links, as many attacks begin with phishing messages. Avoid clicking on unknown links in texts, emails, or social media messages.

This recent Android update underscores the complexities of modern mobile security. Google’s Threat Analysis Group frequently uncovers vulnerabilities that may already be exploited in real-world scenarios. These findings trigger coordinated responses involving chip manufacturers, device makers, and security researchers. In this instance, Qualcomm received the report in December and provided fixes to device manufacturers in early 2026.

While the process may appear slow from the outside, it involves numerous companies collaborating to prevent widespread exploitation. Security updates may not seem exciting, but they are crucial for protecting billions of smartphones globally.

This latest Android update serves as a stark reminder of the importance of timely software updates. A zero-day flaw linked to Qualcomm graphics hardware was already being targeted before many users were even aware of its existence. Installing updates promptly is one of the simplest yet most effective ways to protect your device and personal data.

So, the next time your Android device prompts you to install a security patch, consider this: Do you install it immediately, or do you tap “remind me later”?

For further information, consult CyberGuy.com.

Dr. Oz Advocates for Changes to ACA Amid Enrollment Concerns

Dr. Mehmet Oz, head of the Centers for Medicare and Medicaid Services, indicates a significant reduction in Affordable Care Act enrollment, citing millions of improper enrollments as the rationale for aggressive audits.

Dr. Mehmet Oz, the Administrator for the Centers for Medicare and Medicaid Services (CMS), has raised concerns about the integrity of the Affordable Care Act (ACA), claiming that the current enrollment figures are inflated by millions of fraudulent or ineligible participants. In a recent interview, Oz suggested that the ACA is burdened by an excess of “improper” enrollments, signaling a shift in federal health policy that may lead to a substantial reduction in the program’s scope.

Oz’s assertion comes at a time when the ACA reports approximately 23 million participants. He argues that this figure is “too high” and should more accurately reflect around 19 million enrollees. This implies that nearly four million individuals currently benefiting from subsidized health care could soon be subject to federal eligibility audits.

“In fact, the fact that we have 23 million makes me think we have too many participants in the ACA,” Oz stated. This stance emerges as open enrollment data for the current year indicates a decline of approximately 1.2 to 1.3 million sign-ups compared to the previous year. This decrease is largely attributed to the expiration of enhanced federal tax credits that had previously shielded low-income families from escalating premiums.

The administration’s rationale for reducing ACA enrollment is supported by a report from the Paragon Health Institute, a conservative think tank. This report estimates that up to five million individuals may be improperly enrolled in subsidized plans for 2024, with potential costs to taxpayers reaching up to $20 billion due to these errors.

Dr. Oz elaborated on various scenarios contributing to this fiscal leakage, including cases where individuals inaccurately report their income—either overstating it to qualify for subsidies or understating it to maximize credits. He also pointed out instances of “duplicate” enrollments, where individuals are simultaneously covered by Medicaid or by plans in multiple states. Additionally, some participants may have access to employer-sponsored insurance but opt for subsidized ACA plans instead, a choice that is prohibited if the employer’s offer is deemed “affordable” under federal guidelines.

“Either their income would not qualify them, they made too much or made too little, or they didn’t file the forms, maybe on purpose,” Oz explained, emphasizing the administration’s concerns.

In response to these issues, the administration has already implemented measures to shorten the open enrollment period and tighten income verification requirements. Critics, however, argue that these so-called “integrity” measures effectively create barriers to entry, suppressing enrollment through bureaucratic obstacles.

While Dr. Oz frames the crackdown as a necessary cleanup of “fraud, waste, and abuse,” nonpartisan health policy experts have expressed skepticism regarding the administration’s claims. They caution that there is a significant difference between “bookkeeping errors” and “criminal fraud,” suggesting that the administration may be conflating the two to advance a broader political agenda.

Cynthia Cox, director of the program on the ACA at KFF, noted that while fraud is indeed a concern in any large-scale government program, the scale described by Dr. Oz lacks substantial evidence. She estimated that while there are likely a few hundred thousand questionable enrollments, the figure of five million is an extreme outlier. “The scale of it may be overstated at times,” she remarked, indicating that most participants are legitimately seeking coverage in a complex system.

Richard Frank, a senior fellow at the Brookings Institution, further criticized the administration’s figures as “implausible.” He argued that what CMS leadership characterizes as fraud often stems from shifting life circumstances, such as mid-year income changes or relocations between states. He warned that labeling these situations as fraudulent could disenfranchise eligible Americans who may not have the necessary documentation to prove their status on short notice.

The push to reduce ACA enrollment is occurring alongside a broader strategy by the administration. Recently, Vice President JD Vance and Dr. Oz withheld $259 million in Medicaid funding from Minnesota, citing widespread fraud. This action was condemned by Democratic lawmakers as a punitive measure against a blue state, but for the administration, it serves as a model for a national strategy.

Simultaneously, the administration is attempting to attract a different demographic: young, healthy, and currently uninsured Americans. This strategy involves promoting high-deductible, low-premium plans. The rationale is clear: by bringing “young invincibles” into the risk pool, the overall cost of the marketplace could stabilize. However, this creates a paradox where the administration is aggressively pushing some individuals out through audits while simultaneously inviting others in with the promise of cheaper, albeit less comprehensive, coverage.

For millions of self-employed Americans and small business owners who rely on the ACA, the coming months are likely to be marked by increased scrutiny and rising costs. With double-digit premium increases already affecting many markets following the lapse of congressional tax credits, the prospect of aggressive federal audits adds another layer of uncertainty to a system already under significant financial strain.

As the administration moves forward with its plans, the implications for the ACA and its enrollees remain to be seen, raising questions about the future of health care coverage in the United States.

According to GlobalNetNews.

Stanford Researcher Sayantani Sindher Investigates New Treatments for Food Allergies

Indian American pediatric allergist Sayantani Sindher is dedicated to improving the lives of children with food allergies through innovative research and treatment options.

Living with food allergies significantly impacts quality of life, affecting family dynamics and mental health. Indian American pediatric allergist Sayantani Sindher emphasizes that the daily stress associated with managing food allergies drives her commitment to advancing food allergy care.

“Food allergies affect 8 to 10% of the U.S. population, so classrooms often have multiple children navigating them,” says Sindher, who serves as a clinical associate professor of medicine and pediatrics and directs the Clinical Translational Research Unit at Stanford University’s Sean N. Parker Centre for Allergy and Asthma Research.

“We worry about food allergies because accidental exposure can cause severe symptoms, even death,” she notes in a recent piece for Stanford’s “Research Matters” series, which highlights the work of Stanford scientists and its potential to advance human health. “However, living with food allergies has a greater quality-of-life toll. Constant vigilance around food can lead to chronic stress and anxiety. Treatment options can help mitigate these effects.”

<pSindher’s primary goal is to improve the lives of children with food allergies and their families. She envisions better guidelines for preventing food allergies and immediate treatment options upon diagnosis in the future.

Early intervention is crucial, as younger immune systems are more responsive to treatment. Sindher discusses an ongoing clinical trial involving babies under two months old with eczema or severe dry skin. Early eczema has been linked to food allergies, and the hope is that treating eczema and minimizing skin damage early will reduce the likelihood of developing food allergies later.

Her research focuses on improving food allergy diagnosis and treatment monitoring. Sindher points out that traditional methods like skin prick testing and blood work are often unreliable. These tests cannot accurately assess symptom severity, have a high false positive rate, and do not effectively monitor treatment outcomes.

“So, we often give allergic individuals the food they’re allergic to and observe their reactions to confirm allergies or treatment response,” writes Sindher. “We’re also exploring better treatment options.”

Initially, food allergy treatment involved strict avoidance of allergens. However, accidental exposures can still occur. Oral immunotherapy, which was approved in 2020, involves administering daily small amounts of the allergen to desensitize the body. While promising, it is not suitable for everyone, carries a risk of reactions, can cause food aversion, and necessitates lifestyle modifications such as adjusting exercise and meal plans.

In a recent trial, Sindher’s team discovered that the injectable medication omalizumab reduces the risk of allergic reactions. This medication is now FDA-approved for children aged one year and older, either as a standalone treatment or in conjunction with oral immunotherapy.

The injection must be administered every two to four weeks to prevent the body from reverting to its allergic state. However, for children with severe food allergies, it has proven to be life-changing. “Patients express relief when they can enjoy ice cream with friends or travel abroad without fear of their child’s allergies,” she notes.

While omalizumab is effective for many, it does not work for everyone, and some children are needle-phobic. Sindher mentions that new drugs and interventions are being developed to lessen the burden on patients. Sublingual immunotherapy, which has fewer side effects than oral immunotherapy, as well as a peanut patch and less-frequent injection options, are currently being explored.

In another study, her lab is conducting food challenges with individuals prescribed omalizumab, both at the start of treatment and six months later, while collecting blood samples to identify biomarkers that indicate medication effectiveness.

“We’re also conducting quality of life surveys and burden of treatment assessments to better understand how to help patients safely consume food and reduce stress in their daily lives,” Sindher adds.

Allergy immunology is unique in that it involves treating the entire family, including parents, children, and siblings. “It’s like an old-timey doctor who knows everything about the family, from their vacations to their pets,” she explains.

“My research allows me to see them every two weeks, fostering a deep bond,” writes Sindher. “I bridge the gap between research and clinical practice, using patient insights to inform my work and making informed decisions for families.”

According to Stanford University, Sindher’s work is paving the way for innovative solutions in food allergy treatment, ultimately aiming to enhance the quality of life for affected families.

Scientists Discover Factor Influencing Brain Health and Alzheimer’s Risk

Researchers have identified a subtle factor that may significantly affect brain health and increase the risk of Alzheimer’s disease.

Recent studies have uncovered a previously overlooked factor that could play a crucial role in brain health and the development of Alzheimer’s disease. This discovery has significant implications for understanding the complexities of cognitive decline and the risk factors associated with neurodegenerative disorders.

Alzheimer’s disease, a progressive neurological disorder, is characterized by memory loss, cognitive decline, and changes in behavior. It is the most common form of dementia, affecting millions of individuals worldwide. As the global population ages, the urgency to identify risk factors and potential preventative measures has never been greater.

The new research highlights the importance of examining not only genetic predispositions but also environmental and lifestyle factors that may contribute to brain health. Scientists have long recognized that a combination of genetics, lifestyle choices, and environmental influences can impact the likelihood of developing Alzheimer’s. However, this recent study sheds light on a specific factor that has been less understood.

While the details of the factor itself remain under investigation, researchers emphasize the need for a holistic approach to brain health. This includes maintaining a healthy diet, engaging in regular physical activity, and fostering social connections, all of which have been shown to support cognitive function.

The findings suggest that even subtle changes in daily habits or environmental exposures could have a significant impact on brain health over time. As researchers continue to explore the mechanisms behind this factor, there is hope that new strategies for prevention and intervention can be developed.

Understanding the interplay between various risk factors is essential for developing effective treatments and preventative measures for Alzheimer’s disease. The ongoing research aims to provide clearer insights into how this sneaky factor influences brain health and contributes to the onset of Alzheimer’s.

As the scientific community delves deeper into this topic, it is crucial for individuals to remain informed about the potential risks associated with brain health. Staying proactive about cognitive wellness may help mitigate the effects of this newly identified factor.

In conclusion, the discovery of this sneaky factor marks a significant step forward in the quest to understand Alzheimer’s disease and its risk factors. Continued research in this area will be vital for developing effective strategies to combat this debilitating condition.

According to GlobalNetNews, the implications of these findings could reshape how we approach brain health and Alzheimer’s prevention in the future.

Indian-American Jayesh Mishra Faces High Bills Despite Co-Pay Card

Jayesh Mishra, a California resident, faced unexpected medical bills for his psoriatic arthritis treatment despite relying on a co-pay card, highlighting the complexities of pharmaceutical assistance programs.

In 2025, Jayesh Mishra, a resident of Mission Viejo, California, began experiencing scaly, itchy red patches on his skin. This was soon accompanied by painful swelling in the joints of his hands, making it increasingly difficult for him to perform his job at a bank.

After consulting his primary care physician, Mishra was referred to a rheumatologist, who diagnosed him with psoriatic arthritis. Although there is no cure for the condition, the doctor informed him that several new medications could effectively manage the autoimmune disease. She recommended Otezla, a medication specifically approved for treating psoriatic arthritis.

Initially, Mishra hesitated to start the treatment due to concerns about the high cost of the medication and potential side effects. He thought he could manage his symptoms with over-the-counter drugs. However, by September, the pain had become unbearable, prompting him to accept a starter pack provided by Otezla’s manufacturer, Amgen. The medication proved effective, alleviating both his skin lesions and joint pain, which had been disrupting his sleep.

With the support of his rheumatologist, Mishra obtained approval for Otezla from his insurer, UnitedHealthcare, and enrolled in Amgen’s copayment assistance program. His doctor assured him that the co-pay card, which functions similarly to a credit card, would cover a significant portion of the medication’s high list price—approximately $5,000 for a 30-day supply, as reported by GoodRx.

Mishra was informed that the copay card would cover up to $9,450 annually, leading him to feel relieved. “I was happy when I got the message,” he recalled, noting that his doctor had reassured him, saying, “You shouldn’t have to pay anything out-of-pocket. Your copay card will cover this.”

Initially, Mishra paid nothing for his medication. However, that changed when he received his second bill.

For the second month’s supply of Otezla, Mishra was billed $441.02. Faced with the reality of his copay card being depleted, he chose to ration his medication rather than refill his prescription. The insurance statement from UnitedHealthcare’s pharmacy benefit manager, Optum Rx, revealed that it had not provided a negotiated discount, covering only $308.34 of the total charge of $5,253.85 for a 30-day supply. This left Mishra responsible for the remaining balance.

The situation reflects a broader issue within the healthcare system, where copay assistance programs often create a “tug-of-war” between drug manufacturers and insurers, according to Aaron Kesselheim, a professor of medicine at Harvard Medical School. As insurers increasingly restrict the use of copay cards, their value has become less predictable. Many insurance plans do not count the funds from copay programs toward a patient’s deductible, leaving patients vulnerable to high out-of-pocket costs.

“When you purchased your medication, a Manufacturer Coupon was used,” Mishra’s explanation of benefits statements noted in small print. It further stated that the amount covered by the copay card “was not applied towards your Deductible and Out of Pocket Maximum.”

Caroline Landree, a spokesperson for UnitedHealthcare, clarified that “the copay card is an arrangement between the patient and the pharmacy. It is used outside of insurance.”

In contrast, Elissa Snook, a spokesperson for Amgen, emphasized that copay assistance programs are intended to help patients initiate and maintain their prescribed therapies. However, she acknowledged that the value of this assistance can diminish quickly when health plans require patients to pay the full list price of a medication.

In the United States, the list prices for brand-name drugs can be prohibitively high, making it difficult for many patients to afford necessary medications. Insurers often negotiate discounts through pharmacy benefit managers, which can lead to significant savings for patients. However, copay assistance programs can complicate this dynamic, as they may encourage patients to opt for more expensive brand-name drugs instead of exploring cheaper alternatives.

Despite the availability of a generic version of Otezla since 2021, Amgen has taken legal action to block U.S. sales of its generic competitors, ensuring the brand-name drug remains protected by patent until 2028. In other countries, including Canada, patients can often purchase Otezla for significantly less, sometimes under $100 a month.

Mishra humorously noted that one of his children suggested he could fund a trip to visit relatives in India simply by purchasing his medication while there.

As the months progressed, Mishra faced mounting challenges with his health plan, which included a $5,000 deductible and a tax-free health savings account (HSA). After using the copay card for his first month’s supply of Otezla, he found that the card was depleted after the second month. He resorted to using his HSA to cover the remaining balance of approximately $400.

Concerned about the costs for subsequent months, Mishra began rationing his medication, skipping doses to extend his supply. Unfortunately, this led to a resurgence of his symptoms. In January, he received another copay card, again valued at $9,450, but it still fell short of covering the full cost of his medication. He again used his HSA to pay the remaining balance, which amounted to $550.

As his symptoms improved, Mishra contacted UnitedHealthcare in late February to inquire about the cost for March’s supply. He was informed that he would need to pay $4,450 to meet his out-of-pocket maximum. Upon further inquiry, he learned that the actual price was $6,995.36.

Mishra’s experience underscores the complexities and challenges associated with copay cards and pharmaceutical assistance programs. While these programs can provide crucial support for patients, they often come with unexpected limitations and costs. As Mishra aptly put it, “Personally, I’m not in financial distress—I can afford it. But it was sticker shock, and it just doesn’t seem right.”

This case highlights the need for patients to thoroughly understand their insurance plans and the implications of using copay cards, as well as the importance of discussing medication options with healthcare providers.

According to KFF Health News, Mishra’s story is part of a larger investigation into medical billing practices and the challenges faced by patients in navigating the healthcare system.

Cannabis Compounds Show Potential to Reverse Disease in Adults

Compounds in cannabis, particularly cannabidiol (CBD) and cannabigerol (CBG), may offer new treatment options for metabolic dysfunction-associated steatotic liver disease, a common chronic liver condition affecting many adults worldwide.

Research from the Hebrew University of Jerusalem suggests that compounds found in cannabis could pave the way for innovative treatments for the world’s most prevalent chronic liver disorder. The study, published in the British Journal of Pharmacology, highlights the potential of cannabidiol (CBD) and cannabigerol (CBG) in reducing liver fat and enhancing metabolic health in experimental models.

CBD is the more extensively researched non-intoxicating cannabinoid, while CBG serves as a precursor cannabinoid from which CBD is derived. Unlike THC, the primary psychoactive component of cannabis, both CBD and CBG do not induce a “high,” making them promising candidates for long-term medical applications.

Metabolic dysfunction-associated steatotic liver disease (MASLD) currently impacts approximately one-third of the global adult population, as indicated by health data. This condition is closely associated with obesity and insulin resistance, yet there are few approved pharmaceutical treatments available. Consequently, patients often rely on challenging lifestyle changes to manage their condition.

Lead study author Joseph Tam, director of the Multidisciplinary Center for Cannabinoid Research at Hebrew University, stated, “Our findings identify a new mechanism by which CBD and CBG enhance hepatic energy and lysosomal function.”

The research emphasizes a process known as “metabolic remodeling,” where the cannabis compounds create a “backup battery” for the liver by increasing levels of phosphocreatine, a high-energy molecule stored in muscle cells. This energy reserve enables the liver to function more effectively under the stress of a high-fat diet, an unexpected finding noted by the research team.

Additionally, the study revealed that CBD and CBG restored the activity of “cellular cleaning crews,” known as cathepsins. These enzymes operate within the cell’s recycling centers to break down harmful fats and waste. As a result, the liver became more adept at clearing dangerous lipids, including triglycerides and ceramides, which are known to cause inflammation.

While both CBD and CBG demonstrated effectiveness, CBG yielded more pronounced results in specific areas, such as reducing total body fat mass, lowering “bad” LDL cholesterol, and improving insulin sensitivity. The researchers believe this study opens new avenues for utilizing plant-based compounds to treat metabolic diseases by focusing on cellular energy management and waste disposal.

Despite these promising findings, the research team cautioned that the study was conducted in a controlled experimental setting. Further clinical trials are essential to ascertain the appropriate application of these compounds for human patients.

Recent studies have also raised concerns regarding the use of cannabis as a medical treatment. A major analysis published in JAMA examined over 2,500 scientific papers from the past 15 years, including reviews, clinical trials, and guidelines related to medical marijuana. This review underscored significant discrepancies between public perception and scientific evidence regarding the effectiveness of cannabis for various medical conditions.

The researchers concluded that only a limited number of conditions have clear, well-established benefits from cannabinoid therapies supported by high-quality clinical data. “Whenever a substance is widely used, there is likely to be a very wide set of outcomes,” noted Dr. Alex Dimitriu, who is double board-certified in psychiatry and sleep medicine. He emphasized that this study illustrates the reality that cannabis is not a universal remedy.

The strongest evidence currently supports FDA-approved cannabinoid medications for treating specific conditions, including appetite loss related to HIV/AIDS, chemotherapy-induced nausea and vomiting, and certain severe pediatric seizure disorders.

Individuals interested in exploring marijuana for medical purposes are encouraged to consult with a healthcare provider to discuss potential risks and benefits, ensuring informed decision-making regarding their health.

According to Fox News, the implications of this research could significantly impact the future treatment landscape for liver diseases.

Ancient Herb Dubbed ‘Nature’s Valium’ Promises Better Sleep and Reduced Anxiety

Experts discuss valerian root, often dubbed “nature’s Valium,” highlighting its potential benefits for sleep and anxiety while cautioning against misleading comparisons to the prescription sedative.

Valerian root, an herbal supplement known for its calming properties, has gained popularity as “nature’s Valium.” However, experts express caution regarding this comparison, suggesting it may mislead users about the herb’s effectiveness and safety.

Valerian, derived from the roots of the Valeriana officinalis plant, has been used for centuries to promote relaxation and improve sleep quality. This flowering plant is native to Europe and Asia but has also become established in parts of northeastern America, according to the American Botanical Council (ABC).

The herb has a long history of medicinal use, primarily aimed at alleviating anxiety and stress, as well as enhancing sleep. Historically, valerian has also been utilized for treating migraines, fatigue, and stomach cramps. It can be consumed in various forms, including teas, tinctures, capsules, and tablets, as noted by the National Institutes of Health (NIH).

Despite its widespread use, the NIH points out that research on valerian’s efficacy is relatively limited. However, some clinical trials have investigated its effects. Stefan Gafner, Ph.D., chief science officer of the American Botanical Council, noted that a 2020 review published in the Journal of Evidence-Based Integrative Medicine found both powdered root and root extracts to provide a “clear” benefit in treating anxiety.

Gafner emphasized that valerian could be a “safe and effective herb to promote sleep and prevent associated disorders.” However, he cautioned against equating valerian with diazepam, the active ingredient in Valium. “While both are used to relieve anxiety, valerian is a much milder ingredient, primarily suited for mild cases of anxiety and sleep issues,” he explained.

Unlike valerian, diazepam carries a risk of dependence and is typically prescribed for short-term use. The potential adverse effects associated with diazepam are also significantly different from those of valerian. Gafner expressed his support for valerian root as a remedy for anxiety and stress, stating, “I have used it myself and believe it’s an ingredient with well-documented benefits, especially for people with problems falling asleep.” He added that valerian is generally well-tolerated but advised caution when operating heavy machinery or driving after use.

Dr. Joseph Mercola, a board-certified family medicine physician and author, also weighed in on the topic. He cautioned that the comparisons between valerian and Valium may “exaggerate what the science actually shows.” Mercola explained that valerian root contains compounds that may enhance calming brain chemicals, particularly the neurotransmitter GABA, which helps to reduce nerve activity and promote relaxation.

While some studies indicate modest improvements in sleep quality or reduced time to fall asleep, others have found no significant difference compared to a placebo. Mercola highlighted potential side effects of valerian, including headaches, dizziness, digestive upset, and next-day grogginess. He advised against using valerian as a primary strategy for managing anxiety, stress, or sleep issues.

Mercola emphasized the importance of addressing the underlying causes of poor sleep rather than relying solely on herbal sedatives. “When you fix those foundations, you often find that you no longer need an herbal sedative at all,” he stated. He recommended lifestyle changes, such as exposure to bright sunlight during the day to regulate circadian rhythms and promote melatonin production at night.

Additionally, Mercola suggested that complete darkness at night supports the hormonal signals necessary for deep, restorative sleep. He also noted that certain nutrients, such as magnesium, can help regulate the nervous system and promote relaxation.

In conclusion, while valerian root may offer some benefits for sleep and anxiety, experts urge caution in its use and advise individuals to consider a holistic approach to improving sleep quality. By focusing on lifestyle adjustments and addressing the root causes of sleep disturbances, individuals may find more effective and sustainable solutions.

Fox News Digital reached out to valerian root manufacturers for comment on this topic.

According to Fox News Digital, the discussion surrounding valerian root highlights the need for careful consideration when exploring herbal remedies for anxiety and sleep issues.

Indian National Sentenced to 43 Months for Selling Fake Cancer Drugs

A 45-year-old Indian national has been sentenced to 43 months in prison for selling counterfeit cancer medications, highlighting a serious threat to vulnerable patients.

Sanjay Kumar, a 45-year-old Indian national, has been sentenced to 43 months in prison for his role in a scheme to sell counterfeit cancer medications worth tens of thousands of dollars. This fraudulent operation, which Kumar privately referred to as “just water,” came to a close last week in a Houston court, where he was also ordered to serve one year of supervised release following his prison term.

The sentencing follows Kumar’s guilty plea last year to conspiracy to traffic in counterfeit goods. This charge underscores a chilling disregard for the lives of patients battling serious illnesses.

Between August 2018 and June 2024, Kumar and his associates orchestrated the sale of what they falsely claimed was Keytruda, a vital immunotherapy drug manufactured by Merck Sharp & Dohme LLC. However, the vials sold by Kumar were dangerous imitations, lacking any active ingredients necessary for effective treatment. Keytruda is a critical medication for patients diagnosed with advanced melanoma, lung cancer, and several other aggressive cancers.

The investigation, conducted by Homeland Security Investigations and the Food and Drug Administration, revealed that the substances Kumar distributed were chemically inconsistent with the legitimate medication. Laboratory tests confirmed that the vials contained no active ingredients, rendering them completely ineffective against the diseases they were purported to treat.

Undercover federal agents ultimately apprehended Kumar after purchasing approximately $89,000 worth of the counterfeit drug. During a meeting in Houston prior to his arrest, Kumar reportedly acknowledged the risks posed by his products, admitting to agents that the counterfeit Keytruda would not treat cancer and callously comparing it to plain water.

Federal prosecutors emphasized the severity of Kumar’s actions, stating, “The defendant’s actions were not just a violation of intellectual property; they were a direct assault on the hope of vulnerable patients.”

The case was prosecuted by the Justice Department’s Computer Crime and Intellectual Property Section (CCIPS) in conjunction with the U.S. Attorney’s Office for the Southern District of Texas. Officials highlighted that this sentence serves as a warning to international traffickers who exploit the American healthcare system for fraudulent purposes.

Kumar’s conviction is part of a broader initiative by the CCIPS, which has secured over 180 convictions related to intellectual property and cybercrime since 2020. For the patients who may have unknowingly received Kumar’s counterfeit products, this sentencing marks a crucial step in addressing a case that prioritized profit over human life.

According to the Justice Department, the case underscores the ongoing efforts to combat the trafficking of counterfeit pharmaceuticals and protect patients from such dangerous schemes.

GLP-1 Drugs Associated with Increased Fracture Risk and Osteoporosis

Recent studies indicate that GLP-1 drugs, including Ozempic and Wegovy, may increase fracture risk and osteoporosis in older adults with Type 2 diabetes, prompting calls for closer monitoring of bone health.

A new study suggests that GLP-1 medications, such as Ozempic and Wegovy, may elevate the risk of fractures by 11% in adults aged 65 and older who have Type 2 diabetes, compared to those using other diabetes treatments.

These GLP-1 drugs have revolutionized the management of Type 2 diabetes and obesity, but recent findings indicate that healthcare providers should be more vigilant regarding bone health in older patients prescribed these medications. A study published in February in the Journal of Clinical Endocrinology & Metabolism revealed that older adults with Type 2 diabetes who began using GLP-1 medications experienced a statistically significant increase in the risk of fragility fractures.

Dr. Michal Kasher Meron, an endocrinologist at Meir Medical Center in Israel and the study’s lead author, emphasized that while an 11% increase may seem modest, it is significant for a vulnerable population. “Both older age and Type 2 diabetes are independent risk factors for fragility fractures,” she stated. “This is a population that deserves special attention.”

Fragility fractures are typically caused by minor falls or routine activities and are often associated with osteoporosis. Such fractures can lead to hospitalization, loss of independence, and even increased mortality among older adults, according to Dr. Kasher Meron.

The study monitored over 46,000 adults aged 65 and older for nearly three years. After making necessary adjustments, researchers found that those using GLP-1 medications had a modest but statistically significant increase in fracture risk.

Previous studies involving younger patients using older GLP-1 medications did not indicate an increased fracture risk. However, the newer and more potent versions are now commonly prescribed to older adults, which alters the risk landscape. “In older adults treated with contemporary medications, the fracture risk picture looks different and warrants close attention,” Dr. Kasher Meron noted.

It is important to highlight that the study was observational, indicating an association rather than causation. Researchers could not ascertain whether the increased risk was due to weight loss, dietary changes, muscle loss, or a direct effect on bone health.

Despite these findings, Dr. Kasher Meron advocates for assessing bone health before initiating GLP-1 medications in older patients rather than treating it as an afterthought. The study’s results coincide with additional research presented at the American Academy of Orthopaedic Surgeons’ annual meeting, which raised further concerns regarding bone health.

In an analysis of over 146,000 adults with obesity and Type 2 diabetes, those using GLP-1 medications were found to have a 29% higher relative risk of developing osteoporosis over five years compared to nonusers. Additionally, rates of gout were slightly elevated, affecting 7.4% of GLP-1 users versus 6.6% of nonusers, representing a 12% relative increase. Osteomalacia, a condition characterized by softening of the bones, was rare but occurred approximately twice as often in GLP-1 users, according to the study, which has not yet undergone peer review.

Experts suggest several mechanisms may contribute to these findings. GLP-1 medications suppress appetite and can lead to rapid weight loss, which is known to reduce bone density. This reduction occurs partly because less mechanical load is placed on the skeleton. Dr. John Horneff, an associate professor of orthopedic surgery at the University of Pennsylvania, likened this phenomenon to astronauts experiencing low bone density after extended periods in a zero-gravity environment.

Moreover, a decrease in caloric intake may result in lower consumption of calcium, vitamin D, and protein—nutrients essential for maintaining bone strength. Rapid weight loss can also temporarily elevate uric acid levels, a byproduct of tissue breakdown, potentially explaining the rise in gout cases.

Despite these concerns, experts caution against discouraging the appropriate use of GLP-1 medications, which have demonstrated significant benefits for blood sugar control, weight loss, and cardiovascular risk reduction. In addition to bone density screenings, experts recommend that patients ensure adequate nutrition and engage in resistance training to help preserve muscle and bone during weight loss.

A spokesperson for Novo Nordisk, the manufacturer of GLP-1 medications, stated that the company prioritizes patient safety and collaborates closely with the U.S. Food and Drug Administration (FDA). Liz Skrbkova, head of U.S. media relations for Novo Nordisk, emphasized that the known risks and benefits of these drugs are reflected in the current FDA-approved labeling. She noted that semaglutide, one of the GLP-1 medications, has shown cardiovascular, kidney, and liver benefits when used under medical supervision.

“Osteoporosis is a complex condition that develops over many years as a result of interdependent risk factors,” Skrbkova added.

These findings underscore the need for healthcare providers to closely monitor bone health in older adults prescribed GLP-1 medications, ensuring that the benefits of these treatments are balanced with potential risks.

According to Fox News Digital, the implications of these studies are significant for the management of diabetes and obesity in older populations.

Tim Tebow Calls on Congress to Combat Child Trafficking and Abuse

Tim Tebow recently urged Congress to take decisive action against child trafficking and exploitation, emphasizing the urgent need to protect vulnerable children during a Senate Judiciary Committee hearing.

Former NFL quarterback Tim Tebow made a passionate appeal on Capitol Hill this past week, urging lawmakers on the Senate Judiciary Committee to pass legislation aimed at combating child exploitation, trafficking, and abuse. He described this effort as a fight “for people who cannot fight for themselves” during their “darkest hour of need.”

Tebow, who is the founder and chair of the Tim Tebow Foundation, delivered his heartfelt testimony to garner support for the Renewed Hope Act of 2026. This bipartisan legislation seeks to enhance federal resources dedicated to fighting child exploitation and abuse.

In his remarks, Tebow framed the crisis as a critical battle for the most vulnerable members of society. He stated that his foundation is working “imperfectly, but in every way that we can” to support the fight against child exploitation. This includes providing additional resources to law enforcement and funding long-term restoration efforts for victims.

Currently, the Tim Tebow Foundation supports 52 safe homes for children and is in the process of expanding its assistance to an additional 19 homes. “It is a thin line between tortured and treasured,” Tebow told lawmakers, emphasizing the urgency of the situation. “And you are that thin line,” he added, urging Congress to act swiftly to approve the bill.

Reflecting on his past, Tebow remarked, “I spent way too much of my life chasing a much less important MVP. I want to spend the rest of my life chasing the most vulnerable people.”

The Renewed Hope Act of 2026, which has already cleared a House committee markup earlier this year, aims to establish a dedicated workforce of over 200 analysts, investigators, and forensic specialists within the Department of Homeland Security’s Homeland Security Investigations (HSI). This team would focus on coordinating and synchronizing child sexual exploitation investigations.

The legislation also seeks to equip and train officers specifically in victim identification, location, and rescue operations for children identified in sexual abuse databases or those who remain unknown.

Support for the Renewed Hope Act comes at a critical time, as the number of unidentified child victims in exploitation databases has surged in recent years. According to the Tim Tebow Foundation, there are an estimated 57,000 unidentified victims of child trafficking, many of whom remain hidden from official statistics and protection systems. This concern was echoed by others who testified during the emotional hearing.

Tebow highlighted the alarming statistics, noting that in the last six months alone, over 338,000 unique IP addresses based in the U.S. have been identified as trading child sexual abuse images on “peer-to-peer” networks. “Every day, [these children] are praying that we are going to respond,” he said during his testimony. “But how are we going to respond?”

He expressed gratitude to members of Congress from both parties who are coming together to support the Renewed Hope Act of 2026. “This legislation gives our nation the opportunity to build a stronger rescue team of analysts and investigators so that children who are suffering can be identified and protected. This is a problem we can solve,” he stated.

Senator Josh Hawley, R-Mo., who chairs the Senate Judiciary Subcommittee on Crime and Counterterrorism, has long prioritized issues related to child trafficking, which he has described as a “scourge” on society. “I am convening this subcommittee hearing to expose how our youth are groomed, exploited, and overlooked by the existing system,” he said this week. “Congress must dismantle the criminal networks that profit from exploiting the most vulnerable among us and put an end to child trafficking.”

As the conversation around child trafficking and exploitation continues to gain momentum, Tebow’s emotional plea serves as a reminder of the urgent need for legislative action to protect the most vulnerable members of society, according to Fox News.

The Rise of Online Prediction Betting on College Campuses

Online prediction betting is emerging as a silent addiction on college campuses, raising concerns about its potential impact on mental health and financial well-being among students.

On a typical evening in a college dormitory, a student scrolling through his phone may not be browsing social media or watching videos. Instead, he could be placing small wagers on socio-economic issues, such as whether inflation will rise, which political candidate will win a primary election, or the likelihood of a geopolitical event occurring within a specified timeframe.

What often begins as casual curiosity—an experiment in predicting the future—can quickly escalate into a pattern of repeated bets placed throughout the day. Each wager is accompanied by the same anticipation and adrenaline once associated with traditional casino gambling.

While the stakes may initially seem modest, often just a few dollars at a time, the psychological hook lies not in the size of the wager but in the constant cycle of prediction, uncertainty, and reward. For many young users, these platforms blur the line between information consumption and financial speculation, creating an environment where betting becomes intertwined with the everyday act of following the news.

A new form of gambling is quietly spreading across college campuses and among younger generations. Unlike traditional casinos or sports betting, online prediction markets—platforms where users wager on the outcomes of real-world events—are rapidly gaining traction among students and young professionals. Many now view these activities not as gambling but as a sophisticated form of speculation or “information trading.” However, emerging research suggests that the behavioral dynamics underlying these platforms may pose significant risks.

A study published in JAMA Internal Medicine highlights the rapid expansion of sports betting, revealing that total wagers in the United States skyrocketed from $4.9 billion in 2017 to $121.1 billion in 2023. Notably, 94 percent of those wagers are now placed online, illustrating how digital platforms have transformed betting into a constant and easily accessible activity.

The researchers also documented a 23 percent increase in internet searches related to gambling addiction following the expansion of legal sports betting. Some states experienced increases as high as 50 percent after online sportsbooks were introduced, suggesting that accessibility through smartphones may be accelerating the development of gambling disorders.

Understanding this phenomenon requires a look back at a pivotal moment in American regulatory history. In 2018, the U.S. Supreme Court issued its decision in Murphy v. National Collegiate Athletic Association, striking down the Professional and Amateur Sports Protection Act. This ruling effectively allowed states to legalize sports betting for the first time in decades.

Prior to that decision, legal sports wagering in the United States had been largely confined to Nevada. However, the Court’s ruling triggered a wave of legalization as states rushed to capture new tax revenue from gambling activity. Within a few years, the number of states with operational sportsbooks expanded from one in 2017 to 38, transforming sports betting into a ubiquitous feature of the American digital economy.

The rapid expansion of online betting has particularly notable effects among younger populations and college-age users who are already immersed in digital environments where information, entertainment, and financial transactions occur seamlessly on the same device. Surveys conducted by the National Collegiate Athletic Association indicate that approximately 22 percent of male college athletes report betting on sports at least once in the past year. Broader public health research estimates that 2.5 million Americans meet the criteria for severe problem gambling, with another five to eight million experiencing mild to moderate gambling problems.

Data compiled by the American Gaming Association show that nearly half of sports bettors are under the age of 35, highlighting how younger generations have become the fastest-growing segment of the digital wagering economy. For a generation already navigating unprecedented financial pressures—including student debt, housing costs, and economic uncertainty—the allure of turning information into profit can be particularly powerful.

One of the fastest-growing platforms in this emerging ecosystem is Polymarket, a blockchain-based prediction market that allows users to place financial bets on the probability of future events. Participants purchase shares representing the likelihood of an outcome, such as whether a political candidate will win an election or whether inflation will exceed a certain level. These shares fluctuate in price based on the collective expectations of traders in the market.

If the predicted event occurs, the shares pay out at full value; if not, they expire worthless, effectively transforming uncertainty itself into a tradable financial instrument. The interface resembles a financial trading platform rather than a casino, reinforcing the perception that participants are engaging in analytical forecasting rather than gambling.

Across American college campuses, prediction markets have evolved from a niche curiosity into a full-scale social phenomenon fueled by aggressive marketing, influencer campaigns, and fraternity networks. Platforms like Polymarket actively court college students through referral programs and campus outreach, sometimes recruiting fraternities and student organizations to help sign up new users.

In one instance, roughly 20 students from a fraternity chapter at Columbia University were invited to the company’s Manhattan headquarters, where they received $10 each in betting credit to try the platform. Some students reportedly turned that initial credit into about $60 in winnings in a single afternoon while watching football games and placing bets on prediction markets.

These platforms are regulated as financial derivatives rather than traditional gambling, making them accessible to users as young as 18 years old. This creates a three-year window during which college freshmen can legally engage in prediction betting long before they would be eligible to use most online sportsbooks. For university administrators and public health experts, the concern is that what begins as casual experimentation with a few dollars in betting credit can quickly normalize a culture of constant wagering within campus social life.

The legal status of these markets has evolved rapidly, with regulatory action by the Commodity Futures Trading Commission previously forcing companies to restrict U.S. trading activity. However, ongoing regulatory debate has allowed prediction-style markets to re-emerge in new forms, gaining popularity among younger users who are comfortable navigating cryptocurrency and digital finance.

The appeal of betting platforms—whether sportsbooks or prediction markets—lies in the fundamental neurobiology of reward. Humans are biologically wired to respond to uncertainty and risk with bursts of dopamine, the neurotransmitter that reinforces behaviors associated with anticipation and reward.

Neuroscience research has shown that intermittent rewards tied to uncertain outcomes stimulate dopamine release more strongly than predictable rewards. This means that the act of betting itself can become reinforcing, regardless of whether the individual ultimately wins or loses money. Each wager becomes a miniature experiment in anticipation, and the brain gradually learns to crave the emotional surge associated with the possibility of a favorable outcome.

Prediction markets amplify this dynamic by transforming nearly every news event into a potential betting opportunity, creating a continuous stream of uncertainty that encourages users to speculate repeatedly throughout the day.

Society has only recently begun to grapple with the addictive design of digital platforms, particularly social media, which employ many of the same psychological mechanisms to capture attention and maximize engagement. Universities, policymakers, and public health researchers are now actively studying the effects of social media addiction on mental health, sleep disruption, and academic performance among younger generations.

However, prediction betting may prove even more dangerous because it introduces direct financial stakes into an already addictive digital environment. Unlike social media, where the currency of engagement is attention, prediction markets attach real money to every interaction, transforming digital participation into financial risk-taking.

Over time, the psychological trajectory can begin to resemble that of substance addiction, where individuals become increasingly preoccupied with the activity, escalate their level of participation in pursuit of the same emotional reward, and continue the behavior despite mounting financial harm.

The parallels with drug addiction become particularly striking when examining how behavior escalates once dependency develops. In substance use disorders, individuals often find themselves willing to pay almost any price to obtain the next dose because the pursuit of the dopamine surge becomes increasingly urgent and overrides rational judgment.

Gambling addiction follows a similar pattern, where individuals chase losses, increase the size and frequency of wagers, and devote disproportionate time and mental energy to betting activities in an attempt to recreate the emotional high associated with earlier wins. Prediction markets may accelerate this progression because they are framed not as gambling but as analytical forecasting, creating the illusion that intellectual skill or superior information can overcome the underlying probabilities.

For young users who view themselves as digitally sophisticated interpreters of news and data streams, the line between informed speculation and compulsive betting can blur rapidly, allowing a powerful new form of addiction to take root largely unnoticed until the financial and psychological consequences become impossible to ignore.

Universities and policymakers face an emerging challenge that extends beyond traditional concerns about campus gambling pools or sports wagering. Prediction markets and online sportsbooks are creating a generation of young adults who learn to associate everyday information—from political news to economic data—with financial bets placed in real time.

While technological innovation has always reshaped financial markets, the speed and scale at which digital betting platforms are expanding raise important questions about consumer protection, public health, and the responsibility of institutions that educate young people.

Addressing this emerging form of addiction will require greater awareness among universities, clearer regulatory frameworks for digital prediction markets, and a broader cultural recognition that the boundary between investing, speculation, and gambling is becoming increasingly difficult to distinguish in the digital age. Without that recognition, the next major addiction crisis may not originate in a laboratory or on a street corner but rather on the screens carried in the pockets of millions of college students, according to The American Bazaar.

Alarming Report Identifies Factors Behind Rising Cancer Rates in Young Adults

New research highlights alarming trends in cancer rates among young adults, revealing significant factors contributing to this troubling surge.

A recent report has shed light on the rising incidence of cancer among young adults, a trend that has raised concerns among health experts and researchers alike. The findings indicate that various lifestyle and environmental factors are playing a critical role in this alarming increase.

According to the report, the surge in cancer cases among individuals aged 15 to 39 has been particularly pronounced in certain types of cancer, including breast, colorectal, and testicular cancers. This trend is not only troubling due to the increasing number of diagnoses but also because it suggests a shift in the age demographics typically affected by these diseases.

One of the key factors identified in the report is the impact of lifestyle choices. Experts point to rising obesity rates, sedentary behavior, and poor dietary habits as significant contributors to the increasing cancer risk among young adults. The prevalence of processed foods and sugary beverages has been linked to higher rates of obesity, which is a known risk factor for several types of cancer.

In addition to lifestyle factors, environmental influences are also being scrutinized. The report highlights concerns over exposure to harmful chemicals, including so-called “forever chemicals,” which are persistent in the environment and have been associated with various health issues, including cancer. These chemicals can be found in everyday products, from food packaging to household items, raising questions about their long-term effects on health.

Furthermore, the report notes that early detection and treatment options for young adults may not be as robust as those available for older populations. This gap in healthcare access and awareness can lead to later-stage diagnoses, which are often more difficult to treat and have poorer outcomes.

As the healthcare community grapples with these findings, there is an urgent call for increased awareness and preventive measures. Public health campaigns aimed at educating young adults about the risks associated with unhealthy lifestyles and environmental exposures are essential. Additionally, healthcare providers are encouraged to prioritize screenings and preventive care for younger patients.

The implications of this report extend beyond individual health, as rising cancer rates among young adults could place additional strain on healthcare systems and resources. As more young people are diagnosed with cancer, there will be a growing need for specialized care and support services tailored to this demographic.

In conclusion, the alarming rise in cancer rates among young adults underscores the need for a multifaceted approach to prevention and treatment. By addressing lifestyle factors, environmental exposures, and healthcare access, it may be possible to reverse this troubling trend and improve outcomes for future generations.

These findings are particularly significant as they highlight the importance of ongoing research and public health initiatives aimed at understanding and mitigating the factors contributing to cancer in young adults. As the landscape of cancer care continues to evolve, it is crucial to remain vigilant and proactive in addressing these emerging challenges, according to Fox News Health.

Wolf Species Made Famous in ‘Game of Thrones’ Revived, Company Claims

A Dallas-based company claims to have resurrected the dire wolf, an extinct species made famous by “Game of Thrones,” using advanced genetic technologies.

A Dallas-based biotechnology company, Colossal Biosciences, has announced that it has successfully brought back the dire wolf, a species that last roamed the Earth over 12,500 years ago. The dire wolf gained popularity through the hit HBO series “Game of Thrones,” where it is depicted as a larger and more intelligent version of the common wolf, fiercely loyal to the Stark family.

Colossal Biosciences asserts that it has created three dire wolves through genome-editing and cloning techniques, marking what it claims to be the world’s first successful “de-extinction” of an animal. However, some experts question the validity of this claim, suggesting that the company has merely genetically modified existing gray wolves rather than truly resurrecting the extinct species.

According to Colossal, dire wolves inhabited the American midcontinent during the Ice Age, with the oldest confirmed fossil dating back approximately 250,000 years, discovered in the Black Hills of South Dakota. The three new wolves include two adolescent males named Romulus and Remus, and a female puppy called Khaleesi.

The scientists at Colossal utilized blood cells from a living gray wolf and employed CRISPR technology—short for “clustered regularly interspaced short palindromic repeats”—to make genetic modifications at 20 different sites. These alterations were designed to replicate traits believed to have helped dire wolves survive in cold climates, such as larger body size and longer, lighter-colored fur. Of the 20 edits made, 15 correspond to genes found in actual dire wolves.

The ancient DNA used for the project was extracted from two dire wolf fossils: a tooth from Sheridan Pit, Ohio, estimated to be around 13,000 years old, and an inner ear bone from American Falls, Idaho, which dates back approximately 72,000 years. The modified genetic material was then transferred into an egg cell from a domestic dog. Afterward, the embryos were implanted into surrogate domestic dogs, leading to the birth of the genetically engineered pups 62 days later.

Ben Lamm, CEO of Colossal Biosciences, described the achievement as a significant milestone in the company’s efforts to demonstrate the effectiveness of its de-extinction technology. “It was once said, ‘any sufficiently advanced technology is indistinguishable from magic,’” Lamm stated. “Today, our team gets to unveil some of the magic they are working on and its broader impact on conservation.”

Colossal has previously announced similar projects aimed at genetically altering cells from living species to create animals resembling other extinct species, including woolly mammoths and dodos. In conjunction with the announcement of the dire wolves, the company also revealed the birth of two litters of cloned red wolves, which are critically endangered. This development, according to Colossal, demonstrates the potential of their de-extinction technology to aid in conservation efforts.

In late March, Colossal’s team met with officials from the U.S. Department of the Interior to discuss their projects. Interior Secretary Doug Burgum praised the work on social media, calling it a “thrilling new era of scientific wonder.” However, some scientists remain skeptical about the feasibility of restoring extinct species.

Corey Bradshaw, a professor of global ecology at Flinders University in Australia, expressed doubts regarding Colossal’s claims. “So yes, they have slightly genetically modified wolves, maybe, and that’s probably the best that you’re going to get,” Bradshaw remarked. “And those slight modifications seem to have been derived from retrieved dire wolf material. Does that make it a dire wolf? No. Does it make a slightly modified gray wolf? Yes. And that’s probably about it.”

Colossal Biosciences reports that the newly created wolves are thriving in a 2,000-acre ecological preserve in Texas, which is certified by the American Humane Society and registered with the USDA. Looking ahead, the company aims to restore the species in secure ecological preserves, potentially on indigenous lands.

As the debate continues regarding the ethical implications and scientific validity of de-extinction efforts, the work of Colossal Biosciences represents a bold step into the future of genetic engineering and conservation.

According to Fox News, the implications of such advancements could reshape our understanding of extinct species and their potential return to the ecosystem.

HMPV Respiratory Virus Spreads Across Northern California and Beyond

Human metapneumovirus (HMPV) is spreading rapidly across Northern California and other regions, raising concerns among public health officials about its impact on vulnerable populations.

Data from Wastewater SCAN indicates that human metapneumovirus (HMPV) is prevalent in Northern California, particularly in cities such as San Francisco, Marin, Vallejo, Napa, Novato, Santa Rosa, Sacramento, and Davis.

Public health officials and wastewater surveillance networks have reported a significant increase in HMPV cases across Northern California and several other regions in the United States. According to data from Wastewater SCAN and the Centers for Disease Control and Prevention (CDC), while the virus peaked in January, levels have remained elevated into early March. This rise in detections has prompted medical experts to issue warnings regarding the risks associated with this lesser-known but highly contagious respiratory pathogen.

The current outbreak is particularly concentrated in Northern California municipalities, including San Francisco, Sacramento, Santa Rosa, and Napa. However, the virus’s geographic footprint is expanding beyond the West Coast. Dr. Marc Siegel, a senior medical analyst, notes that HMPV is a single-stranded RNA virus, similar to influenza and COVID-19, and its prevalence is increasing not only in the West but also across the country.

Data from the National Wastewater Surveillance System (NWSS), a division of the CDC, confirms that HMPV concentrations are also rising sharply in the Midwest and Northeast. This comprehensive monitoring of sewage samples enables health officials to identify infection patterns in communities before they become evident in clinical testing. Current data suggest that while the traditional winter seasonal wave is beginning to decline, the viral load in the environment remains a public health concern.

Human metapneumovirus belongs to the same viral family as respiratory syncytial virus (RSV). Despite its current prevalence, HMPV is a relatively recent discovery in virology, first identified by researchers in 2001. Since then, it has been recognized as a leading cause of upper and lower respiratory tract infections, often circulating alongside more prominent seasonal illnesses.

The symptoms of HMPV often resemble those of the common cold, influenza, or COVID-19, which can lead to under-diagnosis in the general population. According to the CDC, the most common symptoms in healthy children and adults include cough, fever, nasal congestion, and shortness of breath. Currently, there is no specific antiviral treatment or vaccine for HMPV, so medical management is primarily focused on supportive care and symptom relief.

While many cases are mild, the virus poses a significant threat to vulnerable populations. Those at highest risk for severe illness, such as pneumonia, include young children, older adults, and individuals who are immunocompromised. Clinical data indicate that HMPV is responsible for a substantial burden on healthcare systems globally, leading to over 650,000 hospitalizations annually worldwide, according to Dr. Siegel.

In pediatric cases, HMPV can lead to more serious complications beyond standard respiratory distress. Rare effects can include asthma attacks, wheezing, difficulty breathing, bronchiolitis, ear infections, croup, and fever, as noted by the CDC. Bronchiolitis, an infection of the small airways, is particularly concerning for infants and toddlers whose respiratory systems are still developing.

For older adults and those with underlying health issues, HMPV can exacerbate existing conditions, leading to life-threatening complications. Adults with chronic obstructive pulmonary disease (COPD) are especially vulnerable to complications if they contract the virus. Dr. Siegel confirmed that the virus can worsen chronic lung conditions, often resulting in prolonged hospital stays and a need for supplemental oxygen or mechanical ventilation.

The rise of HMPV highlights the evolving nature of respiratory disease surveillance in the post-pandemic era. During the COVID-19 pandemic, many common respiratory viruses saw a decline in transmission due to social distancing and masking. As these behaviors have shifted, viruses like HMPV and RSV have returned with altered seasonality and increased intensity. Wastewater monitoring has become a critical tool in tracking these changes in real-time.

Historically, HMPV has been overshadowed by the “big three” respiratory illnesses: COVID-19, influenza, and RSV. However, the economic and social impact of HMPV is becoming increasingly apparent to policymakers. The absence of a rapid diagnostic test commonly available in primary care settings means many patients may be unaware they have the virus, potentially leading to inappropriate antibiotic prescriptions for a viral infection.

HMPV is transmitted through typical respiratory routes, including secretions from coughing and sneezing, close personal contact, and touching contaminated surfaces. Health officials emphasize that standard hygiene practices remain the most effective defense against the spread of the virus. Recommendations include frequent handwashing, disinfecting shared surfaces, and staying home when symptomatic to help curb the current regional spikes.

In the broader context of global health, HMPV presents a persistent challenge for vaccine development. As a paramyxovirus, it shares structural similarities with RSV, which recently saw the approval of its first vaccines for older adults and infants. Research into an HMPV vaccine is ongoing, but clinical trials have yet to yield a commercially available preventative measure. Until such a breakthrough occurs, public health efforts will rely on surveillance and hospital capacity management.

Regional health departments in Northern California are closely monitoring the situation as spring approaches. While the tapering of the winter wave offers some relief, the elevated status of the virus in early March suggests that the tail of the outbreak could persist for several weeks. Residents in affected areas, particularly in the Sacramento and San Francisco Bay Area corridors, are advised to remain vigilant regarding respiratory health.

The emergence of data from the NWSS underscores the growing importance of environmental virology. By tracking the presence of HMPV in municipal wastewater, officials can provide early warnings to hospitals to prepare for an influx of patients with pneumonia or bronchiolitis. This proactive approach is essential for managing the seasonal surges that now characterize the American respiratory landscape.

As the Midwest and Northeast begin to experience similar sharp increases in HMPV detection, the national health community is preparing for a potential late-season surge in these regions. Patterns observed in California often serve as a bellwether for trends that eventually spread across the continental United States. Consequently, epidemiologists are scrutinizing Northern California data to predict the duration and severity of outbreaks forming in the eastern half of the country.

In summary, human metapneumovirus has emerged as a significant public health threat that necessitates greater public awareness. With hundreds of thousands of annual hospitalizations and a lack of specific medical interventions, the virus remains a primary concern for the elderly and young children. As wastewater levels remain high, the medical community continues to advocate for increased testing and a greater emphasis on preventative hygiene to protect those most at risk for severe complications, according to Source Name.

Infectious Diseases Cross Borders, Highlighting Global Health Challenges

In 2026, the U.S. faces a resurgence of measles outbreaks, highlighting the critical importance of vaccination amid growing vaccine skepticism and changing public health guidelines.

In 2026, the United States has experienced a significant increase in outbreaks of measles, a highly contagious yet vaccine-preventable disease. In just two months, over 1,136 cases have been reported across 28 states, a stark contrast to the 2,281 cases documented in 45 states in 2025, according to the Centers for Disease Control and Prevention (CDC). Alarmingly, more than 90% of those infected this year were either unvaccinated or had an unknown vaccination status. Among these cases, 24% were children under the age of five, while 57% were between the ages of five and nineteen. It is noteworthy that measles was declared eliminated in the U.S. in 2000.

To address this outbreak, Jay Bhattacharya, director of the National Institutes of Health (NIH) and acting director of the CDC, has urged families to vaccinate against measles. The CDC states that two doses of the measles vaccine are 97% effective in preventing the disease’s spread.

The recent resurgence of measles coincides with a growing skepticism surrounding vaccines. A 2025 poll conducted by the KFF and the Washington Post revealed that 16% of respondents had skipped or delayed a recommended vaccine, while 35% of parents expressed concerns that vaccines do not undergo sufficient safety testing before being recommended for children. Additionally, 26% of parents felt that the CDC recommends too many childhood vaccines.

Vaccination rates for the MMR (measles, mumps, and rubella) vaccine among U.S. kindergartners have declined from 95.2% during the 2019-2020 school year to 92.5% in the 2024-2025 school year. At a recent media briefing on CDC vaccine guidelines, Dr. Richard Besser, a pediatrician and CEO of the Robert Wood Johnson Foundation, attributed current vaccine hesitancy to a lack of trust in public health that emerged during the COVID-19 pandemic.

“People’s trust in vaccination is now damaged in ways that we’re seeing play out around the country,” he stated. “Viruses don’t respect the borders of states. If you are not vaccinated, measles will find you, and measles will infect you.”

The implications of vaccine mistrust on public health are particularly concerning, especially given the differing vaccine recommendations from the CDC and other reputable public health organizations like the American Academy of Pediatrics (AAP). The new CDC schedule has reduced routine recommendations from 17 diseases to 11, moving vaccines such as flu, RSV, hepatitis A and B, rotavirus, and some meningococcal vaccines into “shared clinical decision-making” categories.

The AAP has criticized the new CDC guidelines as “dangerous and unnecessary,” stating that it will continue to follow its immunization schedule, which is supported by over 200 health organizations. Dr. Manisha Panchal, a pediatrician from the San Francisco Bay Area, emphasized the importance of vaccines in reducing the burden of infectious diseases. “When we look at the science behind every individual vaccine, you can see that we’ve come a long way in terms of infectious diseases, largely because of vaccines,” she remarked.

Conversely, Dr. Kirk Milhoan, a pediatric cardiologist and chair of the newly formed Advisory Committee on Immunization Practices (ACIP), has indicated a preference for prioritizing patient autonomy over vaccine mandates. He has suggested a reevaluation of the oral polio and MMR vaccine mandates in the United States, advocating for decisions to be made collaboratively between patients and healthcare providers.

The ACIP, whose recommendations may influence CDC policy, is scheduled to meet on March 18. Concerns about the potential weakening of herd immunity arise from the possibility that the CDC may move away from mandating certain childhood vaccines for school admissions. Dr. Besser expressed alarm, stating, “If you’re sending your vaccinated child to kindergarten, they might be sitting next to a child who is unvaccinated, which could potentially give them something quite serious.”

Dr. Besser also voiced concern over Dr. Milhoan’s comments regarding the review of vaccine mandates, drawing from his experiences visiting a polio hospital in India. “I saw the outcome of what happens in communities that have not had the same access to vaccination, and it’s debilitating,” he said. He cautioned that parents who have never witnessed the effects of polio may struggle to understand the necessity of vaccination against it.

Dr. Panchal echoed these sentiments, noting that communities that have experienced the burden of infectious diseases are often more aware of the consequences of not being vaccinated. She highlighted that the South Asian community in the Bay Area tends to be very pro-vaccine, attributing this to cultural factors and a history of witnessing the impact of disease.

Dr. Besser emphasized the need for public health leaders and trusted local voices to collaborate with communities to provide vaccines in familiar settings such as churches and community centers. He criticized the U.S. decision to withdraw from the World Health Organization, warning that it could jeopardize both American and global health. “Infectious diseases do not respect borders,” he stated, noting that many emerging pathogens arise in areas where humans, animals, and the environment intersect.

In response to the revised CDC vaccine schedule, several states have taken steps to uphold their vaccination guidelines. At least 27 states and Washington, D.C., have rejected some or all of the new CDC recommendations, with many opting to follow AAP guidelines. In late 2025, California enacted legislation to maintain its vaccination schedule, placing the California Department of Public Health in charge of any future changes.

For families uncertain about vaccine decisions, Dr. Panchal encourages open discussions with healthcare providers rather than relying on informal advice from friends. “Doctors are very well versed in understanding the research and the data, and can help you interpret it,” she advised.

As the U.S. grapples with the resurgence of measles and the complexities of vaccine hesitancy, the importance of informed decision-making and community engagement remains paramount in safeguarding public health.

According to India Currents.

Ozempic-Style Drugs May Reduce Heart Attack Complications, Study Finds

New research suggests that GLP-1 weight-loss drugs may significantly reduce complications after heart attacks by improving blood flow to heart tissue.

Groundbreaking research indicates that a popular class of weight-loss drugs could play a crucial role in preventing life-threatening heart complications by reopening blocked blood vessels following heart attacks. The study, published this week in Nature Communications, was conducted by researchers from the University of Bristol and University College London.

The research identifies a biological signaling pathway involving the brain, gut, and heart, which may explain how GLP-1 drugs—medications that mimic the hormone glucagon-like peptide-1—help protect heart tissue from a condition known as “no-reflow.” This condition occurs when tiny blood vessels within the heart muscle remain constricted even after the main artery has been cleared during emergency treatment.

Dr. Svetlana Mastitskaya, the study’s lead author and a senior lecturer at Bristol Medical School, highlighted the significance of the findings. “In nearly half of all heart attack patients, tiny blood vessels within the heart muscle remain narrowed, even after the main artery is cleared during emergency medical treatment,” she stated in a press release. “This results in a complication known as ‘no-reflow,’ where blood is unable to reach certain parts of the heart tissue.” The lack of blood flow can increase the risk of heart failure and death within a year, but GLP-1 medications may offer a preventive solution.

The study reveals that when the GLP-1 hormone is released in the gut or administered as a medication, it sends signals to the brain. The brain, in turn, signals the heart to activate specific potassium channels in tiny cells known as pericytes. When these channels open, the pericytes relax, allowing small blood vessels, or capillaries, to widen and improve blood flow to the heart muscle.

Using animal models and cellular imaging, the researchers tracked how GLP-1 interacts with heart tissue. They discovered that when potassium channels were removed, the protective effects of the drugs on the heart were lost, confirming the channels’ critical role in this process.

The findings suggest that existing GLP-1 medications, which are already prescribed for type 2 diabetes and obesity, could be repurposed as emergency treatments during or immediately after a heart attack to minimize tissue damage.

However, the researchers acknowledged several limitations in their study, including its reliance on animal models. Clinical trials will be necessary to determine whether the brain-gut-heart pathway operates with the same timing and efficacy in humans. Moreover, while the study emphasizes the drug’s immediate benefits during a heart attack, it does not clarify whether long-term use of the medication provides any pre-existing level of protection.

This research was primarily funded by the British Heart Foundation, underscoring the potential implications for future heart attack treatments.

According to Fox News, the study opens new avenues for understanding how existing medications can be utilized to enhance heart health and reduce complications following cardiac events.

AI Uncovers $163K in Fraudulent Medical Bill Charges

A man successfully reduced a hospital bill by over $100,000 using AI tools to identify billing errors, highlighting the potential of technology in managing medical expenses.

In a remarkable case, a man utilized an AI chatbot to significantly reduce a hospital bill following his brother-in-law’s tragic heart attack. The initial bill for just four hours of emergency care totaled an astonishing $195,628. However, before his sister-in-law could pay, he urged her to wait and requested an itemized bill that included CPT codes—the standardized billing codes used by hospitals.

After receiving the itemized bill, he input the information into Claude, an AI chatbot. Within minutes, Claude identified numerous discrepancies, including duplicate charges, services billed as “inpatient” despite the patient never being admitted, and supply costs inflated by 500% to 2,300% above Medicare rates. Additionally, there were charges for procedures that had not occurred. To ensure accuracy, he cross-checked the findings with ChatGPT, which corroborated Claude’s results.

Armed with this information, he drafted a six-page letter detailing each violation. As a result, the hospital agreed to reduce the bill to $33,000, marking an impressive 83% decrease—all achieved without any medical training and with the help of a $20 app.

This story, while extraordinary, is not as isolated as it may seem. The Medical Billing Advocates of America estimates that approximately 75% of medical bills contain errors. On average, hospital bills exceeding $10,000 have around $1,300 in mistakes. Alarmingly, less than 1% of denied insurance claims are ever appealed, indicating that many patients may be unaware of their rights and the potential for errors in their bills.

AI technology is transforming the way patients can approach their medical billing disputes. With AI tools, individuals no longer need an extensive understanding of CPT codes or a background in medical billing to challenge their bills effectively. The process is straightforward:

First, contact your healthcare provider and request an itemized bill that includes CPT codes. It is important to ask for the full line-by-line breakdown rather than a summary, as patients are legally entitled to this information.

Next, open an AI tool such as ChatGPT, Claude, Grok, or Gemini (free versions are available) and paste the following request:

“I’m pasting my itemized medical bill below. Please: (1) Explain every charge in plain English, (2) Flag any duplicate or suspicious charges, (3) Compare each charge to average costs, (4) Identify billing code errors or bundling violations, and (5) Draft a dispute letter I can send to the billing department. Here’s my bill:”

After pasting your bill, the AI will analyze each line and highlight any discrepancies or errors it identifies.

If the AI uncovers mistakes—something that is likely—contact the billing department and ask to speak with a supervisor. Be sure to reference the specific codes and findings from your AI analysis. Hospitals are often willing to resolve disputes when patients come prepared with detailed information.

For those looking for additional resources, Counterforce Health (counterforcehealth.org) is a free AI tool specifically designed to assist with insurance denial appeals and is worth bookmarking for future reference.

As the landscape of healthcare billing continues to evolve, it is crucial for patients to take a proactive approach in reviewing their medical bills. Utilizing AI tools can empower individuals to challenge inaccuracies and potentially save significant amounts of money.

In a world where discussions about AI are prevalent, practical applications like this demonstrate how technology can be harnessed to address real-life challenges. For those seeking further insights into leveraging AI effectively, consider subscribing to the free newsletter, Splash of AI, which offers weekly tips and tools designed to simplify the use of technology in everyday life.

Sharing this information with someone who is grappling with a confusing medical bill could lead to substantial savings. It takes less time than brewing a cup of coffee and could save hundreds or even thousands of dollars.

Kim Komando, a trusted voice in technology, provides straightforward advice without the jargon. Her national radio show, available on over 500 stations, along with a free daily newsletter, YouTube content, and podcasts, offers valuable insights for navigating the tech landscape.

For more information, visit Komando.com.

According to Fox News, the integration of AI in managing medical bills is becoming an essential tool for patients seeking to rectify billing errors.

Shreya Parchure Uses AI to Aid Stroke Survivors in Speech Recovery

Shreya Parchure, an Indian American doctoral student, is pioneering an AI tool to personalize speech therapy for stroke survivors, enhancing recovery prospects for those affected by post-stroke aphasia.

Shreya Parchure, an Indian American researcher and doctoral student at the University of Pennsylvania, is making significant strides in the field of speech therapy for stroke survivors. Her innovative approach utilizes artificial intelligence (AI) to personalize treatment for individuals suffering from post-stroke aphasia, a condition that impairs the ability to understand or produce speech and affects approximately one-third of stroke survivors.

Growing up across two continents, Parchure developed a deep appreciation for the importance of language in enhancing quality of life. Her clinical rotations in a neurocritical care unit further solidified her commitment to advancing research and care for patients with aphasia. During her interactions with patients, she witnessed firsthand the profound impact that speech therapy can have on recovery. One patient, who initially struggled to speak, gradually regained her ability to communicate through dedicated therapy. “She was overjoyed,” Parchure recalls, highlighting how progress in speech therapy can instill hope in patients.

Traditional speech therapies for post-stroke aphasia often follow standardized protocols. However, Parchure and her team at the Laboratory for Cognition and Neural Stimulation (LCNS) are exploring the potential of “explainable AI.” This set of machine learning methods focuses on providing clear rationales behind AI-generated results, enabling healthcare providers to interpret and trust the recommendations made by the technology.

While some AI models have utilized neuroimaging and the duration since a stroke to assess aphasia severity, Parchure’s research expands on these methods by incorporating how language is formed and processed in the brain. “Explainable AI can integrate clinically available data—such as age, education, or the size of a stroke—with the linguistic difficulty of words,” she explains. This multifaceted approach allows the AI model to predict recovery timelines and suggest tailored treatments based on individual patient circumstances.

“When we have an AI making a prediction, we really want to know why,” Parchure emphasizes. She has leveraged speech samples from patients with post-stroke aphasia to train an explainable AI algorithm, testing its ability to account for various language tasks and make recovery predictions based on a diverse array of clinically relevant information. The tool also considers personal attributes, such as the size of the stroke and the level of social support available to the patient.

“Incorporating language into the fold adds a new layer of considering human and brain complexity,” Parchure notes. The explainable AI tool can predict speech performance on a word-by-word basis, which can help clinicians identify the underlying factors affecting a patient’s speech abilities. This granularity informs more nuanced treatment plans and recovery predictions.

“It’ll help tailor speech therapy for where exactly people are having trouble,” Parchure states. “We can really meet patients where they are in a more personalized manner.” To facilitate this, Parchure and her colleagues have developed an AI-powered application for use in both clinical and research settings. A particularly innovative aspect of this research is the creation of a “digital twin” for each patient, which serves as a predictive tool for language recovery.

The simulated “twin” allows for a comparative analysis of how a patient may respond to different treatments, enhancing the efficiency of clinical trials by enabling researchers to compare projected outcomes with actual recovery results. “The goal of my MD-PhD training has been to translate advances in research in a way that will benefit patients,” Parchure explains. Her work has already garnered recognition, including the Best Poster award in Translational Research at the 2025 PSOM Student Research Symposium.

Looking ahead, Parchure envisions a future where AI plays a crucial role in personalizing speech therapy, ultimately helping stroke survivors with aphasia reconnect with the joy of language. “Over the next decade, I believe we will see significant advancements in this area,” she concludes.

According to Penn Today, Parchure’s research represents a promising development in the intersection of technology and healthcare, offering hope to countless individuals affected by stroke.

Origin of Deadly Cancer in Young Adults Revealed in New Report

Colorectal cancer rates are rising among younger adults, with significant increases in diagnoses and a call for enhanced screening and research efforts, according to a new report from the American Cancer Society.

Colorectal cancer (CRC) is increasingly becoming a significant health concern for younger adults, with individuals aged 65 and under now accounting for 45% of new diagnoses, a notable rise from 27% in 1995. This alarming trend is highlighted in a recent report titled “Colorectal Cancer Statistics, 2026,” published by the American Cancer Society in the journal CA: A Cancer Journal for Clinicians.

As the leading cause of cancer death among adults under 50, CRC is showing a troubling increase in incidence among younger populations. While rates among seniors have been declining, the opposite is true for those aged 20 to 49, where diagnoses are rising at a rate of 3% per year. The report indicates that 75% of colorectal cancers diagnosed in adults 50 and under are identified at an advanced stage, with half of these cases occurring between the ages of 45 and 49. Despite being eligible for routine screenings, only 37% of individuals in this age group participate.

The report also notes a concerning rise in rectal cancer, which now represents approximately one-third (32%) of all colorectal cancer cases, up from 27% in the mid-2000s. Rebecca Siegel, senior scientific director of surveillance research at the American Cancer Society and lead author of the report, emphasized the urgency of addressing this trend. “After decades of progress, the risk of dying from colorectal cancer is climbing in younger generations of men and women, confirming a real uptick in disease because of something we’re doing or some other exposure,” she stated in a press release.

Siegel called for intensified research efforts to determine the causes of this increase and to improve early detection through better education for both clinicians and the public regarding symptoms. She stressed the importance of increasing screening rates among individuals aged 45 to 54.

The report projects that in 2023, there will be approximately 158,850 new cases of colorectal cancer diagnosed, resulting in an estimated 55,230 deaths. Researchers have identified that more than half of CRC cases can be linked to high-risk behaviors, including poor nutrition, excessive alcohol consumption, smoking, lack of physical activity, and obesity.

Dr. William Dahut, chief scientific officer at the American Cancer Society, reiterated the critical need for eligible adults to begin screening at the recommended age of 45. “These findings further underscore that colorectal cancer is worsening among younger generations and highlight the immediate need for eligible adults to begin screening at the recommended age of 45,” he said. He also pointed out the importance of continued funding for research aimed at discovering new therapies and improving patient care.

When detected at an early stage, colorectal cancer has a five-year survival rate of 95%, underscoring the importance of early diagnosis and intervention.

As the landscape of colorectal cancer continues to evolve, the findings of this report serve as a crucial reminder of the need for awareness, education, and proactive health measures to combat this rising threat among younger adults, according to the American Cancer Society.

Google Uses AI to Decode Dolphin Communication

Google is leveraging artificial intelligence to decode dolphin communication, aiming to facilitate human interaction with these intelligent marine mammals.

Google is embarking on an ambitious project to harness artificial intelligence (AI) in order to decode the complex communication of dolphins, with the ultimate goal of enabling humans to converse with these intelligent creatures.

Dolphins have long been celebrated for their remarkable intelligence, emotional depth, and social interactions with humans. In collaboration with researchers from the Georgia Institute of Technology and the Wild Dolphin Project (WDP), a Florida-based non-profit that has dedicated over 40 years to studying and recording dolphin sounds, Google is developing a new AI model named DolphinGemma.

The WDP has been instrumental in correlating different types of dolphin sounds with specific behavioral contexts. For example, signature whistles are often used by mothers to reunite with their calves, while burst pulse “squawks” are typically observed during aggressive encounters among dolphins. Additionally, “click” sounds are frequently employed during courtship or when dolphins are pursuing sharks.

Utilizing the extensive data collected by the WDP, Google has created DolphinGemma, which builds upon its existing lightweight AI model known as Gemma. This innovative model is designed to analyze the vast library of dolphin vocalizations, detecting patterns, structures, and potential meanings behind their communications.

Over time, DolphinGemma aims to categorize dolphin sounds in a manner akin to human language, organizing them into what could resemble words, sentences, or expressions. According to a blog post by Google, “By identifying recurring sound patterns, clusters, and reliable sequences, the model can help researchers uncover hidden structures and potential meanings within the dolphins’ natural communication—a task previously requiring immense human effort.”

The project also envisions the creation of a shared vocabulary between dolphins and humans. By augmenting the identified sound patterns with synthetic sounds that refer to objects dolphins enjoy, researchers hope to establish a basis for interactive communication.

DolphinGemma employs advanced audio recording technology from Google’s Pixel phones, which enables the capture of high-quality sound recordings of dolphin vocalizations. This technology is capable of filtering out background noise, such as waves, boat engines, and underwater static, ensuring that the AI model receives clear audio data. Researchers emphasize that clean recordings are crucial for the effectiveness of AI models like DolphinGemma, as noisy data can lead to confusion.

Google plans to release DolphinGemma as an open model this summer, allowing researchers worldwide to utilize and adapt it for their own studies. Although the model has been primarily trained on Atlantic spotted dolphins, it has the potential to assist in the study of other species, such as bottlenose or spinner dolphins, with some adjustments.

In the words of Google, “By providing tools like DolphinGemma, we hope to give researchers worldwide the means to mine their own acoustic datasets, accelerate the search for patterns, and collectively deepen our understanding of these intelligent marine mammals.”

As this groundbreaking project unfolds, it holds the promise of not only enhancing our understanding of dolphin communication but also fostering a deeper connection between humans and these remarkable creatures.

According to Google, the advancements made through DolphinGemma could pave the way for unprecedented interactions with dolphins, enriching both scientific knowledge and human experience.

Breakthrough in Alzheimer’s Prevention Linked to Decades-Old Seizure Drug

Researchers have discovered that levetiracetam, a decades-old seizure medication, may prevent the progression of Alzheimer’s disease if administered years before symptoms manifest.

A promising breakthrough in Alzheimer’s prevention has emerged from a recent study suggesting that levetiracetam, a medication traditionally used to treat seizures, may help halt the disease’s progression. Originally approved by the FDA in November 1999 under the brand name Keppra, levetiracetam is primarily prescribed for partial-onset seizures in adults, with its use later expanding to include children and various seizure types.

Researchers at Northwestern University have found that levetiracetam can prevent the formation of toxic amyloid beta peptides, which are small protein fragments commonly associated with Alzheimer’s disease. The study, published in Science Translational Medicine, revealed that the medication effectively inhibited the formation of amyloid-beta 42 in both animal models and cultured human neurons. This effect was also observed in post-mortem brain tissue from individuals with Down syndrome, a group at heightened risk for developing Alzheimer’s.

“While many of the Alzheimer’s drugs currently on the market, such as lecanemab and donanemab, are approved to clear existing amyloid plaques, we’ve identified this mechanism that prevents the production of the amyloid-beta 42 peptides and amyloid plaques,” said Jeffrey Savas, the study’s corresponding author and an associate professor of behavioral neurology at Northwestern University Feinberg School of Medicine. “Our new results uncovered new biology while also opening doors for new drug targets.”

Savas explained that the brain is better equipped to avoid the pathways that produce toxic amyloid-beta 42 proteins during younger years. However, as individuals age, this ability diminishes. “This is not a statement of disease; this is just a part of aging. But in brains developing Alzheimer’s, too many neurons go astray, and that’s when you get amyloid-beta 42 production,” he noted. This accumulation can lead to the formation of tau tangles—abnormal clumps of protein inside brain neurons—which can ultimately kill brain cells, trigger neuroinflammation, and result in dementia.

For levetiracetam to serve as an effective Alzheimer’s preventive, high-risk individuals would need to begin treatment “very, very early,” potentially up to 20 years before elevated levels of amyloid-beta 42 are detected. “You couldn’t take this when you already have dementia because the brain has already undergone a number of irreversible changes and a lot of cell death,” Savas cautioned.

The research team also analyzed existing clinical data to assess whether Alzheimer’s patients taking levetiracetam experienced a slower cognitive decline. They found that these patients had a “significant delay” in the time from cognitive decline to death compared to those not on the medication. “Although the magnitude of change was small (on the scale of a few years), this analysis supports the positive effect of levetiracetam to slow the progression of Alzheimer’s pathology,” Savas stated.

Looking ahead, the research team aims to recruit individuals with genetic forms of Alzheimer’s for further testing. However, the study does have limitations, including its reliance on animal models and cultured cells, with no human trials conducted to date. As the study was observational, it cannot definitively prove that levetiracetam caused the prevention of toxic brain proteins.

Savas acknowledged that while levetiracetam shows promise, it is not without its drawbacks. The medication breaks down in the body relatively quickly, prompting the research team to work on developing a “better version” that would have a longer duration of action and more effectively target the mechanism responsible for preventing plaque production.

Common side effects of levetiracetam include drowsiness, weakness, dizziness, irritability, headache, loss of appetite, and nasal congestion. The medication has also been associated with potential mood and behavior changes, such as anxiety, depression, agitation, and aggression. In rare cases, it may lead to severe allergic reactions, skin reactions, blood disorders, and suicidal ideation.

Funding for this study was provided by the National Institutes of Health and the Cure Alzheimer’s Fund. For further details, Fox News Digital reached out to both the drug manufacturer and the researchers for additional comments.

Nobel Laureate Develops Machine to Harvest Water from Desert Air

A Nobel Prize-winning chemist has created a solar-powered device that extracts potable water from desert air, offering hope to over two billion people facing water scarcity.

A Nobel Prize-winning chemist has developed a groundbreaking solar-powered device that extracts potable water from arid desert air, potentially transforming the lives of billions facing water scarcity.

In an era where climate change and resource scarcity dominate global headlines, the development of a solar-powered machine capable of harvesting water from the air presents a beacon of hope. This innovation comes from a Nobel laureate whose work promises to address one of the most pressing challenges of our time: access to clean drinking water. With over two billion people living in regions plagued by water scarcity, the implications of this technology are profound, offering a potential lifeline to those in dire need.

The machine can extract up to 1,000 liters of water per day, operating through a combination of solar energy and advanced materials science. At its core, the device employs a metal-organic framework (MOF), a class of compounds known for their ability to trap and release water molecules. These MOFs are engineered to be highly efficient, even in low-humidity environments, making them ideal for desert conditions where traditional water sources are scarce.

The potential impact of this technology cannot be overstated. As global temperatures rise and precipitation patterns become increasingly erratic, traditional water sources such as rivers and aquifers are under unprecedented stress. In many regions, particularly in parts of Africa, the Middle East, and Asia, communities are already experiencing severe water shortages. This scarcity not only threatens human health but also exacerbates food insecurity and economic instability. By providing a sustainable source of clean water, the new device could alleviate some of these pressures and improve the quality of life for millions.

Historically, attempts to extract water from the air have faced significant challenges. Traditional methods, such as dehumidifiers, require substantial energy inputs and are often impractical in remote or resource-poor areas. The innovation here lies in the integration of solar power, which not only makes the device sustainable but also economically viable in regions with abundant sunlight. This aligns with global efforts to transition towards renewable energy sources and reduce carbon emissions.

The development of this technology also highlights the crucial role of interdisciplinary research in addressing complex global issues. The project is a testament to the power of collaboration between chemists, engineers, and environmental scientists, each contributing their expertise to solve a multifaceted problem. Such collaborations are increasingly essential as the challenges we face grow more interconnected and complex.

Moreover, the deployment of this water-harvesting technology could have significant geopolitical implications. Water scarcity is a known driver of conflict, with disputes over access to water resources contributing to tensions between communities and even nations. By providing a decentralized and independent water source, this device could help mitigate such conflicts, promoting peace and stability in vulnerable regions.

Despite the promise of this technology, several challenges remain. The initial cost of production and deployment may be prohibitive for some communities, necessitating support from governments and international organizations to ensure widespread access. Additionally, ongoing maintenance and technical support will be essential to ensure the long-term functionality of the devices, particularly in remote areas.

Nevertheless, the potential benefits far outweigh these challenges. As the global population continues to grow, the demand for freshwater will only increase. Innovations like this water-harvesting machine are crucial to meeting this demand sustainably. Furthermore, they exemplify the kind of forward-thinking solutions required to address the myriad environmental challenges posed by climate change.

In conclusion, the development of a solar-powered machine capable of extracting water from desert air represents a significant step forward in the quest for sustainable water solutions. By harnessing the power of the sun and the ingenuity of modern materials science, this technology has the potential to transform lives and communities across the globe. As we look to the future, innovations like this will be essential in building a more resilient and equitable world, where access to clean water is a universal right, not a privilege, according to GlobalNetNews.

Pankhuri Gupta Receives 2026 Richard King Award for Genetic Research

Pankhuri Gupta, an Indian American researcher, has received the 2026 Richard King Trainee Award for her groundbreaking work in identifying gaps in clinical genetic data reporting and patient care.

Pankhuri Gupta, an Indian American researcher, has gained national recognition for addressing a critical issue in modern medicine: the disconnect between genetic knowledge and its application in patient care. Gupta, a research genetic counselor at the University of Washington, has been awarded the 2026 Richard King Trainee Award, presented by the American College of Medical Genetics and Genomics (ACMG) Foundation. This honor recognizes the most outstanding research publication by a trainee in the journal *Genetics in Medicine*.

Her award-winning study, titled “Imprecision Medicine,” focuses on the concept of “variants of uncertain significance” (VUS). In the intricate realm of DNA sequencing, VUS refers to genetic alterations whose effects on an individual’s health are not yet fully understood. As scientific knowledge advances, many of these uncertain variants are eventually reclassified as either benign or pathogenic.

Gupta’s research revealed a significant issue: the transition from laboratory findings to clinical records is often flawed. She discovered that at least 1.6% of genetic classifications in electronic health records were outdated when compared to current global databases. While this percentage may appear minor, it represents a considerable number of patients who are relying on clinical information that is no longer accurate, particularly in the context of life-altering diagnoses.

Working under the guidance of Dr. Andrew Stergachis, Gupta illustrated how these systematic reporting gaps can obstruct the potential of personalized medicine. “Uncertainty in genomic medicine can be challenging for patients,” Gupta remarked, emphasizing her motivation to enhance transparency in the process.

The editorial board of *Genetics in Medicine* selected Gupta’s work from a competitive pool of international submissions. Robert D. Steiner, the journal’s editor-in-chief, noted that while many high-quality papers were received, Gupta’s manuscript distinguished itself through its scientific merit and practical implications for the field.

Gupta’s path to this prestigious award is rooted in her commitment to the medical community in the Pacific Northwest. After obtaining her master’s degree in genetic counseling from the University of Washington in 2024, she was chosen as one of only ten fellows nationwide for a distinguished program supported by the Warren Alpert Foundation.

Currently, she leads initiatives at the Brotman Baty Institute to reclassify uncertain variants within a database that includes records for over 8,000 patients. In addition to her laboratory work, Gupta serves on the advisory board for the University of Washington’s genetic counseling program, where she mentors the next generation of specialists who will tackle these genomic challenges.

The Richard King Trainee Award is named in honor of the founding editor-in-chief of *Genetics in Medicine*. It aims to support early-career professionals in producing high-level research that advances the application of genetic information in saving lives.

According to *Genetics in Medicine*, Gupta’s contributions are paving the way for more accurate and effective patient care in the field of genetics.

China Advances in Ultrasound Brain Technology Development

Chinese company Gestala is pioneering non-invasive ultrasound brain-computer interfaces, aiming to treat chronic pain without the need for surgical implants.

In the evolving landscape of brain-computer interfaces (BCIs), the image of surgical procedures and implanted devices is being challenged by innovative non-invasive technologies. One such advancement comes from Gestala, a company based in Chengdu, China, with additional offices in Shanghai and Hong Kong. Gestala is developing ultrasound-based BCIs that utilize focused sound waves to stimulate and study brain activity, offering a promising alternative to traditional surgical methods.

This approach leverages the same ultrasound technology commonly used in medical imaging, but instead of visualizing internal organs, it aims to target neural circuits. Unlike conventional BCI systems, which often rely on electrodes to detect electrical signals from neurons, Gestala’s method employs high-frequency sound waves. These waves can be finely tuned in terms of intensity and focus to interact with specific brain regions.

Current ultrasound treatments have already been approved for conditions such as Parkinson’s disease, uterine fibroids, and certain tumors. This established clinical background provides a solid foundation for companies like Gestala as they venture into the more complex realm of interpreting brain signals through ultrasound.

Gestala’s inaugural product focuses on chronic pain management. The company plans to target the anterior cingulate cortex, a brain region associated with the emotional experience of pain. Preliminary pilot studies indicate that stimulating this area could reduce pain intensity for up to a week in some patients. Initially, the device will be a stationary system used in clinical settings, requiring patients to visit hospitals for treatment sessions. However, Gestala envisions a future where a wearable helmet could be developed for supervised use at home.

Beyond chronic pain, Gestala has ambitious plans to explore applications for depression, other mental health conditions, stroke rehabilitation, Alzheimer’s disease, and sleep disorders. Each of these conditions presents unique challenges, as they involve different brain networks and require tailored clinical approaches.

In addition to treatment, Gestala is investigating the potential of ultrasound technology to interpret brain activity. The long-term vision is to create a device capable of detecting patterns associated with chronic pain or depression and delivering targeted stimulation in response. Unlike traditional brain implants that capture electrical signals from limited areas, an ultrasound-based system could potentially access broader regions of the brain, which is why researchers are closely monitoring these developments.

However, the journey toward practical applications is fraught with challenges. Ultrasound technology faces inherent limitations, such as the distortion of sound waves by the skull, which complicates the acquisition of precise signals. In research environments, detailed readings of neural activity often necessitate the use of specialized implants that facilitate clearer ultrasound transmission through bone.

Moreover, ultrasound measures changes in blood flow, which occurs at a slower rate than the electrical firing of neurons. This delay may restrict applications that require rapid, detailed signal decoding, such as real-time speech translation. Thus, while stimulation presents one challenge, accurately reading brain activity introduces an additional layer of complexity.

At present, this technology remains experimental, and consumers are unlikely to find brain helmets available for purchase in electronics stores anytime soon. However, the direction of this research is significant. If non-invasive ultrasound devices can effectively alleviate chronic pain or enhance mental health treatments, they may encourage more patients to seek therapy without the fear of undergoing brain surgery.

As the field progresses, the introduction of devices capable of analyzing brain states raises important privacy concerns. Data related to brain activity is deeply personal, necessitating clear regulations regarding its storage, sharing, and protection. Furthermore, the intersection of artificial intelligence and brain interface startups highlights the growing relationship between digital technology and neuroscience, which could transform medicine, wellness, and human interaction with technology.

Brain-computer interfaces, once viewed as distant and experimental, are now at the forefront of global research and investment. China’s initiative to develop ultrasound-based BCIs adds momentum to a field already influenced by established companies like Neuralink and emerging ventures supported by OpenAI. While progress is steady, the technical hurdles remain significant. The future trajectory of this technology will depend on researchers’ ability to translate promising laboratory results into safe, reliable treatments for real-world applications.

As the potential for sound waves to interpret mental states unfolds, important questions arise regarding the ethical use of such information. Who should have access to this data, and how should it be utilized? These are critical considerations as the field of brain-computer interfaces continues to advance, shaping the future of healthcare and technology.

According to Fox News, the ongoing developments in this area reflect a broader trend in the integration of neuroscience and technology, paving the way for innovative solutions to complex health challenges.

Indian Nurses Association of New York Offers Free Webinar for Registered Nurses

The Indian Nurses Association of New York is offering a free continuing education webinar for registered nurses, featuring a presentation on hepatic steatosis and its complications.

The Indian Nurses Association of New York (INANY), a prominent organization dedicated to community health and nursing excellence, is set to host an educational webinar for registered nurses on Friday, March 6th, from 8:00 PM to 9:00 PM. This initiative highlights INANY’s commitment to supporting lifelong learning within the nursing profession, as participants will earn one free continuing education credit.

The webinar will be led by Vinci Johnson, a Nurse Practitioner at South Shore University Hospital, who brings nearly twenty-five years of experience in various intensive care units. Johnson will address the important and clinically relevant topic, “From Hepatic Steatosis to Decompensated Liver Cirrhosis.”

Hepatic steatosis, commonly referred to as fatty liver disease, occurs when excess fat, primarily triglycerides, accumulates in liver cells. While this condition is often reversible, untreated fatty liver can lead to more severe health issues, including inflammation, cirrhosis, liver failure, and even liver cancer. During the session, Johnson will delve into the disease process, potential complications, and the latest scientific advancements in treatment. The goal is to provide nurses with enhanced clinical insight and increased confidence in managing patients with hepatic steatosis, ultimately aiming to improve patient outcomes and prevent the progression to advanced liver disease.

INANY serves the New York metropolitan area as a chapter of the National Association of Indian Nurses of America (NAINA), which works closely with the American Nurses Association (ANA)—the professional organization representing approximately five million registered nurses across the United States. In addition to offering continuing education programs, INANY is actively involved in providing nursing scholarships, organizing community health fairs, and leading charitable initiatives, such as back-to-school supply drives, food and clothing collections, and participation in blood donation campaigns.

Registration for the webinar is free, and interested participants can register by scanning the QR code on the event flyer. For further information, individuals may contact Dr. Shyla Roshin, INANY President, at 646-262-8105; Annie Sabu, Chair of the Education Committee, at 516-474-5834; Shini Xavier, Chair of the Advanced Practice Nurses Committee, at 917-225-8244; or Dr. Shabnampreet Kaur, INANY Secretary, at 929-231-4994.

According to GlobalNetNews, this webinar underscores INANY’s dedication to enhancing nursing education and improving community health outcomes.

Diabetes Surge Among Americans Linked to ‘Healthy’ Breakfast Choices

Dr. Mark Hyman warns that seemingly healthy breakfast options may contain hidden sugars, contributing to a surge in diabetes among Americans.

Many Americans unknowingly consume breakfast foods marketed as “healthy,” which may be detrimental to their health, according to Dr. Mark Hyman, a physician and co-founder of Function Health in California. He emphasizes that a significant portion of the American diet is laden with unhealthy ingredients.

“The amount of refined starches and sugars that are everywhere is just staggering to me, given what we know about how harmful they are,” Hyman stated in an interview with Fox News Digital. “I don’t think people really understand.”

Hyman, who is also the author of the new book “Food Fix Uncensored,” expressed his astonishment at the breakfast choices many people make. “People just eat sugar for breakfast,” he noted, listing common offenders such as muffins, bagels, croissants, and sugar-sweetened coffees and teas.

In addition to traditional sweet breakfast items, some cereal brands and breakfast staples have introduced “protein-packed” products in response to health trends promoting higher protein consumption. However, Hyman cautioned that many of these protein smoothies are often loaded with sugar.

<p”Now, we’re seeing this halo of protein in certain things,” he remarked. “My joke is, if it has a health claim on the label, it’s definitely bad for you.”

To combat these unhealthy breakfast habits, Hyman recommends opting for whole sources of protein and fat. He believes that a small amount of carbohydrates is acceptable as part of a balanced breakfast. For his own morning meal, Hyman prefers a protein shake made with whey protein, avocado, and frozen berries. He also advocates for eggs and avocados as a nutritious protein-and-fat combination.

“It’s not that complicated — people need to just think about their breakfast not being dessert,” he asserted. “No wonder we’re in this cycle of obesity and diabetes. One in three teenage kids now has type 2 diabetes or pre-diabetes. That’s just criminal.”

Rather than focusing on calorie counting and maintaining a caloric deficit for weight loss and health, Hyman encourages individuals to consider how different foods affect their well-being. “When you look at the way in which different types of calories affect your biology, you can just choose what you’re eating, and then you don’t have to worry about how much,” he explained.

Hyman elaborated that consuming a diet low in starch and sugar, while higher in protein and fat, can prevent insulin spikes and blood sugar fluctuations. “You won’t develop those swings in blood sugar, you won’t develop the spikes in insulin, you won’t deposit hungry fat … You will break that cycle,” he said.

He also pointed out that people tend to “self-regulate when they eat real food” as opposed to processed options, which often disrupt normal mechanisms of satiety and fullness. “Ultraprocessed food and junk food or highly processed food is not food,” he stated. “It doesn’t support the health and well-being of an organism. It doesn’t do that. It does the opposite.”

As the conversation around health and nutrition continues to evolve, Hyman’s insights serve as a reminder to scrutinize the foods we consume, particularly those that are marketed as healthy. The hidden sugars in many breakfast items could be contributing to a growing public health crisis, and making informed choices may be key to reversing the trend.

For more information on this topic, refer to the insights shared by Dr. Mark Hyman in his interview with Fox News Digital.

Bobby Ghoshal Appointed New CEO of Experity, an Indian-American Leader

Bobby Ghoshal has been appointed as the new CEO of Experity, aiming to transform the urgent care experience for millions of Americans.

Bobby Ghoshal stepped into the role of chief executive officer at Experity this week, inheriting a mission to redefine how millions of Americans experience urgent care.

The announcement of his appointment came during the company’s annual Urgent Care Connect conference and marks the culmination of a deliberate, year-long transition plan.

Ghoshal, a veteran Indian American tech leader, succeeds founder David Stern, who will transition to the role of executive chairperson. While Stern laid the groundwork for the market-leading platform, Ghoshal is tasked with shaping its future.

With over 30 years of experience in the healthcare software-as-a-service (SaaS) sector, Ghoshal is no stranger to the high-stakes environment of healthcare technology. He has built a reputation for driving growth through a combination of operational discipline and technological foresight.

Before joining Experity as president and chief operating officer in August 2025, Ghoshal held a key executive position at ResMed, where he led the Residential Care Software business, a division that generated over $600 million in revenue.

His extensive resume showcases his expertise in scaling complex healthcare ecosystems. During his tenure at ResMed, Ghoshal served as chief technology officer and as COO of Brightree, a software vendor specializing in out-of-hospital care. Throughout his career, he has successfully managed more than $2.5 billion in acquisitions, demonstrating his strategic capability in navigating the financial and technical intricacies of the medical technology industry.

“At Experity, the CEO role sets the pace and direction for everything we do,” Stern stated. He noted that since Ghoshal joined the company last year, he has concentrated on building strong connections with customers and earning the trust of the internal team.

Ghoshal’s arrival coincides with a period of rapid technological evolution at Experity. Under his leadership as COO, the company began integrating artificial intelligence into its clinical workflow through tools like “AI Scribe” and “Care Agent.” These innovations aim to eliminate the administrative friction that often hampers patient care.

For Ghoshal, the mission is deeply personal. He has expressed a strong commitment to “humanizing” the tech-heavy environment of modern clinics. By leveraging his background in engineering and commercial execution, he aims to create a “touchless” electronic medical record (EMR) experience that allows doctors to focus on patients rather than computer screens.

<p“It is my privilege to lead our next chapter of transformation,” Ghoshal said during the announcement. He emphasized that his focus will remain on accelerating innovation and empowering providers to deliver high-velocity, high-quality care.

As he takes the helm, Ghoshal will oversee a workforce of approximately 575 employees across locations in Tennessee, Illinois, South Dakota, and Georgia. Supported by the private equity firm GTCR, his leadership signifies a strategic pivot toward a future where AI and automated workflows become the standard for on-demand healthcare.

According to The American Bazaar, Ghoshal’s vision for Experity is set to transform the urgent care landscape significantly.

Common Nighttime Noise Exposure Linked to Heart Problems, Study Finds

Exposure to nighttime traffic noise above 50 decibels is linked to increased cholesterol levels and cardiovascular risks, according to a comprehensive European study involving over 272,000 adults.

Living near busy roads may pose a significant risk to heart health, according to a recent European study published in the journal Environmental Research. The research indicates that exposure to nighttime road traffic noise is associated with detrimental changes in blood composition, leading to elevated cholesterol levels and increased cardiovascular risks.

The study analyzed data from the U.K. Biobank, the Rotterdam Study, and the Northern Finland Birth Cohort 1966, encompassing over 272,000 adults aged 30 and older. Researchers estimated nighttime road noise exposure at the homes of participants using national noise maps, and they collected blood samples to assess various metabolic biomarkers associated with disease.

Findings revealed that individuals exposed to higher levels of nighttime noise—particularly those exceeding 55 decibels—exhibited changes in 48 different blood substances. Notably, 20 of these associations remained consistent across all study cohorts.

Increased exposure to loud noise correlated with higher concentrations of cholesterol-related biomarkers, including low-density lipoprotein (LDL), intermediate-density lipoprotein (IDL), and unsaturated fatty acids. The study indicated that as noise levels rose, starting at around 50 decibels, cholesterol markers increased steadily.

The authors concluded that their findings provide compelling evidence that nighttime road traffic noise exposure above 50 dB is linked to alterations in blood cholesterol and lipid profiles in adults. Yiyan He, a doctoral researcher at the University of Oulu in Finland and co-author of the study, emphasized that while small effect sizes are typical in this type of research, the associations observed were statistically robust and consistent across multiple biomarkers, particularly those related to LDL and IDL lipoproteins.

He noted, “Despite the modest nature of environmental exposures like traffic noise, we observed clear exposure-response patterns beginning at around 50 dB, indicating that metabolic changes become more pronounced with increasing noise levels.” This finding aligns with public health recommendations, as the World Health Organization suggests maintaining nighttime noise levels around 40 to 45 dB.

He further explained that the 55 dB level is often regarded as a benchmark associated with significant noise annoyance and sleep disturbances. In their study, researchers found associations not only at this level but also indicated effects beginning at around 50 dB.

The strength and consistency of the cholesterol-related associations were unexpected, as such changes are typically subtle. He stated, “We found consistent associations across multiple large European cohorts, which strengthens confidence that the findings may reflect real biological patterns.” The study also suggested a potential threshold effect, with minimal impacts observed below approximately 50 dB.

Importantly, the research indicated that these findings were consistent across various demographics, including gender, education levels, and obesity status. However, the study was limited to White Europeans, which may affect the generalizability of the results. Additionally, there was a lack of data regarding fasting status in the U.K. Biobank, which can influence levels of certain metabolites, particularly fatty acids.

He acknowledged that fewer than 10% of participants were fasting for at least eight hours, and the primary focus of the findings was on cholesterol-related biomarkers, which are generally less sensitive to short-term fasting. The researchers also faced limitations regarding bedroom location, indoor noise exposure, and the amount of time spent at home, which could introduce non-differential exposure misclassification.

Despite these limitations, He noted that many would likely bias results toward the null, making the consistent associations observed noteworthy. “Our findings suggest that nighttime traffic noise is a health-relevant exposure, not merely an annoyance,” she stated. “While the changes in cholesterol and lipid levels for any individual may be small, traffic noise affects a large population, indicating a potentially substantial public health impact.”

To mitigate these risks, He recommends improving sound insulation, employing noise-reducing strategies, and positioning bedrooms away from noisy areas when possible. “Since sleep is a crucial pathway linking noise to health, protecting the nighttime sleep environment is especially important,” she added.

These insights underscore the need for further investigation into the health implications of environmental noise, particularly as urban areas continue to grow and traffic noise becomes an increasingly prevalent issue.

According to Fox News, the study highlights the importance of addressing nighttime noise exposure as a significant factor in public health considerations.

Cancer-Linked Herbicide Faces Scrutiny After Controversial Order

HHS Secretary Robert F. Kennedy Jr. supports President Trump’s glyphosate order while acknowledging the inherent risks of pesticides, which he describes as “toxic by design.”

A significant controversy has emerged in the Make America Healthy Again (MAHA) movement regarding glyphosate, a widely used herbicide. This debate has intensified following an executive order signed by President Donald Trump aimed at ensuring an adequate supply of elemental phosphorus and glyphosate-based herbicides, which are deemed essential for national defense.

Historically, supporters of MAHA have advocated for a pesticide-free agenda, raising concerns about the potential health risks associated with glyphosate. Dr. Marc Siegel, a senior medical analyst for Fox News, has expressed his belief that there is substantial evidence linking glyphosate to neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple sclerosis. He argues that this connection warrants a reduction in exposure to the herbicide.

“With Parkinson’s, this association appears to be due to the gut, vagus nerve, and brain axis, where exposure affects the microbiome in the gut, which then ascends slowly to the brain, causing the neurodegenerative disease years later,” Siegel explained. He also noted a growing correlation between high-dose glyphosate exposure, particularly in occupational settings, and various health issues, including metabolic disorders, liver disease, and certain cancers, specifically lymphoma. Siegel emphasized that ongoing research supports the need to limit glyphosate exposure.

Research has indicated that glyphosate, commonly found in products like Roundup, could elevate cancer risks. A study conducted by the University of Washington, published in the journal Mutation Research, revealed that exposure to glyphosate increased the risk of non-Hodgkin lymphoma by 41%. Furthermore, the nonprofit Investigate Midwest recently analyzed data from the U.S. Geological Survey and the National Cancer Institute, concluding that pesticides may contribute to rising cancer rates.

Among the top 500 counties for pesticide use per square mile, over 60% reported cancer rates exceeding the national average of 460 cases per 100,000 people. Investigate Midwest, based in Illinois, conducted interviews with more than 100 farmers, environmentalists, lawmakers, and scientists in collaboration with the Pulitzer Center’s StoryReach U.S. Fellowship. Notably, Iowa, which utilized 53 million pounds of pesticides last year, has the second-highest cancer rate in the nation.

Bill Billings, a resident of Red Oak, Iowa, was diagnosed with cancer in 2014. He shared, “The cancer specialist said, very directly, my cancer is a result of being exposed to chemicals.”

Kelly Ryerson, founder of Glyphosate Facts and the Instagram account @glyphosategirl, began her journey into researching glyphosate due to her own health struggles. Based in California, Ryerson previously dealt with chronic illness and autoimmune issues, which she noticed improved after eliminating gluten from her diet. After attending a medical conference at Columbia University’s Celiac Disease Center, she began to scrutinize modern farming practices rather than attributing her health issues solely to gluten.

“A lot of times, farmers are spraying Roundup on our grains right before harvest to facilitate an easier harvest,” Ryerson explained. “After that easier harvest, because everything’s dry at the same time, those crops go directly to the mill and may end up in our food supply, at alarmingly high levels.”

In 2015, the International Agency for Research on Cancer (IARC), part of the World Health Organization, classified glyphosate as “probably carcinogenic to humans.” This classification was based on limited evidence of cancer in humans, particularly non-Hodgkin lymphoma in some studies, and sufficient evidence in experimental animals.

A spokesperson for Monsanto, the company that produces Roundup, stated that it will comply with President Trump’s executive order to continue producing glyphosate and elemental phosphorus. “President Trump’s executive order reinforces the critical need for U.S. farmers to have access to essential, domestically produced crop protection tools, such as glyphosate,” the spokesperson said.

HHS Secretary Robert F. Kennedy Jr. has been a long-time critic of Roundup, having worked with his legal team in 2018 to secure a $289 million settlement for a man who alleged that the weed killer caused his non-Hodgkin lymphoma. Following the backlash to Trump’s executive order, Kennedy expressed his support for the order but acknowledged the inherent risks of pesticides.

“Pesticides and herbicides are toxic by design, engineered to kill living organisms,” Kennedy posted on X. “When we apply them across millions of acres and allow them into our food system, we put Americans at risk. Chemical manufacturers have paid tens of billions of dollars to settle cancer claims linked to their products, and many agricultural communities report elevated cancer rates and chronic disease.”

Fox News Digital reached out to the White House for comment regarding the ongoing debate surrounding glyphosate and its implications for public health.

According to Investigate Midwest, the conversation around glyphosate and its health risks continues to evolve as more research emerges.

Survivor Voices Remain Silenced in Wake of Epstein Files

Despite the recent release of the Epstein files, the voices of trafficking survivors remain largely unheard, highlighting systemic failures in seeking justice for victims of sexual exploitation.

As the Epstein files make headlines, revealing the names and stories of numerous high-profile individuals, the voices of the victims remain largely silenced. Reports indicate that Jeffrey Epstein victimized at least 1,000 women and children, yet their pursuit of justice has been obstructed by a legal system that often views them as “problems to be managed” rather than individuals deserving protection and support.

The issue of human trafficking extends far beyond the Epstein case, with staggering statistics illustrating the scope of the problem. “More than one million people are trafficked annually,” said Pilar Marrero, a journalist and author, during an American Community Media (ACoM) briefing on February 13, 2026. “The majority are young women and girls,” she added, noting that nearly 99% of sex trafficking cases do not lead to prosecution.

Jacquelyn Aluotto, Co-Founder and President of No Trafficking Zone, emphasized the pervasive nature of this injustice. “When victims did speak out, not only were they retaliated against, but they saw that their powerful predators faced no consequences. Justice is going to just be a myth,” she stated.

Dr. Michele Goodwin, a Professor of Constitutional Law and Global Health Policy at Georgetown University, pointed out that the roots of this injustice lie in a historical connection between power, violence, and the silencing of sexual assault survivors. Many individuals do not identify as victims due to intense psychological manipulation and the shame associated with their exploitation, which further complicates their ability to come forward.

This silencing was starkly illustrated in the recent release of the Epstein documents, where the Justice Department unveiled the names and images of many survivors. “This is absolutely shocking and inconsistent with what would be the rule of law,” Goodwin remarked, highlighting the systemic failures that prioritize male harmony over the safety of women and children.

Despite early attempts by Epstein’s survivors to seek justice—such as Maria Farmer’s outreach to the New York Police Department and the Federal Bureau of Investigation in 1996—no formal investigation was initiated. Aluotto reiterated that women are often not taken seriously in sex trafficking cases, stating, “Not only are these women not taken seriously, but in the past, agencies haven’t worked together to understand the crime.”

Virginia Giuffre, a prominent accuser of Epstein and Prince Andrew, became the first survivor to publicly share her experiences in 2011. In February 2022, Prince Andrew reached a financial settlement with Giuffre, although he did not admit any wrongdoing and continues to deny her claims. Tragically, Giuffre died by suicide on April 25, 2025.

The vulnerability to trafficking often intersects with poverty and exploitation, disproportionately affecting marginalized groups such as homeless youth and those aging out of the foster care system. Previous trauma can heighten this vulnerability, making individuals prime targets for predators who employ grooming tactics to establish trust.

Giuffre reflected on this in her memoir, “Nobody’s Girl: A Memoir of Surviving Abuse and Fighting for Justice,” stating, “So many young women, myself included, have been criticized for returning to Epstein’s lair even after we knew what he wanted from us.” She emphasized that such criticisms overlook the complex backgrounds of victims and the manipulative tactics employed by traffickers.

Traffickers exploit unique vulnerabilities, often luring victims with false promises of assistance or job opportunities. For many, the nightmare begins in familiar settings. Courtney Litvak, a survivor trafficked at age 17 and held captive for three years, recounted, “It began at my very own high school.” In Texas, 55% of survivor leaders reported being groomed or recruited through their schools, where institutions often prioritize liability over accountability.

Litvak explained that traffickers sometimes engage in peer-on-peer exploitation, incentivizing students to recruit classmates into organized crime networks. Once ensnared, victims often find their identities systematically dismantled. “How can a victim or survivor be focused at all on their education when they are in what’s called survival mode?” she asked, highlighting the psychological toll of trafficking.

Carmen McDonald, Executive Director of the Survivor Justice Center, noted that many survivors fear reporting crimes against them, often feeling unsafe even on the streets. This fear is compounded for immigrant survivors, who face additional barriers such as language hurdles and the threat of deportation. “Our clients are calling us and telling us they’re afraid to report crimes against them,” McDonald said.

Immigrant survivors of sex trafficking encounter unique challenges that hinder their ability to seek justice. Many are unaware of their rights and may be manipulated by traffickers who use their legal status against them. McDonald explained that predators often file false police reports against survivors or withhold identity documents to maintain control.

Legal remedies like the T visa exist to protect immigrant survivors, but many remain uninformed about these options. The complexities of immigration law, which can change rapidly, further complicate their situations. “There is no such thing as a perfect victim,” Litvak asserted, emphasizing the need for a more nuanced understanding of survivors’ experiences.

Dr. Goodwin highlighted the unrealistic expectations placed on survivors by the legal system, which often requires them to act as their own investigators. “What 6-year-old…10-year-old, 14-year-old is filing a police report?” she questioned, illustrating the challenges faced by young victims in navigating the legal landscape.

Influential perpetrators frequently leverage their power to discredit victims. In Epstein’s case, his legal team reframed minors as “prostitutes” to shift blame, despite the legal reality that minors cannot consent. This manipulation allows powerful individuals to evade significant consequences while survivors face ongoing stigma.

As society processes the revelations from the Epstein files, advocates stress the importance of shifting focus from high-profile abusers to supporting survivors in their healing journeys. Aluotto emphasized the need to “follow the money trail” and hold co-conspirators and corporations accountable to disrupt the high-profit, low-risk nature of human trafficking.

Dr. Goodwin urges a collective effort to prioritize the needs of Epstein’s survivors, advocating for a broader societal conversation that connects political power to violence and creates pathways for survivors to reclaim their lives. “Hopefully, it opens the door for deeper, broader, honest conversations in our society,” she concluded, emphasizing the urgency of addressing these systemic issues.

In summary, the voices of trafficking survivors must be amplified as society grapples with the implications of the Epstein files. Only through collective action and a commitment to justice can we hope to create a safer world for all.

According to India Currents.

Common Vision Issues Linked to Home Lighting Choices in America

New research indicates that dim indoor lighting, rather than screen time, may contribute to the rising rates of myopia, which could affect nearly half of the global population by 2050.

Recent studies have highlighted a concerning trend: nearsightedness, or myopia, is on the rise worldwide. The World Health Organization estimates that by 2050, nearly half of the global population will be affected by this vision issue.

While heavy use of smartphones and other digital devices has been linked to an 80% increased risk of myopia—especially when combined with excessive computer usage—new research suggests that dim indoor lighting may also play a significant role in this epidemic.

For years, scientists have sought to understand the various triggers of myopia. Laboratory experiments have shown that myopia can be induced by blurring vision or using different lenses. Conversely, spending time outdoors has been found to slow its progression, indicating that environmental factors are at play.

According to the American Optometric Association (AOA), myopia occurs when the eyeball elongates too much from front to back. This elongation causes light to focus in front of the retina, resulting in distant objects appearing blurry.

Researchers at the State University of New York (SUNY) College of Optometry have identified a potential trigger for this elongation. When individuals focus on close objects, such as smartphones or books, their pupils naturally constrict. However, this constriction is not solely a response to brightness; it also serves to sharpen the image.

Urusha Maharjan, a doctoral student at SUNY Optometry who conducted the study, explained, “In bright outdoor light, the pupil constricts to protect the eye while still allowing ample light to reach the retina.” She further noted that in dim lighting, the combination of focusing on close objects and a narrowed pupil can significantly reduce the amount of light reaching the retina.

The researchers propose that when the retina is deprived of adequate light during prolonged close-up tasks, it sends signals for the eye to grow. In dim environments, the limited light reaching the retina may not be sufficient to halt this growth, leading to an increased risk of myopia.

In contrast, outdoor environments provide much brighter light levels than indoor settings. This ensures that even when the pupil narrows to focus on nearby objects, the retina still receives a strong signal, promoting healthy eye development.

The research team acknowledged some limitations of their study, including a small subject group and the challenge of directly measuring internal lens changes. The bright backgrounds used to simulate outdoor conditions resulted in pupils being too small for standard measurement equipment.

“This is not a final answer,” said Dr. Jose-Manuel Alonso, a distinguished professor and senior author of the study. “But the study offers a testable hypothesis that reframes how visual habits, lighting, and eye focusing interact.”

The findings of this study were published in the journal Cell Reports, and they open new avenues for understanding the relationship between lighting conditions and eye health.

As the prevalence of myopia continues to rise, it becomes increasingly important to consider how our indoor environments may contribute to this global health issue. Adjusting lighting conditions and encouraging outdoor activities could be vital steps in mitigating the myopia epidemic.

For more information on this topic, refer to the research conducted by the SUNY College of Optometry.

Researchers Create E-Tattoo to Monitor Mental Workload in High-Stress Jobs

Researchers have developed a face-mounted electronic tattoo, or “e-tattoo,” designed to monitor mental workload in high-stress professions using advanced brainwave technology.

In an innovative study published in the journal Device, scientists have introduced a groundbreaking electronic tattoo device, referred to as an “e-tattoo,” that can help individuals in high-pressure work environments monitor their brain activity and cognitive performance.

The research team, led by Dr. Nanshu Lu from the University of Texas at Austin, emphasizes that mental workload is a crucial element in human-in-the-loop systems, significantly affecting cognitive performance and decision-making processes. This device aims to provide a more cost-effective and user-friendly method for tracking mental workload, particularly in demanding fields such as aviation, healthcare, and emergency response.

Dr. Lu noted that the e-tattoo could be particularly beneficial for professionals like pilots, air traffic controllers, doctors, and emergency dispatchers, who often operate under intense stress. Additionally, the technology could enhance training and performance for emergency room doctors and operators of robots and drones.

The primary objective of the study was to develop a means of measuring cognitive fatigue among individuals in high-stakes careers. The e-tattoo is designed to be temporarily affixed to the forehead and is significantly smaller than existing monitoring devices.

Utilizing electroencephalogram (EEG) and electrooculogram (EOG) technologies, the e-tattoo measures both brain waves and eye movements. Traditional EEG and EOG equipment tends to be bulky and expensive, but the e-tattoo presents a compact and affordable alternative.

Dr. Lu explained that the device is designed to be as thin and flexible as a temporary tattoo sticker, allowing for comfortable wear while providing accurate readings. She stated, “Human mental workload is a crucial factor in the fields of human-machine interaction and ergonomics due to its direct impact on human cognitive performance.”

The study involved six participants who were tasked with identifying letters displayed on a screen. Each letter appeared sequentially at various locations, and participants were instructed to click a mouse when they recognized either the letter or its position from a previously shown set. The difficulty of the tasks increased progressively, and the researchers observed shifts in brainwave activity that indicated a heightened mental workload as challenges intensified.

The e-tattoo consists of a battery pack, reusable chips, and a disposable sensor, making it a practical solution for real-time monitoring. Currently, the device is a lab prototype, with a production cost of approximately $200.

Dr. Lu highlighted that further development is necessary before the e-tattoo can be commercialized. This includes enhancing the device’s ability to decode mental workload in real-time and validating its effectiveness with a larger group of participants in more realistic settings.

As the demand for effective stress management tools in high-pressure jobs continues to grow, the e-tattoo represents a promising advancement in cognitive performance monitoring, potentially transforming how professionals manage their mental workload.

According to Fox News, the e-tattoo could pave the way for improved performance and training in various high-stakes occupations.

Olive Oil May Enhance Brainpower During Aging, Study Finds

New research indicates that extra virgin olive oil may enhance brain health by improving gut bacteria and cognitive function in older adults.

A recent study conducted by researchers at Universitat Rovira i Virgili in Spain has revealed that extra virgin olive oil may play a significant role in protecting brain health, particularly in older adults. This finding adds to the existing body of evidence that highlights the cardiovascular benefits of olive oil.

The study specifically examined the effects of virgin olive oil compared to refined olive oil on cognitive function and gut microbiota diversity. Researchers found that individuals who consumed virgin olive oil exhibited improved cognitive abilities and a more diverse gut microbiome, which is considered an important indicator of intestinal and metabolic health.

“This is the first prospective study in humans to specifically analyze the role of olive oil in the interaction between gut microbiota and cognitive function,” stated Jiaqi Ni, the lead author of the study and a researcher at the Department of Biochemistry and Biotechnology at URV.

The research involved a two-year analysis of over 600 participants aged 55 to 75, all of whom were classified as overweight or obese and had metabolic syndrome—conditions that elevate the risk of heart disease. Throughout the study, the researchers monitored the participants’ consumption of both refined and virgin olive oil, alongside their gut microbiota.

Findings from the study suggest that the increase in gut bacteria diversity may be a key factor in the enhanced brain health observed in those consuming virgin olive oil. In contrast, participants who primarily consumed refined olive oil demonstrated a decline in gut microbiota diversity over time.

The distinction between refined and virgin olive oils lies in their processing methods. Refined olive oil undergoes industrial treatments that remove impurities, which can degrade the oil and strip it of beneficial antioxidants and vitamins.

In a follow-up assessment, researchers evaluated changes in cognitive function among participants. Those who regularly consumed extra virgin olive oil showed notable improvements in memory, attention, and executive function over the two-year period. Conversely, refined olive oil did not yield similar cognitive benefits.

“Not all olive oils have benefits for cognitive function,” Ni emphasized, highlighting the importance of choosing high-quality oils.

This research underscores the notion that the quality of dietary fats is as crucial as their quantity, according to Jordi Salas-Salvadó, the principal investigator of the study. “Extra virgin olive oil not only protects the heart but can also help preserve the brain during aging,” he remarked.

It is important to note that this observational study focused on older Mediterranean adults with specific health risks, which may limit the applicability of the findings to the broader population. Additionally, the study does not establish a direct causal relationship between olive oil consumption and cognitive changes.

Researchers acknowledged that factors such as smoking and lower education levels were more prevalent among participants who used refined oil, which could potentially skew the results despite their efforts to adjust the data. Furthermore, the reliance on self-reported dietary habits introduces a risk of inaccuracies.

The study has been published in the journal Microbiome.

According to Fox News, the implications of this research could encourage individuals to reconsider their dietary choices, particularly when it comes to the type of olive oil they incorporate into their diets.

New Study Finds Leprosy in the Americas Before European Arrival

The discovery of Mycobacterium lepromatosis indicates that leprosy existed in the Americas long before European explorers arrived, reshaping historical perceptions of the disease.

Recent research has revealed that leprosy, also known as Hansen’s disease, was present in the Americas long before the arrival of European explorers. This finding challenges the long-held belief that the disease was introduced to the continent by settlers.

Scientists from the Institut Pasteur in Paris, France, in collaboration with a U.S. university, announced the discovery of a second species of bacteria responsible for leprosy. Previously, it was widely accepted that Mycobacterium leprae was the sole bacterium causing the disease, which was thought to have been brought to the Americas by early European explorers and settlers.

The identification of Mycobacterium lepromatosis suggests that this bacterium has been infecting humans in the Americas for at least 1,000 years prior to European contact. Dr. Maria Lopopolo, the first author of the study and a researcher at the Laboratory of Microbial Paleogenomics at the Institut Pasteur, emphasized the significance of this discovery. “This discovery transforms our understanding of the history of leprosy in America. It shows that a form of the disease was already endemic among Indigenous populations well before the Europeans arrived,” she stated.

The study was initiated after Mycobacterium lepromatosis was first identified in a Mexican patient in 2008, followed by its detection in red squirrels in the British Isles in 2016. Researchers utilized advanced genetic techniques to reconstruct the genomes of Mycobacterium lepromatosis from ancient individuals in Argentina and Canada. Their findings indicated that the two strains from these regions were closely related, suggesting that the bacteria spread rapidly throughout the continent.

The results confirmed that Mycobacterium lepromatosis had already established itself across both North and South America. The research team collaborated with Indigenous communities, various international institutions, and archaeologists, analyzing over 800 DNA samples from ancient human remains and recent medical cases exhibiting signs of leprosy.

Nicolás Rascovan, the lead author of the study at the Institut Pasteur, remarked on the implications of their findings. “We are just beginning to uncover the diversity and global movements of this recently identified pathogen,” he noted. “This study allows us to hypothesize that there might be unknown animal reservoirs.”

According to the Centers for Disease Control and Prevention (CDC), leprosy can affect the nerves, skin, and eyes of patients, but it is treatable with antibiotics. In the United States, up to 225 people are diagnosed with Hansen’s disease each year, while approximately 250,000 cases are reported globally, as stated by the CDC.

This groundbreaking research not only alters the historical narrative surrounding leprosy in the Americas but also opens new avenues for understanding the disease and its transmission. The study highlights the importance of interdisciplinary collaboration in uncovering the complexities of human health and disease.

As scientists continue to investigate the origins and spread of Mycobacterium lepromatosis, the findings underscore the need for ongoing research into the historical interactions between Indigenous populations and infectious diseases, reshaping our understanding of public health in the context of global history.

These revelations about leprosy’s presence in the Americas prior to European contact prompt a reevaluation of the historical context of the disease and its impact on Indigenous communities. The research serves as a reminder of the intricate relationship between humans and pathogens throughout history, emphasizing the importance of studying ancient diseases to inform modern public health strategies.

For further details, refer to the study published by the Institut Pasteur.

Supporting Working Families with Flexible and Affordable Childcare Options

KidsPark provides flexible, affordable childcare solutions that support working families, particularly low- and middle-income parents, while highlighting the essential role of immigrant workers in the childcare industry.

KidsPark, a national franchise, is dedicated to offering accessible and responsible hourly daycare for families who may not require full-day childcare. This innovative approach allows parents to drop off their children at any time during operating hours, paying only for the hours they need without the necessity of reservations.

Founded 37 years ago, KidsPark has grown significantly, with daycare centers now operating in nine states. Sisters Beth Christie and Heather Alanis joined the franchise 17 years ago, opening the first KidsPark center in the Dallas-Fort Worth area. “We have families who use us five days a week, or parents who just drop in as needed,” Beth explained.

KidsPark aims to support low- and middle-income parents, for whom traditional childcare costs can be prohibitively high, often forcing them out of the workforce for extended periods. Many parents juggle conflicting work schedules to ensure that one is always available for their children. However, affordable childcare is still needed during the overlap when both parents are working. “The hourly drop-off allows them to minimize their childcare costs,” Beth noted.

Currently, parents pay $12 per hour for one child, with an additional $6 per hour for each sibling—rates that are often lower than those of independent babysitters. “Having quality staff that can take good care of your children while keeping rates low for parents is definitely a balancing act,” Beth added.

KidsPark primarily hires young individuals, often college students, with all current teachers in their 20s and the directors in their 30s. From the outset, immigrants have played a crucial role in the success of KidsPark Arlington. “We’ve always relied on people who have come here from another country, or are first- or second-generation,” Heather stated.

Many of these young workers are pursuing careers in nursing or education. “It’s just fun to see caregiving as a personality type,” Beth remarked. “The young women who work for us tend to be very family-oriented.” Over the years, the center has employed cousins and sisters, fostering a collaborative environment among staff members, all of whom come from immigrant backgrounds.

Immigrants and children of immigrants also bring valuable bilingual skills, which benefit children from diverse backgrounds, particularly in a multicultural area like Dallas. This region is home to many immigrant workers who play vital roles in sectors such as construction, manufacturing, and healthcare. “We want our staff to reflect our customers,” Beth emphasized. “We’ve loved having teachers that are bilingual.”

According to Beth, “The teachers that have come from immigrant families have generally been the kindest, most diligent, hard workers.” She expressed admiration for the young women who have worked at the center, noting their strong work ethic and the love they bring to their roles.

As KidsPark continues to grow, its commitment to providing flexible, affordable childcare remains steadfast, ensuring that working families have the support they need while recognizing the invaluable contributions of immigrant workers in the childcare sector. This model not only addresses the childcare crisis but also highlights the importance of community and collaboration in fostering a nurturing environment for children.

For more insights on the role of immigrant workers in the childcare industry, refer to the American Immigration Council.

Indian-American Women at Increased Risk for Breast Cancer Due to Lack of Screening

Indian American women face rising breast cancer risks, often overlooked due to cultural barriers and a lack of disaggregated health data, as illustrated by the experiences of women like Srila.

During the early days of the pandemic, Srila, a healthcare professional in the Bay Area, discovered a lump in her breast. “While showering, I used to feel a little bit of something tough, but I didn’t pay much attention,” she recalled.

Having lived in the U.S. for over 20 years and balancing her career with family responsibilities, Srila was due for her biennial mammogram in 2020. However, as the world shut down and daily anxieties mounted, she found it difficult to prioritize what seemed like a non-urgent health issue. Instead, she focused on running fundraisers for a Bay Area nonprofit she co-founded to send critical pandemic supplies to India.

“I’m normally a very attentive and science-driven person, but there was so much chaos with the pandemic going on,” she said.

By August 2020, the grape-sized lump and persistent tightness in her breast could no longer be ignored. Upon contacting her primary care physician, she was urged to come in immediately. At 47, Srila was unaware of the alarming trend: breast cancer rates among Asian American women under 50 were rising significantly.

According to a 2024 report from the American Cancer Society, Asian American and Pacific Islander (AAPI) women experienced the fastest-growing breast cancer incidence of any racial or ethnic group between 2012 and 2021, with a rise of 2.6% per year. Dr. Lihua Liu, a professor at the University of Southern California, noted that cancer was once seen as a disease primarily affecting the elderly, but statistics indicate a troubling shift. Between 2000 and 2021, new breast cancer cases among AAPI women under 50 surged by 52%.

Moreover, a 2019 CDC study found that immigrant Asian women faced a two- to three-fold higher risk of developing breast cancer compared to their U.S.-born counterparts, even after accounting for known risk factors such as reproductive history and family history. The reasons for this elevated risk among women arriving from Asia remain unclear.

For Indian American women like Srila, the situation is even more complex due to the lack of disaggregated data on South Asian communities. This absence makes it difficult to fully understand the scope of their risk.

Dr. Liu emphasized that closer studies reveal significant differences in screening rates, stage at diagnosis, treatment, and health outcomes among various Asian groups. Census data often lumps together individuals from diverse backgrounds, including Indian, Pakistani, Nepalese, and Sri Lankan, obscuring the specific trends affecting South Asian populations. Despite being the second-largest Asian group in the U.S. with a median age of 34, Indian Americans have received less attention regarding their increasing breast cancer risk compared to other health issues like heart disease and diabetes.

Dr. Preeti Farmah, a breast surgical oncologist at El Camino Health, explained that breast cancer risk factors can be inherited or genetic, but they are also influenced by lifestyle and environmental factors. For immigrant Asian American women, the process of westernization plays a crucial role in shaping these risks.

As Asian Americans adopt American lifestyles, they often experience changes in diet, reproductive practices, and environmental exposures that increase their vulnerability to breast cancer. Dr. Farmah noted that adopting a westernized lifestyle can lead to higher obesity rates, declining fertility rates, and a tendency to have children later in life. These factors extend the body’s total window of estrogen exposure, modestly increasing breast cancer risk.

Additionally, the demands of balancing careers and family life in the U.S. often result in fewer pregnancies and shorter breastfeeding durations, further compounding the risk. Chronic stress can also elevate cortisol levels, which may contribute to increased breast cancer risk.

Dr. Farmah explained that estrogen acts as a fuel for cancer cells. As dietary habits shift toward higher fat and processed foods, combined with reduced physical activity, obesity becomes a significant risk factor. “When you have fatty tissue, it can also produce estrogen,” she added.

Dense breast tissue, which disproportionately affects AAPI women, complicates detection. Both small breast cancers and dense tissue appear white on mammograms, making them harder to identify. Dr. Farmah noted that this increases the likelihood of undetected cancers, as subtle signs may remain hidden.

Cultural barriers also play a significant role in preventive care. Many first-generation Asian Americans delay seeking preventive care due to health care norms from their home countries, where visits to doctors typically occur only when one is ill. Dr. Harpreet Pannu, a Kaiser internist in San Jose, explained that this mindset can hinder participation in preventive health measures.

A Rutgers study of Indian and Pakistani women in the U.S. linked poor mammogram screening rates to lifestyle and cultural factors, including lack of family support, transportation issues, modesty concerns, and beliefs about cancer as divine punishment. With two-thirds of Indian Americans born outside the U.S., these cultural norms significantly influence their approach to mammograms.

According to the CDC, AAPI women aged 40 to 49 have among the lowest mammography rates of any racial group, with only 54% reporting a mammogram in the past two years, compared to 60% of White women.

As immigrant women navigate a new culture and healthcare system while balancing work and family, preventive care often falls by the wayside.

However, early detection can lead to better outcomes. Nibedita, a Los Angeles resident, had her first mammogram at 40, which was negative. A few months later, during a self-exam, she discovered a lump. Her doctor quickly referred her for an ultrasound and biopsy, leading to a diagnosis of triple-negative breast cancer (TNBC), an aggressive form of the disease that occurs at higher rates in women of Indian subcontinent ancestry than in White women. Fortunately, her cancer was caught early, allowing her to undergo successful treatment.

Srila’s journey took a similar turn after her initial consultation. Within days, an ultrasound and needle biopsy confirmed a triple-positive breast cancer diagnosis. Following conflicting treatment recommendations, she sought a second opinion from a Stanford oncologist, who advised chemotherapy before surgery. Despite the challenges of undergoing treatment during the pandemic, Srila persevered through six cycles of chemotherapy, followed by surgery and radiation.

Tragically, her cancer metastasized to her brain, leading to multiple tumors. The experience highlighted the differences in follow-up care protocols between the U.S. and India, where full-body scans are more common after treatment.

Despite the setbacks, Srila remains determined. “I don’t want to live to breathe. I want to live to live,” she said, emphasizing her desire to continue pursuing her passions. She is currently undergoing active treatment and monitoring, benefiting from specialized care and advanced medical technology.

This article was produced in partnership with the USC Annenberg Center for Health Journalism’s “Healing California” Ethnic Media Collaborative.

Sheel Dodani Receives $100,000 Hackerman Award for Protein Research

Indian American scientist Sheel Dodani has been awarded the prestigious $100,000 Hackerman Award for her innovative research in protein technology aimed at enhancing human health and environmental sustainability.

Sheel Dodani, an Indian American scientist, has received the esteemed 2026 Norman Hackerman Award in Chemical Research from The Welch Foundation. This award, which includes a $100,000 prize and a bronze sculpture, recognizes her groundbreaking work in the field of engineered proteins, specifically their application as anion sensors in biological systems.

Dr. Dodani is an associate professor of chemistry and biochemistry at the University of Texas at Dallas. Her research has been described as “using creative and daring chemistry to engineer technologies” that significantly contribute to human health and environmental improvement. Fred Brazelton, chair and director of The Welch Foundation, praised her achievements, stating, “Dr. Dodani is using creative and daring chemistry to engineer technologies that can measure and manipulate anions in living systems for the betterment of human health and the environment.”

The Hackerman Award is named after the foundation’s former scientific advisory board chair and aims to honor the accomplishments of early-career chemical scientists in Texas who are committed to advancing the fundamental understanding of chemistry. The award not only highlights individual achievement but also underscores the importance of innovative research in the scientific community.

Dr. David Hyndman, dean of the School of Natural Sciences and Mathematics at UT Dallas, remarked on the significance of Dodani’s work, stating, “Sheel Dodani’s research is opening an important new window into the chemistry of life.”

Dodani’s research group has developed the first coherent suite of genetically engineered fluorescent proteins that serve as biosensors for inorganic anions. While much attention has been given to cations—positively charged particles that are crucial for biological processes—anions, or negatively charged particles, have not been as thoroughly explored. This gap in understanding is particularly notable given the vital role that anions play in various biological functions.

One prominent example of an anion is chloride, which is essential for regulating fluid balance, blood pressure, and pH levels in the human body. The biosensors developed by Dodani have revolutionized researchers’ ability to track and visualize the behavior and interactions of these biologically significant anions in real time within living systems.

By utilizing fluorescent biosensors, researchers can now observe how anions behave in cells, paving the way for new therapeutic avenues. This includes the potential identification of small molecules that could treat chloride channel dysfunctions associated with diseases such as cystic fibrosis.

Reflecting on her research journey, Dodani noted, “This work began with a fundamental question: How can we bind an anion in water?” She explained that her team turned to nature’s supramolecular machines—proteins—to find answers. Through protein engineering, they have unlocked new functionalities in fluorescent proteins that enable the observation of anion biology, which has traditionally been challenging to study directly in living cells.

Dodani expressed gratitude for the support from The Welch Foundation, stating, “The Welch Foundation gave us the opportunity to pursue this direction early on. At the time, there was no established framework for investigating anions in water, let alone in living systems. By integrating concepts from different disciplines, we have started to answer questions that were previously out of reach.”

The Welch Foundation plays a crucial role in providing resources that allow researchers like Dodani to take risks in their scientific inquiries. This support is vital for those who aim to tackle complex questions that could have significant implications for human health and the environment.

Born and raised in Plano, Texas, Dodani completed her Bachelor of Science in chemistry at UT Dallas. She then pursued her PhD at the University of California, Berkeley, followed by a postdoctoral fellowship at the California Institute of Technology. In 2016, she returned to UT Dallas as a faculty member in the School of Natural Sciences and Mathematics, where she continues to make impactful contributions to the field of chemistry.

According to The American Bazaar, Dodani’s innovative research not only enhances our understanding of anions but also holds promise for future advancements in medical and environmental applications.

Living at High Altitudes May Lower Risk of Common Diseases

Living at high altitudes may lower the risk of diabetes, as red blood cells absorb glucose more effectively in low-oxygen environments, according to a new study from the Gladstone Institutes.

Research suggests that residing at high altitudes could significantly reduce the risk of developing diabetes. A study conducted by the Gladstone Institutes in San Francisco has shed light on this phenomenon, revealing how red blood cells behave in low-oxygen environments.

The findings, published in the journal Cell Metabolism, indicate that at elevated altitudes, red blood cells take on the role of “sponges,” absorbing substantial amounts of glucose from the bloodstream. This adaptation occurs as oxygen levels drop, prompting these cells to modify their metabolism to enhance oxygen delivery throughout the body.

This metabolic shift also results in lower levels of circulating blood sugar, which researchers believe accounts for the reduced diabetes risk observed in populations living in mountainous regions. A previous study involving over 285,000 adults in the United States found that individuals residing at altitudes between 1,500 and 3,500 meters were significantly less likely to develop diabetes compared to those living at sea level, even after controlling for variables such as diet, age, and ethnicity.

“Red blood cells represent a hidden compartment of glucose metabolism that has not been appreciated until now,” said Isha Jain, a senior investigator at Gladstone and a professor of biochemistry at UC San Francisco. “This discovery could open up entirely new ways to think about controlling blood sugar.”

In earlier experiments, Jain’s team studied mice to gain insights into hypoxia, a condition characterized by reduced oxygen levels in the blood. They observed that mice exposed to thin air cleared sugar from their bloodstream almost immediately after eating, a characteristic typically associated with a lower risk of diabetes. However, the researchers initially struggled to determine where the sugar was being directed.

“We looked at muscle, brain, liver—all the usual suspects—but nothing in these organs could explain what was happening,” said Yolanda Martí-Mateos, a postdoctoral scholar in Jain’s lab and the study’s first author.

The breakthrough came when the team employed an alternative imaging method, which revealed that the red blood cells themselves were the missing “glucose sink.” Under hypoxic conditions, the mice produced an increased number of red blood cells, each of which absorbed significantly more glucose than they did under normal conditions.

To further explore this phenomenon, the researchers developed a drug called HypoxyStat, which mimics the effects of high altitude. In laboratory tests, this drug was able to completely reverse high blood sugar levels in diabetic mice.

Despite the promising results, the researchers acknowledged certain limitations in their study. The research focused on a specific strain of mice known for its sensitivity to blood sugar. While similar results have been observed in humans, testing additional strains would be necessary to confirm the universality of the findings.

Additionally, the team only studied young male mice, as age and sex can significantly influence red blood cell production. More research is needed to determine whether these findings apply to female and older populations.

“This is just the beginning,” Jain stated. “There’s still so much to learn about how the whole body adapts to changes in oxygen, and how we could leverage these mechanisms to treat a range of conditions.”

As researchers continue to investigate the implications of these findings, they may pave the way for new strategies in diabetes management and treatment, potentially benefiting millions of individuals at risk of this common disease.

According to Fox News, the study highlights the intricate relationship between environmental factors and metabolic health, opening new avenues for research and potential therapeutic interventions.

11 Indian-American Innovators Recognized in Forbes’ 250 Greatest Innovators

Forbes has recognized 11 Indian Americans in its “250 America’s Greatest Innovators” list, highlighting their significant contributions to technology and medicine as the nation celebrates its 250th anniversary.

Forbes recently unveiled its “250 America’s Greatest Innovators” list to commemorate the United States’ 250th anniversary, showcasing a diverse group of visionary founders and executives who are reshaping global technology and medicine. Among the honorees are 11 Indian Americans, whose groundbreaking work spans from the early days of the internet to the cutting-edge developments in generative AI.

Leading this distinguished group is Vinod Khosla, co-founder of Sun Microsystems and a prominent venture capitalist, who secured the No. 10 spot. Khosla is renowned for his “black swan” investing style, with early investments in OpenAI and green technology solidifying his reputation as a leading risk-taker in the industry.

Close behind Khosla are tech giants Satya Nadella and Sundar Pichai, who have been instrumental in “re-founding” Microsoft and Alphabet, respectively. Their leadership has pivoted these legacy companies toward an AI-first future, reflecting the transformative power of innovation in the tech landscape.

The Forbes list emphasizes that innovation is often a marathon rather than a sprint. Suma Krishnan, who ranks No. 127, has made significant strides in treating “butterfly skin” disease. She co-founded Krystal Biotech in her 50s to develop the first topical gene therapy, marking a pivotal moment in medical innovation.

Similarly, Jay Chaudhry, ranked No. 128, has been recognized for his pioneering work in “zero trust” cloud security at Zscaler, which has disrupted the traditional firewall industry and redefined security protocols in the digital age.

The Indian American diaspora continues to make substantial contributions to technical infrastructure. Neha Narkhede, co-founder of Confluent and now CEO of Oscilar, is celebrated at No. 155 for her work in real-time data streaming. At MIT, Sangeeta Bhatia, ranked No. 161, has been honored for her innovative approach to merging microchips with biology, revolutionizing drug testing methodologies.

The diversity of this group extends into the daily lives of millions. Aman Narang, who ranks No. 177, has transformed the restaurant industry with Toast’s management platform. Baiju Bhatt, at No. 183, has democratized retail investing through Robinhood and is now pivoting to space-based solar power with Aetherflux. Naval Ravikant, ranked No. 230, has broadened access to startup funding via AngelList, further contributing to the entrepreneurial ecosystem.

The final names on the list reflect a commitment to human equity and efficiency. Shiv Rao, ranked No. 235, has been recognized for his AI medical scribe, Abridge, which automates clinical documentation to alleviate physician burnout. Shan Sinha, at No. 202, has made significant contributions to data management and healthcare safety, while Shivani Siroya, ranked No. 238, has been lauded for her work with Tala, which utilizes mobile data to provide credit to the “unbanked” in emerging markets.

This impressive collection of 11 innovators underscores a robust pipeline of talent that has become essential to the American economy. Whether they began their journeys in a garage or now lead major conglomerates, these individuals have successfully transformed complex scientific and digital theories into everyday realities.

According to Forbes, the achievements of these innovators highlight the critical role that diverse perspectives play in driving progress and shaping the future.

Heavy Snow Increases Risk of Heart Attacks, Experts Warn

Heavy snowfall poses significant health risks, particularly for those with pre-existing conditions or sedentary lifestyles, as shoveling can lead to serious heart-related events, experts warn.

As the northeastern United States braces for historic snow accumulation this week, health experts are sounding the alarm about the dangers of shoveling heavy, wet snow. The combination of strenuous physical activity and exposure to frigid temperatures can place a significant strain on the heart, particularly for individuals who are not regularly active or who have underlying health issues.

Dr. Marc Siegel, a senior medical analyst for Fox News, emphasized that the risks associated with shoveling snow are heightened by the weight of the snow and the cold winds. “The combination of the wet, heavy snow and the heavy winds make it more of a health risk because it’s much harder to get around,” he told Fox News Digital.

In addition to the physical exertion required for shoveling, heavy, wet snow can create hazardous conditions. As temperatures drop, the snow can freeze, leading to icy surfaces that pose risks for walking and driving. “In the aftermath of the storm, as the temperatures drop, the heavy, wet snow forms ice, which makes walking and driving treacherous,” Siegel noted.

Moreover, heavy snow can infiltrate clothing, increasing the risk of hypothermia in severe cases. Siegel urged individuals to dress appropriately for the conditions, highlighting the importance of wearing gloves, hats, and warm coats. “I saw this morning people who weren’t covered properly… weren’t wearing gloves, didn’t have the full hat, or the kind of overcoat they needed,” he said. “They also weren’t looking out for each other.” He stressed the need for community vigilance during such weather events.

Siegel advised against unnecessary outdoor activity, warning of the dangers posed by fallen power lines and trees weighed down by snow. “Watch out if you are outside for brief periods — for fallen power lines or for trees that are down. That’s very, very dangerous as well,” he cautioned. “That’s where a lot of the injuries come from.”

Dr. Joshua Latzman, a cardiologist at White Plains Hospital Physician Associates in New York, echoed these concerns. He explained that research indicates shoveling heavy snow can impose “significant stress on the heart.” He noted that this risk is exacerbated in cold temperatures, which can elevate blood pressure and constrict coronary arteries. “This can be especially dangerous for people who are out of shape or not used to strenuous activity,” Latzman said.

Many heart-related incidents occur among individuals who are typically inactive. Latzman warned that when someone who is sedentary suddenly engages in heavy shoveling after a storm, the unexpected physical strain can lead to serious emergencies. “Straining to lift something heavy can have the same effect if normal breathing is impacted,” he added.

Those at greater risk include individuals who are obese, smokers or former smokers, people with diabetes, and those with high cholesterol or high blood pressure. Additionally, anyone with a history of heart attacks or strokes should exercise extreme caution, according to the American Heart Association (AMA).

“Anyone with these characteristics, including people who have undergone bypass surgery or coronary angioplasty, should not be shoveling snow,” Latzman concluded.

Siegel advised those who may be at risk to avoid shoveling altogether, suggesting they “get a younger person or somebody who’s in much better shape to do it.” He described shoveling snow as “about the most cardiac expenditure of energy that you can have.” For those who must shovel, experts recommend taking a gradual approach and working at a comfortable pace.

The AMA also suggests covering the mouth and nose while shoveling and dressing in layers, including hats and gloves. Pushing or sweeping snow is generally safer than lifting and throwing it, as it requires less energy and reduces the risk of injury.

In summary, while heavy snowfall can create logistical challenges, it is crucial to recognize the potential health risks associated with shoveling. Taking precautions and being mindful of one’s physical condition can help mitigate these dangers.

For more information on health risks related to snow shoveling, consult the American Heart Association.

Are Social Media Platforms Operating Within Reasonable Guidelines?

Mark Zuckerberg’s recent testimony in a landmark social media addiction trial raises questions about the responsibility of tech companies in addressing addiction and mental health issues.

The term “reasonable” took center stage during Mark Zuckerberg’s recent testimony in a significant social media addiction trial held in Los Angeles Superior Court. The case, brought forth by a plaintiff who claims that social media platforms have contributed to her depression and suicidal thoughts, has drawn considerable attention to the ethical responsibilities of these companies.

As the trial unfolds, TikTok and Snapchat have already reached settlements, leaving Meta, the parent company of Facebook and Instagram, and Google’s YouTube as the remaining defendants. The implications of this case extend beyond the courtroom, as it raises critical questions about the role of social media in users’ mental health and well-being.

During the proceedings, Zuckerberg provided five hours of testimony, which concluded on February 18. Following his appearance, he exited the courthouse through a back door, a move that has sparked speculation about the pressures surrounding the case.

To gain a deeper understanding of the issues at play, Vikram R. Bhargava, an assistant professor of strategic management and public policy at the George Washington University School of Business, offers expert insight. Bhargava’s research focuses on the ethical and policy challenges posed by emerging technologies, including the dynamics of social media and technology addiction.

His work has been featured in prominent business ethics journals, addressing the responsibilities of tech companies in mitigating the risks associated with their platforms. Bhargava emphasizes the need for a clear definition of what constitutes “reasonable” conduct in the tech industry, particularly as it pertains to user engagement and mental health.

As the trial progresses, the outcomes could set important precedents for how social media platforms are regulated and held accountable for their impact on users. The case not only highlights individual experiences but also reflects broader societal concerns about the influence of technology on mental health.

For those interested in exploring this topic further, Bhargava is available for interviews. To arrange a discussion, please contact Claire Sabin at claire.sabin@gwu.edu.

This trial represents a pivotal moment in the ongoing conversation about the responsibilities of social media platforms and their role in society. As the legal proceedings continue, many are watching closely to see how the court will address the complex interplay between technology, addiction, and mental health.

According to GlobalNetNews, the outcomes of this case could have lasting implications for the future of social media regulation and the ethical obligations of tech companies.

Meta Executive Criticizes Encryption Plan for Child Safety Risks

Internal documents reveal a Meta executive’s concerns that the company’s encryption plan could hinder efforts to protect children from online exploitation.

Internal documents unsealed in a New Mexico state court have revealed that a senior Meta executive described the company’s plan to encrypt its messaging services as “irresponsible,” cautioning that this shift could significantly undermine the platform’s ability to safeguard children from online predators.

The records emerged this month during a high-stakes jury trial initiated by New Mexico Attorney General Raúl Torrez. The proceedings, which commenced with opening statements on February 9, underscore a stark contrast between the tech giant’s public commitment to user privacy and its private apprehensions regarding user safety.

In a 2019 chat exchange, Monika Bickert, Meta’s head of content policy, expressed serious concerns as CEO Mark Zuckerberg prepared to announce the transition to default end-to-end encryption for Facebook Messenger and Instagram. Bickert reportedly stated in an internal message, “We are about to do a bad thing as a company. This is so irresponsible.”

The documents indicate that several high-ranking safety and policy officials within Meta recognized that this technical change would effectively “blind” the company to child exploitation material. By implementing encryption, only the sender and recipient can access the content of messages, meaning Meta itself would be unable to scan for illegal imagery or grooming behavior unless a user manually reports such incidents.

Historically, Meta has been a primary source of referrals to the National Center for Missing & Exploited Children. Critics, including law enforcement, have long contended that default encryption enables abusers to operate with greater anonymity.

The lawsuit filed by New Mexico alleges that Meta’s leadership prioritized its public image and competitive positioning over the safety of its youngest users, effectively creating what has been described as a “predator’s playground.”

A Meta spokesperson defended the company’s actions, emphasizing that the rollout of encryption, which was completed for Messenger in late 2023, followed years of development focused on “safety mitigations.” The company asserts that it can still utilize metadata and account signals to identify suspicious patterns without accessing the actual text of messages.

The ongoing trial in Santa Fe marks the first instance of a case against Meta reaching a jury. It brings to light a long-standing technical debate, juxtaposing the fundamental right to digital privacy with the pressing need for corporate accountability.

As testimony continues this month, these internal warnings serve as a poignant reminder of the ethical trade-offs involved in the pursuit of a more private internet, highlighting the complexities of balancing user privacy with the imperative of protecting vulnerable populations.

According to The American Bazaar, the implications of this trial could have far-reaching consequences for how tech companies approach user safety and privacy in the future.

Conduent Data Breach Affects Millions of Individuals Nationwide

A significant ransomware attack on Conduent, a government contractor, has potentially exposed the personal data of millions across several states, raising concerns about identity theft and fraud.

A massive ransomware attack on Conduent, a prominent government technology contractor, has turned out to be far more extensive than initially reported. What began as a limited incident now appears to affect tens of millions of individuals across multiple states, including Texas and Oregon.

In Texas alone, at least 15.4 million residents may have had their personal data compromised. Oregon has reported an additional 10.5 million affected individuals. Notifications have also been sent to hundreds of thousands of people in states such as Delaware, Massachusetts, and New Hampshire. If you rely on state healthcare programs or government services, your data could be part of this breach.

The cyberattack occurred in January 2025 and was later claimed by the Safeway ransomware gang, which asserts that it stole more than 8 terabytes of data. Conduent first disclosed the incident publicly in April, several months after hackers disrupted its systems and caused outages to government services nationwide. Initially, the company estimated that about 4 million people in Texas were affected, but that figure has since risen to 15.4 million, nearly half of the state’s population. Oregon’s attorney general has reported another 10.5 million impacted residents. Combined with notifications from other states, the total number of affected individuals could reach into the dozens of millions.

The stolen data includes sensitive information such as names, Social Security numbers, medical records, and health insurance details. This combination poses a significant risk, as it can be exploited for identity theft, medical fraud, and highly targeted scams.

Conduent processes data for large corporations, state agencies, and government healthcare programs, claiming to support services for over 100 million people nationwide. However, the company has not confirmed whether the breach affects that many individuals.

In a filing with the Securities and Exchange Commission (SEC), Conduent acknowledged that the stolen data included a “significant number” of individuals’ personal information associated with its clients’ end users, meaning those who rely on government agencies and corporate services powered by the company.

Unlike typical retail breaches where credit card information might be compromised, this incident involves deeply sensitive personal and medical information. Social Security numbers and health records are long-term identifiers that cannot simply be canceled or replaced like a debit card.

Healthcare-related data is particularly valuable on the black market, as it can be used to file fraudulent insurance claims, obtain prescription drugs, or open financial accounts. Moreover, because Conduent operates behind the scenes for state agencies, many individuals may not even realize their data was stored by the company.

Conduent has stated that it is still in the process of notifying affected individuals and expects to complete these notifications by early 2026. The company has not provided a clearer timeline or confirmed how many total people will ultimately be alerted. Many individuals could be left waiting months to find out if their information was compromised.

A spokesperson for Conduent provided the following statement: “As previously disclosed in its April 2025 Form 8-K filing with the SEC, in January 2025, Conduent discovered that it was the victim of a cybersecurity incident. With respect to that incident, Conduent has agreed to send notification letters, on behalf of its clients, to individuals whose personal information may have been affected by this incident. Working in conjunction with our clients, we expect to send out all of the consumer notifications by April 15. In addition, a dedicated call center has been set up to address consumer inquiries. At this time, Conduent has no evidence of any attempted or actual misuse of any information potentially affected by this incident.”

Upon discovering the incident, Conduent acted swiftly to secure its networks, restore its systems and operations, notify law enforcement, and conduct an investigation with the assistance of third-party forensic experts. Given the nature and complexity of the data involved, Conduent worked diligently with a dedicated review team, including internal and external experts, to conduct a detailed analysis of the affected files to identify the personal information contained therein, a process that proved to be time-intensive.

Both Conduent and its third-party experts regularly monitor the dark web and have found no evidence of any personal information being released. The company has assured its clients that it has secured the necessary data and is taking the matter seriously. “We regret any inconvenience this incident may have caused,” the spokesperson added.

Individuals concerned about their data can check if it has been compromised by visiting haveibeenpwned.com, where they can enter their email address to see if their information has been involved in any data breaches.

In light of this breach, experts recommend several precautionary measures. A credit freeze can prevent lenders from opening new accounts in your name without your approval. This service is free and can be placed with Equifax, Experian, and TransUnion. Additionally, individuals are entitled to free credit reports from all three major bureaus, allowing them to monitor for unfamiliar accounts or credit inquiries.

Using a password manager can also enhance security by creating strong, unique passwords for each account, reducing the risk of credential-stuffing attacks. Furthermore, enabling two-factor authentication (2FA) adds an extra layer of protection, making it more difficult for unauthorized users to access accounts.

The Conduent breach underscores a growing risk that many individuals may not anticipate. When large government contractors are targeted, millions can be affected simultaneously. As these companies operate behind the scenes, many may not even realize they hold their data. Taking proactive steps now can help mitigate long-term damage and protect against potential identity theft.

For further information on how to protect yourself from identity theft, visit CyberGuy.com.

Some Supplements May Pose Risks for Individuals with Diabetes

Experts caution individuals with diabetes to be vigilant about certain supplements that may adversely affect blood sugar levels and interact with medications.

Health experts are urging individuals with diabetes to exercise caution when considering dietary supplements, as some may pose significant risks by affecting blood sugar levels or interacting negatively with prescribed medications.

Surveys indicate that approximately 75% of U.S. adults have used dietary supplements, with 58% reporting usage within the past 30 days. However, experts emphasize that certain groups, particularly those with diabetes, should be particularly careful.

Dietary supplements encompass a wide range of products, including vitamins, minerals, herbs, amino acids, and probiotics, all designed to fill nutritional gaps and promote overall wellness. Some supplements target specific health functions, such as immune support, muscle recovery, and bone health.

Unlike prescription medications and over-the-counter drugs, dietary supplements are not typically approved by the Food and Drug Administration (FDA) before they hit the market. However, the FDA does regulate these products and can take action against those deemed unsafe or misbranded.

According to the National Institutes of Health (NIH), several supplements may pose serious health risks for individuals with diabetes. Dawn Menning, a registered dietitian and certified diabetes care and education specialist based in California, highlights St. John’s Wort as a supplement to avoid. While it is often marketed as a natural remedy for mild to moderate depression, it can interfere with diabetes medications by altering how the body metabolizes them.

“This can make medications less effective and complicate blood sugar management,” Menning explained. Although some claim that St. John’s Wort can help regulate blood sugar in individuals with type 2 diabetes, the evidence supporting this is limited and mixed.

Menning warns that combining this supplement with insulin or oral diabetes medications may increase the risk of hypoglycemia, a condition characterized by dangerously low blood sugar levels that can lead to dizziness, fatigue, and fainting.

Another supplement of concern is high-dose niacin, which is sometimes used to manage cholesterol levels. However, Menning cautions that it can significantly raise blood sugar levels, making it difficult to maintain an optimal A1c range.

Asian ginseng is often associated with increased energy, focus, and immune health. While it may offer some benefits for individuals with prediabetes and diabetes, there is evidence suggesting that it could lower blood sugar levels when taken alongside diabetes medications.

Jordan Hill, a registered dietitian with Top Nutrition Coaching in Colorado, advises against β-carotene supplementation for people with diabetes. The American Diabetes Association has linked this supplement to increased risks of lung cancer and cardiovascular mortality.

Cinnamon, frequently promoted for diabetes management and weight loss, has shown potential in reducing blood sugar and lowering insulin resistance. However, excessive consumption can lead to hypoglycemia, as well as liver damage due to a compound called coumarin found in cinnamon.

Oral aloe vera is another supplement that has gained popularity for its purported benefits for diabetes and weight loss. However, when combined with diabetes medications, it may cause blood sugar levels to drop too low, increasing the risk of hypoglycemia. Gastrointestinal side effects are also a concern with aloe vera.

Menning notes that for most supplements, there is insufficient evidence to support any beneficial effects on diabetes or its complications. The American Diabetes Standards of Care state that “without underlying deficiency, there are no benefits from herbal or nonherbal (i.e., vitamin or mineral) supplementation for people with diabetes.”

Furthermore, the American Association of Clinical Endocrinology advises caution with all unregulated nutritional supplements due to their inconsistent composition, quality, and potential for harm.

Experts recommend consulting with a healthcare provider before starting any supplement regimen to better understand how it may impact blood sugar levels, medications, or overall diabetes management.

For more information on the risks associated with dietary supplements for people with diabetes, refer to the National Institutes of Health.

Hidden Virus in Gut Bacteria Linked to Increased Colorectal Cancer Risk

A newly discovered virus within gut bacteria may be linked to an increased risk of colorectal cancer, offering new insights into the disease’s development, according to recent research.

Scientists in Denmark have identified a previously unknown virus residing in the gut bacterium Bacteroides fragilis, which may be associated with the development of colorectal cancer. The study, published in *Communications Medicine* earlier this month, reveals that patients diagnosed with colorectal cancer are approximately twice as likely to carry this virus compared to individuals without the disease.

Dr. Flemming Damgaard, PhD, from the Department of Clinical Microbiology at Odense University Hospital and the University of Southern Denmark, emphasized the significance of microorganisms in relation to human health. “These findings highlight the importance of the microorganisms in the gut and their relation to our health,” he stated. “If we want to understand the full picture, we need to look deep into their genetic material.”

For years, medical professionals have noted a higher prevalence of Bacteroides fragilis in colorectal cancer patients. However, since this bacterium is also commonly found in healthy individuals, the reasons for its harmful effects in certain cases remained unclear. This prompted researchers to investigate subtle genetic variations within the bacteria, leading to an unexpected discovery.

“We were very surprised to find a whole virus inside the bacteria from the colorectal cancer patients,” Damgaard remarked. “That was not something we expected when we started our study.”

The identified virus, classified as a bacteriophage, specifically infects bacteria rather than human cells. Notably, this viral type had not been documented prior to this research. The study involved analyzing stool samples from 877 individuals across Europe, the United States, and Asia, revealing that colorectal cancer patients were about twice as likely to carry traces of the virus compared to their cancer-free counterparts.

While the findings indicate a strong statistical association, researchers caution that the study does not establish a causal link between the virus and colorectal cancer. “The major limitation is that we still don’t know why the virus is linked to colorectal cancer,” co-author Ulrik Stenz Justesen explained. “But we are already continuing our research.”

The research team is currently conducting laboratory experiments and animal studies to explore whether the virus influences the behavior of Bacteroides fragilis in a manner that could contribute to cancer development.

Studies have shown that the human body is home to roughly as many microbial cells as human cells, highlighting the intricate relationship between microbes and overall health. “Our understanding of [microbial cells] is still in its infancy,” Damgaard noted. “There are many health-related discoveries to be made in the human microbiota.”

Colorectal cancer ranks among the leading causes of cancer-related deaths globally, according to the World Health Organization. The disease has gained increased visibility due to the deaths of several high-profile individuals, including James Van Der Beek, Catherine O’Hara, Kirstie Alley, Pelé, and Chadwick Boseman, underscoring its impact across various age groups.

While diet and lifestyle factors are significant contributors to colorectal cancer risk, researchers believe that gut bacteria may also play a crucial role. Current screening methods for colorectal cancer include stool tests that detect hidden blood and colonoscopies. In the future, researchers suggest it may be possible to test stool samples for viral markers similar to those identified in this study.

The researchers pointed to cervical cancer as an example of how recognizing a viral cause can enhance prevention efforts. Following the link between HPV and cervical cancer, vaccination programs have significantly reduced new cases. Although it is premature to draw direct comparisons, the researchers remain hopeful that colorectal cancer could follow a similar trajectory if a definitive viral role is established.

“It is too early to act,” Damgaard cautioned. “We have a lot of hope, and that is what we want people to have at this point,” he concluded.

According to Fox News Digital, this research opens new avenues for understanding the complexities of colorectal cancer and the potential role of viruses within the gut microbiome.

Aging Expert Shares Daily Habits to Maintain Independence in Later Years

Dr. Mary Claire Haver shares three daily habits that can help maintain independence and enhance quality of life in the golden years.

In a recent discussion on health and wellness, Dr. Mary Claire Haver, a certified menopause specialist and founder of The ‘Pause Life, emphasized the importance of daily habits that can significantly impact one’s independence in later years.

Dr. Haver pointed out that sleep is a crucial factor in overall health. “If you’re not sleeping, everything else tends to fall apart,” she stated, highlighting the interconnectedness of sleep and other aspects of well-being.

She advocates for simple lifestyle changes that can lead to a longer, healthier life. Among her recommendations are maintaining a balanced diet, engaging in regular physical activity, and prioritizing mental health.

Dr. Haver’s insights come amid a broader conversation about health trends and practices. Recent studies have suggested that dietary habits, such as eating oatmeal, can have unexpected benefits for heart health. Additionally, the temperature of one’s bedroom may also play a role in cardiovascular health, with certain conditions potentially putting the heart at risk.

As the conversation around health continues to evolve, experts are also addressing the impact of lifestyle choices on mental health. For instance, research has indicated that a single dose of a powerful psychedelic can significantly reduce symptoms of depression, showcasing the potential for innovative approaches to mental wellness.

In the realm of nutrition, there is a growing backlash against the low-fat diet era, with some experts arguing that it may have contributed to rising obesity rates. This ongoing debate highlights the complexity of dietary recommendations and their long-term effects on health.

As individuals navigate their health journeys, the importance of staying informed about emerging trends and research cannot be overstated. From celebrity health revelations to practical wellness hacks, there is a wealth of information available to help guide choices.

Ultimately, Dr. Haver’s emphasis on daily habits serves as a reminder that small, consistent changes can lead to significant improvements in health and independence as one ages. By focusing on sleep, nutrition, and mental well-being, individuals can better prepare for their golden years.

For more insights on health and wellness, visit Fox News Health.

Hundreds of Wild Bird Deaths Prompt Park Closures Across Seven Counties

Hundreds of wild bird deaths across seven New Jersey counties have raised concerns about bird flu, prompting health officials to advise residents to avoid contact with dead birds.

In recent days, New Jersey has reported a troubling surge in wild bird deaths, with health experts suspecting bird flu as the cause. Between February 14 and February 16, over 1,100 dead or sick wild birds, predominantly Canada geese, were documented across seven counties, according to the New Jersey Department of Environmental Protection (DEP).

While tests are still pending, officials believe that the highly pathogenic avian influenza (HPAI), commonly referred to as bird flu, is likely responsible for the fatalities. This respiratory disease in birds is caused by influenza A viruses.

“I find the images of the dead and dying birds very troubling, unsettling, and a reminder that avian flu continues to be present,” said Dr. David J. Cennimo, an associate professor of medicine and pediatrics and an infectious diseases specialist at Rutgers New Jersey Medical School. “It is important to note that at the time of this writing, the cause of death has not been announced, and bird flu is only strongly suspected, but the picture is consistent with avian influenza, and there is a good reason for the high-level suspicion.”

In response to the situation, some local parks have temporarily closed as a precautionary measure. Notable closures include Betty Park and Alcyon Park in Gloucester County. The Borough of Pittman has advised residents via social media to avoid approaching any geese in the area.

Common symptoms of HPAI in birds include diarrhea, coughing, sneezing, nasal discharge, and lack of coordination. However, some birds may succumb to the virus without showing any visible signs of illness. While geese have accounted for the majority of the reported deaths in New Jersey, avian influenza also poses a significant risk to domestic birds such as chickens, turkeys, and ducks.

“We have seen cases of avian influenza in other animals, most notably dairy cows and cats,” Dr. Cennimo noted. “If possible, domestic animals should be kept away from sick birds.”

Although the risk to the public remains low, health officials strongly recommend avoiding direct contact with wild birds or any animals that may be infected. The DEP emphasized the importance of public awareness and precautionary measures to mitigate the impact of bird flu on both agriculture and public health.

Dr. Cennimo explained that avian influenza viruses continue to circulate within wild bird populations, and transmission can be exacerbated by the close congregation of birds, particularly during freezing temperatures when water availability is limited.

“The risk to humans remains low at this time,” he confirmed. “If the birds did die of influenza, they could still harbor live virus and potentially infect humans. For this reason, people should avoid handling sick or dead birds, use protective measures like gloves, and wash their hands thoroughly afterward.”

Dr. Rebecca Carriere Christofferson, an associate professor of pathobiological sciences at the LSU School of Veterinary Medicine, highlighted that mass bird deaths are indicative of ongoing transmission of bird flu. “It’s sad from an ecological perspective, but also poses a risk to any nearby agricultural facilities, as we’ve seen spillover into poultry and dairy cattle in the last couple of years,” she stated. “The more transmission, the greater the chance for it to spread to humans.”

Last year, there were reported human deaths linked to bird flu, primarily associated with direct contact with infected animals. Dr. Christofferson emphasized the importance of surveillance in preventing uncontrolled spread, noting that understanding the patterns of the virus can help mitigate ongoing risks to both animal and human populations.

As the situation develops, health officials continue to monitor the situation closely, urging residents to remain vigilant and report any sightings of dead or sick birds.

For further information, refer to the New Jersey Department of Environmental Protection.

FDA Resumes Review of Moderna’s mRNA Influenza Vaccine

The FDA has agreed to review Moderna’s application for the first mRNA-based flu vaccine after initially declining to do so, following a meeting with the company.

The Food and Drug Administration (FDA) has reversed its earlier decision and will now review Moderna’s application for the first mRNA-based flu vaccine. This change comes after a Type A meeting between Moderna and the agency, where the company proposed full approval for adults aged 50 to 64, as well as accelerated approval for those 65 and older, contingent on additional studies involving seniors.

The FDA has set a target date of August 5 for completing its review, which could allow the vaccine to be available in time for the upcoming flu season. This decision marks a significant step in the development of mRNA technology for flu prevention, a field that has faced scrutiny and skepticism from various quarters.

Critics of mRNA technology, including Robert F. Kennedy Jr. and other officials from the U.S. Department of Health and Human Services, have previously expressed doubts about the efficacy and safety of mRNA vaccines for respiratory viruses. Their concerns have led to the withdrawal of some federal funding related to mRNA vaccine research.

As the FDA prepares to review Moderna’s application, experts from George Washington University (GWU) are available to provide insights into the implications of this decision and the potential impact of mRNA technology on public health. Faculty members include Elizabeth Choma, a pediatric nurse practitioner and clinical assistant professor; Jennifer Walsh, a clinical assistant professor focused on pediatrics and health assessment; and Emily Smith, an associate professor specializing in infectious diseases and epidemiology.

Other experts from GWU include Asefeh Faraz Covelli, an associate professor in the Family Nurse Practitioner program; April Barbour, an internist and associate professor of medicine; and Mia Marcus, an associate clinical professor and primary care provider. Additionally, Maria Portela Martinez, an assistant professor of emergency medicine, and Andrew Meltzer, a professor of emergency medicine and chief of the clinical research section, are also available for commentary.

David Diemert, the clinical director of the GW vaccine research unit, and Jose Lucar, an associate professor of infectious diseases, are among the other faculty members who can provide expert opinions on the evolving landscape of vaccine development. Kelly Gebo, the dean of the GW Milken Institute School of Public Health, brings her expertise as an infectious disease physician and epidemiologist, focusing on disparities in healthcare access and outcomes.

The reopening of the review process for Moderna’s mRNA flu vaccine underscores the ongoing evolution of vaccine technology and its potential role in combating seasonal influenza. As the FDA moves forward with its review, the medical community and the public will be closely watching the developments surrounding this innovative approach to flu vaccination.

For further insights and to schedule interviews with GWU experts, interested parties can contact Katelyn Deckelbaum at katelyn.deckelbaum@gwu.edu.

According to Newswise, this decision could pave the way for a new era in flu prevention.

The Importance of Letting Go for Personal Growth and Well-Being

Letting go is a vital psychological process that allows individuals to release attachments to past events, fostering emotional freedom and improving overall well-being.

What does it mean to let go? In my graduate school days, I invited a friend over for dinner, adding, “Oh, and bring your wife!” We had previously met a couple of times, both at their home and mine, and I wanted to make it clear that she was invited too. However, that casual phrase seriously offended him. They cut me off completely, pointedly ignoring me whenever our paths crossed. For many years afterward, I obsessed over this incident, feeling misunderstood and poorly treated by a couple I liked. The memory of that event and its consequences would hurt whenever I was reminded of them. I just couldn’t let it go.

Letting go involves intentionally loosening and releasing an attachment to a past event, outcome, or identity. It is a conscious psychological process that changes your relationship with your history, allowing it to no longer dictate your present. This process is not about forgetting the past or giving up. In most instances, failing to let go can have negative consequences for our well-being.

Many of us have stories about events and relationships in our lives that we’ve struggled to release, often with more serious outcomes. For instance, I read about a woman whose son died in an accident. As a coping mechanism, she kept his social media accounts active, posting as him and responding to comments for years. This obsession affected her bond with her surviving daughter, ultimately harming their relationship.

Another example is a young boy who moved with his parents to a new city and couldn’t get over leaving his best friend behind. Unable to make friends at his new school, he struggled academically as well. Similarly, a man in his 80s preserved his deceased wife’s side of the bedroom exactly as it was for fifteen years after her death, down to the glass of water on the nightstand. He felt that moving anything would amount to betraying her. Unable to move past his loss, he stopped engaging with his children and grandchildren and neglected his own health.

Why is letting go so hard? It can be incredibly challenging. Letting go is not merely an emotional or logical choice; it is a biological and psychological struggle against our brain’s survival instincts. Our brains and nervous systems have evolved to prioritize safety, stability, and connections over happiness or well-being. Any change can feel like a threat to our survival.

Dr. Joe Dispenza, an international lecturer and researcher, describes this struggle as a “civil war” between our logical mind and our biological hardwiring. We are naturally averse to loss, and our brains are wired to feel the pain of loss twice as intensely as the joy of gain. Letting go can feel like losing a piece of ourselves. We often fear the uncertainty of releasing our attachments more than we fear the known discomfort and pain. This leads us to prioritize familiarity over logic, creating a strong need for our “issue” to be resolved.

Recognizing when holding on is causing more harm than the fear of losing is crucial. Letting go is essential for our mental health, personal growth, and future happiness. This action releases the psychological weight that keeps us stuck in unproductive cycles, allowing us to stop fighting a past we cannot change and start focusing on a present we can influence.

When we let go, we begin to experience life more fully, leading to improved overall well-being. We gain emotional freedom as the burdens of grudges, guilt, or pain are lifted, creating space for joy, gratitude, and other positive emotions. This shift also increases our mental energy.

The mental stress associated with chronic anger, anxiety, and depression dissipates. Inner peace is restored, enabling us to discover new opportunities and strengths while developing healthier, more authentic relationships based on trust and respect. By freeing up mental resources and energy, we can be more present with what truly matters, rather than continually looking back. We learn to focus on what we can control, and the resilience and psychological flexibility we cultivate through acceptance make us more adaptable to challenges.

In his book, A New Earth: Awakening to Your Life’s Purpose, Eckhart Tolle explains that true power comes not from the need to retain possession of something but from the inner strength of non-attachment. He states, “Sometimes letting things go is an act of far greater power than defending or hanging on.”

What happens when you don’t let go? Medical research indicates that the inability to let go, particularly the persistence of negative emotions, is a significant predictor of long-term physical and mental decline. Chronic emotional states such as resentment, anger, and rumination trigger sustained physiological responses that can damage multiple body systems.

Chronic stress and anger are leading risk factors for heart disease, comparable to smoking or obesity. The prolonged release of stress hormones like cortisol and adrenaline can damage arteries by causing plaque buildup, increasing the risk of heart attack or stroke. Additionally, holding onto negative feelings can compromise the immune system, making individuals more susceptible to common colds and serious infections.

Loneliness and chronic emotional stress act as a “fertilizer” for disease, promoting systemic inflammation that can accelerate cancer-cell growth or contribute to Alzheimer’s disease. This impact is particularly adverse for those already dealing with serious illnesses. Patients with existing conditions who use defense mechanisms to mask or deny their feelings often experience higher mortality rates.

Failing to let go also adversely affects brain health. Unresolved emotional conflicts are strongly linked to the development of anxiety, severe depression, and PTSD. Prolonged stress can lead to a reduction in brain volume in areas critical for higher functioning, such as the prefrontal cortex and hippocampus.

It is important to clarify what letting go is not. Letting go is an active, courageous choice; it is not giving up, apathy, indifference, or a sign of weakness. It is a mindful decision based on clarity. Letting go does not mean you stop feeling sadness, regret, or disappointment; it means you are no longer a prisoner of those feelings. You do not have to forgive someone to let go of the weight they placed on you. Letting go does not mean you no longer love or care for someone or something you have lost; it allows you to channel those memories or love into ways to honor them.

When you let go, you begin to move forward again. A popular quote summarizes the teachings of the Sufi mystic and poet Rumi on the subject of attachment and detachment: “Life is a balance of holding on and letting go.”

In conclusion, embracing the power of letting go can lead to profound personal transformation and enhanced well-being, allowing us to live more fully in the present.

According to India Currents.

Shaun Desai Appointed Head of Surgery at New York Medical College

Dr. Shaun Desai, an Indian American plastic surgeon, has been appointed chair of the Department of Otolaryngology-Head and Neck Surgery at New York Medical College, effective April 2026.

Dr. Shaun Desai, an accomplished Indian American plastic surgeon, is set to lead the Department of Otolaryngology-Head and Neck Surgery at New York Medical College (NYMC) starting this April. His appointment marks a significant milestone in a career dedicated to restoring both form and function for patients.

Desai, a native of Poughkeepsie, New York, returns to his Hudson Valley roots after an impressive eleven-year tenure at the Johns Hopkins School of Medicine in Baltimore. His extensive experience includes roles as Associate Professor, Medical Director, and Associate Residency Program Director. However, those familiar with his work emphasize his commitment to healing and mentorship above all else.

Dr. David Lubarsky, president and CEO of WMCHealth, expressed enthusiasm about Desai’s appointment, noting that it enhances the quality of care in the region. Lubarsky highlighted Desai’s “extraordinary skill” in complex reconstruction, which will benefit patients throughout the community.

Desai’s philosophy intertwines the art and science of surgery. During his time at Johns Hopkins, he performed thousands of operations, specializing in microvascular reconstruction and facial plastic surgery. His expertise extends beyond American operating rooms; he has also worked in makeshift clinics across Ukraine, India, Tanzania, and Peru. These mission trips reflect his long-standing commitment to global health and education.

His return to NYMC represents a homecoming that aims to merge elite academic research with compassionate clinical care. Dr. Neil W. Schluger, dean of the NYMC School of Medicine, praised Desai’s “distinguished record” in medical education, underscoring his dedication to training the next generation of physicians.

Desai’s passion for mentorship has been recognized through accolades such as the George T. Nager Faculty Teaching Award, awarded by his peers and students at Johns Hopkins. His influence extends beyond the classroom and into the realm of patient safety, where he has led quality improvement initiatives that have raised success rates for microvascular reconstruction to over 97%. Additionally, he has edited a comprehensive textbook for trainees, ensuring that his techniques and philosophies reach a wider audience of surgeons.

Desai’s journey began at The George Washington University, where he completed a prestigious seven-year combined medical program. Following rigorous residency and fellowship training in St. Louis, he achieved dual-board certification, solidifying his expertise in the field.

He succeeds Dr. Augustine Moscatello, who has led the department since 2016. As Desai steps into this leadership role, he brings with him a national reputation, including recognition on Newsweek’s “Top 100 Plastic Surgeons” list. His personal mission is to elevate the standard of care for the community that nurtured his early aspirations.

Desai’s appointment is anticipated to have a profound impact on the department and the broader medical community, as he combines his extensive experience with a heartfelt commitment to patient care and education.

For further details, refer to The American Bazaar.

Jivrajka Family Donates $2 Million to UCLA for Heart Health Chair

The Jivrajka family has donated $2 million to UCLA to establish an endowed chair focused on cardiovascular health, particularly for South Asian and other high-risk communities.

The Jivrajka Family Foundation has made a significant contribution of $2 million to the University of California, Los Angeles (UCLA) to establish an endowed chair dedicated to specialized cardiovascular medicine. This initiative places a strong emphasis on prevention strategies for South Asian and other high-risk populations.

This generous donation creates a permanent funding source aimed at supporting research, clinical innovation, and community outreach in heart health. South Asians are known to face disproportionately higher risks of coronary artery disease and related conditions, making this focus particularly timely and necessary.

Dr. Ravi H. Dave, who serves as the director of interventional cardiology and the Interventional Cardiology Fellowship Program at UCLA, will be the inaugural holder of the endowed chair. He also leads the UCLA Health South Asian Heart Program, which is dedicated to culturally tailored prevention, early detection, and treatment strategies for cardiovascular diseases.

The Jivrajka Family Foundation was established in 2024 by Drs. Jayashree and Vinod Jivrajka, both of whom are physicians originally from Mumbai, India. After completing their education in India, they continued their medical careers in the United States. Their philanthropic efforts reflect decades of commitment to patient care and a desire to give back to the medical profession that has significantly shaped their lives.

In interviews released by the university, the Jivrajkas expressed that cardiovascular disease is a deeply personal concern within the South Asian community. They noted that heart attacks often occur earlier and with fewer warning signs compared to the general population. By endowing this chair, they aim to ensure that research and prevention efforts continue well beyond the limitations of a single grant cycle or campaign.

Endowed chairs provide stable, long-term funding that empowers academic leaders to pursue ambitious projects, recruit top talent, and expand programs without being solely reliant on short-term funding sources. At UCLA, the new chair is expected to enhance efforts to better understand the genetic, metabolic, and lifestyle factors that contribute to elevated cardiac risk among South Asians.

Dr. Dave remarked that this gift will accelerate ongoing work to refine risk assessment tools and expand outreach programs designed to educate families about diet, exercise, and early screening. He emphasized that prevention, rather than just intervention, is crucial to reducing the burden of heart disease.

University leaders have described the donation as transformative, particularly given that Los Angeles is home to one of the largest South Asian populations in the United States. They believe the endowed chair will help bridge clinical care, research, and community engagement in ways that directly address local needs while also contributing to a national understanding of cardiovascular disparities.

For the Jivrajkas, this gift is both a professional commitment and a personal mission. As physicians trained in India who have built their careers in America, they view the establishment of this chair as a full-circle moment. It represents their investment in the next generation of clinicians and scientists who are working to prevent the very diseases they have dedicated their lives to treating.

According to The American Bazaar, this donation underscores the Jivrajka family’s commitment to improving heart health in communities that are often underserved and at higher risk for cardiovascular diseases.

Eating Oatmeal for Two Days May Benefit Heart Health, Study Finds

Recent research from Germany indicates that consuming oatmeal for just two days can significantly lower “bad” cholesterol levels and may reduce diabetes risk in individuals with metabolic syndrome.

A study conducted by researchers at the University of Bonn in Germany has revealed that a short-term diet consisting primarily of oatmeal can lead to notable improvements in cholesterol levels. The trial involved adults who followed a calorie-reduced diet that included almost exclusively oatmeal for two days.

All participants in the study were diagnosed with metabolic syndrome, a condition characterized by a combination of high body weight, elevated blood pressure, increased blood glucose, and high blood lipid levels. According to a press release from the university, the study aimed to assess the impact of oatmeal consumption on these health markers.

The 32 participants consumed oatmeal, which had been boiled in water, three times a day, totaling 300 grams. They were allowed to add fruits or vegetables to their meals but were restricted to approximately half of their normal caloric intake. A control group followed a similar calorie-reduced diet without oats.

While both groups experienced health benefits, those on the oat diet showed a significant improvement in cholesterol levels. After six weeks, the positive effects of the diet remained stable. Marie-Christine Simon, a junior professor at the Institute of Nutritional and Food Science at the University of Bonn, noted that the level of LDL, or “bad” cholesterol, among the oatmeal-eating group decreased by 10%.

“That is a substantial reduction, although not entirely comparable to the effect of modern medications,” Simon stated. Participants also lost an average of two kilograms and experienced a slight decrease in blood pressure.

The researchers concluded that the oat-based diet likely influenced the gut microbiome, leading to these positive health outcomes. The findings were published in the journal Nature Communications.

Simon suggested that a short-term oat-based diet, repeated at regular intervals, could serve as a well-tolerated method for maintaining cholesterol levels within a normal range and preventing diabetes. She expressed interest in further research to determine whether an intensive oat-based diet, repeated every six weeks, could have a lasting preventative effect.

Certified holistic nutritionist Robin DeCicco, who was not involved in the study, commented on the findings, stating that they align with existing knowledge about oats’ potential to lower LDL cholesterol. Oats contain prebiotic fiber, which nourishes beneficial gut bacteria. When these bacteria ferment the fiber, they produce compounds that support digestive health.

“The more beneficial gut bacteria you have in your stomach, the more they can reduce or inhibit the production of LDL bad cholesterol,” DeCicco explained.

In addition to their cholesterol-lowering properties, oats are a whole grain that is naturally low in saturated fat, high in fiber, and a good source of plant-based protein. “All those factors contribute to a heart-healthy, cholesterol-lowering diet,” DeCicco noted.

However, she cautioned that individuals with diabetes or prediabetes should approach oat consumption with care. “While oats can lower cholesterol, they are a high-carbohydrate food,” DeCicco warned. She recommended that those monitoring their blood sugar should prioritize foods lower in starch and higher in protein and fiber, obtaining carbohydrates primarily from vegetables and nuts.

Megan Wroe, a registered dietitian at the Wellness Center at Providence St. Jude Medical Center in Orange County, California, echoed DeCicco’s insights, noting that oat consumption appears to lower cholesterol levels across various populations, with the most significant effects observed in those with elevated cholesterol levels.

Wroe pointed out that while there are no significant risks associated with oat consumption, some individuals may experience cramping or indigestion if they suddenly increase their fiber intake. Additionally, those requiring a gluten-free diet should ensure that their oats are certified gluten-free.

She also highlighted that oatmeal is often prepared with water or milk and may include added sugar and fruit, which can result in a “potentially very high-glycemic meal.” To mitigate this, Wroe recommends consuming oats frequently, opting for steel-cut or rolled varieties, and using fruit for sweetness or low-glycemic sweeteners like monk fruit when necessary.

Wroe further suggested incorporating protein into oatmeal dishes to balance the carbohydrate content. This can be achieved by adding chia or flax seeds, mixing in protein powder, or topping the oatmeal with Greek yogurt.

The findings from this study underscore the potential health benefits of incorporating oatmeal into the diet, particularly for those at risk of metabolic syndrome and related conditions. As research continues, the role of oats in heart health and diabetes prevention may become increasingly significant.

For more information on the study, refer to the findings published in Nature Communications.

Global Association of Physicians of Indian Origin Elects New President at Annual Conference

The Global Association of Physicians of Indian Origin recently held its 16th Annual Conference in Indore, where Dr. Sudhir Parikh was elected president, emphasizing innovation and collaboration in global healthcare.

In a world where the global healthcare landscape is rapidly evolving and constantly challenged, the role of international medical associations has never been more critical. The Global Association of Physicians of Indian Origin (GAPIO) recently held its 16th Annual Conference at the Brilliant Convention Centre in Indore, Madhya Pradesh. This event marked another significant milestone in GAPIO’s mission to enhance the quality of healthcare worldwide.

This year’s gathering was not only a testament to the enduring bonds among physicians of Indian origin but also a platform for innovative discourse and leadership transition. The conference attracted a diverse group of medical professionals from around the globe, creating a vibrant confluence of ideas, expertise, and cultural exchange. The selection of Indore, a city known for its rich history and rapid modernization, as the venue was emblematic of the conference’s theme: bridging tradition with innovation in healthcare.

Over the years, GAPIO has emerged as a pivotal organization, fostering collaboration among physicians of Indian descent across various continents. This year’s event was no exception, showcasing the organization’s commitment to addressing global health challenges.

One of the highlights of the conference was the election of Dr. Sudhir Parikh as the new President of GAPIO. A distinguished allergist and recipient of the Padma Shri award, Dr. Parikh brings a wealth of experience and a visionary approach to the organization. His election signals a commitment to continuing GAPIO’s legacy of leadership in global health advocacy. Dr. Parikh’s career is marked by his dedication to community service and his efforts in promoting health education, both in the United States and India. Under his leadership, GAPIO is expected to further its initiatives in medical education, research, and policy advocacy.

The conference featured a series of panels and discussions addressing some of the most pressing issues in healthcare today. Topics ranged from the integration of artificial intelligence in medical diagnostics to the challenges of healthcare delivery in rural and underserved areas. The emphasis on technology and innovation was particularly poignant, as the medical community grapples with the dual challenges of improving access to care while maintaining high standards of medical practice.

GAPIO’s annual conference serves not only as a forum for professional development but also as a celebration of the contributions of Indian-origin physicians to global health. With an estimated 1.4 million doctors of Indian origin practicing worldwide, their impact on healthcare systems is profound. These physicians often serve as bridges between different healthcare paradigms, bringing a unique blend of skills and perspectives that enrich the global medical community.

The election of Dr. Parikh underscores the importance of leadership that is both globally minded and deeply rooted in cultural heritage. His presidency is expected to usher in a new era of strategic partnerships and collaborations, particularly in the areas of telemedicine and public health. As the world continues to navigate the complexities of the COVID-19 pandemic and other emerging health threats, the role of organizations like GAPIO in fostering international cooperation and knowledge exchange is invaluable.

The conference concluded with a renewed commitment to the organization’s goals and a call to action for its members to continue their work in enhancing healthcare delivery systems worldwide. The success of the 16th Annual Conference serves as a reminder of the power of collective action and the critical role that physicians of Indian origin play in shaping the future of global health.

In summary, the GAPIO conference in Indore was more than just an assembly of medical professionals; it was a celebration of shared values and a testament to the potential of global collaboration. As Dr. Sudhir Parikh takes the helm, the organization is poised to make even greater strides in its mission to improve health outcomes across the globe, according to GlobalNetNews.

Bedroom Temperature Linked to Heart Health Risks, Study Finds

The temperature of your bedroom at night may significantly impact heart health, especially for older adults, with risks increasing as temperatures rise above 75°F, a new study warns.

The temperature of your bedroom at night could have serious implications for heart health, particularly among older adults. A recent study led by Dr. Fergus O’Connor from Griffith University in Queensland, Australia, highlights how elevated bedroom temperatures can stress the cardiovascular system during sleep.

According to Dr. O’Connor, when the human body is exposed to heat, it responds by working harder to circulate blood to the skin’s surface for cooling. This increased workload on the heart can create stress and limit the body’s ability to recover from heat exposure experienced during the day.

The researchers aimed to investigate how real-world bedroom temperatures affect older adults, focusing on a group of 47 participants living in southeast Queensland, with an average age of 72. Unlike many sleep studies conducted in clinical settings, this research was a “free-living” study, allowing participants to maintain their normal activities and sleep schedules.

Throughout an entire Australian summer, from December to March, scientists monitored the participants using high-tech fitness trackers to record heart rates from 9 p.m. to 7 a.m. Additionally, sensors were placed in the participants’ bedrooms to track temperatures, resulting in over 14,000 hours of nighttime sleep data.

The findings revealed that the temperature at which the heart began to show signs of disruption was slightly above 75°F. Specifically, the study found that when bedroom temperatures ranged from 75°F to 79°F, the likelihood of experiencing a “clinically relevant” drop in heart recovery increased by 40%. This risk doubled when temperatures rose between 79°F and 82°F, and above 82°F, the risk nearly tripled compared to cooler environments.

Dr. O’Connor noted that for individuals aged 65 and older, maintaining overnight bedroom temperatures at approximately 75°F can significantly reduce the likelihood of heightened stress responses during sleep.

While the study establishes a strong correlation between heat and heart stress, the researchers caution that its observational design does not definitively prove that heat is the sole cause of these effects. Furthermore, the study’s focus on older adults in Australia may limit its applicability to other populations. Although the wearable devices used in the study are advanced, they do not match the precision of medical-grade electrocardiograms (ECGs) utilized in clinical environments.

Dr. O’Connor also pointed out a notable gap in temperature guidelines. While there are established recommendations for maximum indoor temperatures during the day, there are currently no equivalent guidelines for nighttime conditions.

The study has been published in the journal BMC Medicine.

As the link between bedroom temperature and heart health becomes clearer, it may be wise for older adults to consider adjusting their sleeping environments to promote better cardiovascular health.

For more information on this study, refer to Fox News.

Sagar Bapat Honored with 2026 Pathway to Stop Diabetes Award

Sagar Bapat, an Indian American researcher, has received the 2026 Pathway to Stop Diabetes Award for his innovative T cell-based therapy aimed at combating obesity-induced diabetes.

Sagar Bapat, an Indian American researcher at the University of California, San Francisco, has been awarded the prestigious 2026 Pathway to Stop Diabetes Award by the American Diabetes Association (ADA). His research focuses on developing a novel type of living T cell-based therapy designed to address obesity-induced diabetes.

Bapat’s innovative approach seeks to enhance the thermogenic function of adipose tissue, utilizing targeted cellular therapy and CRISPR technology to create durable, preventative interventions against diabetes linked to obesity. “This award will enable us to pursue a novel type of living T cell-based therapy aimed at modulating adipose tissue function to promote metabolic health,” Bapat stated. “By harnessing the unique mobility and functional versatility of T cells, our goal is to restore healthy tissue function and improve insulin sensitivity in metabolic and inflammatory diseases.”

The Pathway to Stop Diabetes program provides critical funding to early-career scientists who demonstrate exceptional innovation and creativity in their research. Bapat is among seven recipients of the latest awards, which total $11.3 million. This funding allows researchers to explore new ideas without the constraints typically associated with traditional project funding.

<p”Diabetes research is vital to improving the lives of people living with diabetes and ultimately finding a cure,” said Rita Kalyani, the ADA’s chief scientific and medical officer. “The ADA is proud to foster new medical breakthroughs and support early-career investigators who are conducting innovative, high-impact diabetes research. Congratulations to these pioneering scientists.”

Bapat’s work is particularly significant given the rising prevalence of obesity and type 2 diabetes, which is a leading cause of mortality in the United States. The connection between obesity and diabetes is well-established, as obesity is the predominant risk factor for developing insulin resistance and diabetes.

Obesity often arises from a complex interplay of physiological and socioeconomic factors that individuals may find difficult to overcome. In simple terms, obesity results from excessive energy storage in the body. Bapat believes that this condition could potentially be mitigated by activating the body’s dormant systems for burning energy rather than storing it.

To achieve this, Bapat and his team plan to engineer fat-localizing regulatory T cells (Treg cells) that can send signals to convert energy-storing adipose tissue into energy-burning adipose tissue. This innovative approach aims to reverse or prevent obesity and insulin resistance, initially in mice and eventually in humans.

Bapat’s academic background is impressive. He earned his bachelor’s degree from Stanford University in 2009, completed his MD-PhD at the University of California, San Diego, and the Salk Institute for Biological Studies in 2017, and finished a residency in clinical pathology at UCSF in 2020.

As the fight against diabetes continues, Bapat’s research represents a promising step forward in developing effective therapies that could significantly improve metabolic health and quality of life for millions affected by obesity and diabetes.

According to The American Bazaar, Bapat’s innovative work is set to make a lasting impact on diabetes research and treatment.

Wearable Robotics Transforming Human Mobility in Walking and Running

Wearable robotics, including Nike’s Project Amplify and the Hypershell X exoskeleton, are transforming how we walk and run, aiming to enhance movement rather than replace it.

In recent years, the field of robotics has expanded beyond the confines of factories and laboratories, making its way into our daily lives. Wearable robotics, which include powered footwear and lightweight exoskeletons, are emerging as a new consumer category designed to assist movement rather than replace physical effort.

Historically, innovations in sports technology have focused on enhancing speed and performance, often benefiting elite athletes. However, the focus is shifting towards accessibility and support for everyday users. Nike’s Project Amplify exemplifies this trend. Developed in collaboration with robotics partner Dephy, this system integrates a carbon plate within the shoe and a motorized cuff worn above the ankle. The cuff uses sensors to monitor stride patterns in real time, providing subtle assistance that feels natural and smooth, rather than forcing movement.

Previous attempts at creating powered footwear faced challenges due to the weight of batteries and motors, which made the devices feel cumbersome and unbalanced. Modern designs have addressed these issues by relocating energy storage to the ankle or hips, thereby reducing strain on the feet and improving overall balance. Enhanced battery technology and advanced motion sensors allow these systems to adapt to users’ strides dynamically, making the experience feel like an extension of the body. Nike aims for a commercial release of Project Amplify around 2028.

However, Nike is not the only player in this evolving market. The Hypershell X is another notable example, designed as a lightweight outdoor exoskeleton for hikers and long-distance walkers. This system wraps around the waist and legs, employing small motors to alleviate fatigue during climbs and on uneven terrain. The goal is straightforward: to help users go farther without feeling drained. Hypershell has also introduced the X Ultra, a more robust version tailored for steeper terrains and longer excursions, providing stronger assistance while remaining compact enough to wear under standard outdoor gear.

Dnsys has also entered the market with the X1 all-terrain exoskeleton, aimed at hikers and outdoor enthusiasts. Unlike earlier lab prototypes, the X1 has been successfully sold through crowdfunding and direct online orders, marking it as one of the early consumer-ready entries in the wearable robotics space.

Another innovative product is WIM from WIRobotics, a wearable robot that weighs approximately 3.5 pounds and supports natural hip movement while walking. This device is targeted at older adults, active individuals, and those recovering from minor injuries, providing assistance without the bulkiness of traditional medical devices.

The medical applications of wearable robotics have been developing for a longer time. Companies like Ekso Bionics and ReWalk have created powered exoskeletons that assist individuals with spinal cord injuries or strokes in standing and walking. These systems are primarily used in rehabilitation clinics and select personal mobility programs, demonstrating how wearable robotics have evolved from medical settings to consumer-oriented designs.

What unites these diverse products is a common goal: to actively assist movement rather than merely track it. Many individuals face barriers to physical activity that are not solely related to injury; hesitation often plays a significant role. Concerns about knee pain, fatigue, or the fear of slowing down others can deter people from engaging in physical activity. Wearable robotics aim to bridge this confidence gap by reducing fatigue and supporting joints, making movement feel more attainable for those who might otherwise avoid it.

Comparatively, the rise of e-bikes serves as a relevant analogy. Electric assistance has not eliminated cycling; instead, it has broadened the demographic of people who feel comfortable riding a bike. Similarly, powered footwear and wearable robotics could democratize walking and running, making these activities more accessible to a wider audience.

For some, this technology might mean replacing short car trips with walking, while for older adults, it could facilitate prolonged activity without excessive fatigue. Casual runners may find they can complete their workouts with energy to spare, rather than struggling through the final stretch. This shift is not about creating super athletes; it is about empowering more individuals to participate in physical activities.

Even if you are not inclined to use a powered exoskeleton or are not eagerly awaiting the arrival of motorized shoes in 2028, the implications of this technology are significant. For those who experience discomfort during long walks or skip runs due to fatigue concerns, wearable robotics are designed with these challenges in mind. The aim is not to transform anyone into a super athlete but to make movement feel more achievable.

For some, this could translate to walking an extra mile effortlessly, while for others, it might mean keeping pace with friends or feeling more confident about starting a new fitness routine. Wearable robotics are reshaping the conversation around fitness, shifting the focus from speed and performance to comfort and accessibility.

As wearable robotics continue to evolve, the question is not whether they will improve, but how society will choose to integrate them into daily life. If these technologies can help you walk and run with less strain, would you consider using them, or would you prefer to rely solely on your own efforts? This is a conversation worth having as we navigate the future of movement.

According to Fox News, the potential of wearable robotics to enhance everyday mobility is becoming increasingly clear.

Bill Gates to Meet Andhra Pradesh Chief Minister for Strategic Talks

Bill Gates is set to visit Amaravati, Andhra Pradesh, for strategic discussions with Chief Minister N. Chandrababu Naidu, focusing on health and artificial intelligence.

In a significant development highlighting the intersection of technology and governance, Bill Gates, co-founder of Microsoft and a prominent figure in the tech industry, is scheduled to visit Amaravati, the capital of Andhra Pradesh. His meeting with Chief Minister N. Chandrababu Naidu aims to explore opportunities for expanding cooperation in two critical areas: health and artificial intelligence (AI).

This visit underscores Gates’s ongoing commitment to global health and technological advancement while showcasing Andhra Pradesh’s ambition to emerge as a leader in these fields. As India rapidly advances its digital infrastructure and technological capabilities, the country has become a focal point for tech giants, thanks to its vast and diverse market.

Under Naidu’s leadership, Andhra Pradesh has been proactive in leveraging technology to enhance governance and public welfare. Naidu, often recognized as a tech-savvy leader, has played a crucial role in driving digital initiatives across the state, which include e-governance and smart city projects.

The discussions between Gates and Naidu are expected to focus on how AI can be utilized to improve healthcare delivery in the state. India faces numerous healthcare challenges, including a shortage of medical professionals and inadequate infrastructure, particularly in rural areas. AI holds the potential to address some of these issues by facilitating remote diagnostics, predictive analytics for disease outbreaks, and personalized medicine.

Gates’s insights, supported by the resources of the Bill & Melinda Gates Foundation, could be instrumental in developing solutions tailored to the specific needs of Andhra Pradesh. The meeting is also likely to explore collaborative projects that align with the Gates Foundation’s focus on global health issues, such as eradicating infectious diseases and enhancing maternal and child health.

Andhra Pradesh could serve as a pilot region for innovative health interventions that, if successful, might be scaled across India and other developing regions. Gates’s interest in AI aligns with a broader global trend, where technology is increasingly recognized as a catalyst for economic and social development.

AI, in particular, has the potential to revolutionize various sectors, from agriculture to education, offering unprecedented opportunities for growth and efficiency. For Andhra Pradesh, embracing AI could lead to improved agricultural productivity, enhanced educational outcomes, and more efficient public services.

This visit also reflects a symbiotic relationship between global tech leaders and regional governments. As tech companies seek to expand their presence in emerging markets, they find willing partners in governments eager to harness technology for development. This partnership is mutually beneficial: tech companies gain access to new markets and data, while governments receive the technological expertise and investment necessary to drive growth.

In conclusion, Bill Gates’s visit to Andhra Pradesh represents more than just a high-profile meeting. It symbolizes the potential for technology to transform societies and underscores the importance of strategic partnerships in realizing this potential. As Andhra Pradesh continues its journey toward becoming a tech-driven state, the insights and collaboration from Gates and his foundation could play a pivotal role in shaping its future. Both Gates and Naidu share a vision of leveraging technology for the greater good, and this meeting may mark a significant step toward achieving that vision.

According to GlobalNetNews.

ICE Access to Medicaid Data Raises Concerns Among States Regarding Immigrants

The Trump administration’s decision to grant Immigration and Customs Enforcement access to Medicaid data is causing significant concern among hospitals and states regarding the privacy of immigrant patients.

The Trump administration’s recent decision to allow Immigration and Customs Enforcement (ICE) access to Medicaid data has left hospitals and states grappling with the implications for immigrant patients. This move raises critical questions about patient privacy and the potential chilling effect on healthcare access for vulnerable populations.

Under the new policy, hospitals must consider whether to inform immigrant patients that their personal information, including home addresses, could be used by ICE in deportation efforts. This warning could deter many from enrolling in Emergency Medicaid, a program that reimburses hospitals for emergency treatment provided to immigrants who do not qualify for standard Medicaid coverage.

Leonardo Cuello, a research professor at Georgetown University’s Center for Children and Families, expressed concern over the potential consequences of this policy. “If hospitals tell people that their Emergency Medicaid information will be shared with ICE, it is foreseeable that many immigrants would simply stop getting emergency medical treatment,” he said. Cuello highlighted that a significant portion of Emergency Medicaid cases involve the delivery of U.S. citizen babies, raising the question of whether mothers will avoid hospitals during labor due to fear of deportation.

For over a decade, hospitals and states have assured patients that their personal information, including immigration status, would remain confidential when applying for federal health care coverage. A 2013 ICE policy memo had previously guaranteed that information from health coverage applications would not be used for enforcement activities. However, this assurance has been undermined by recent policy changes under the Trump administration, which has initiated an aggressive immigration crackdown.

Last spring, the Centers for Medicare & Medicaid Services (CMS), part of the Department of Health and Human Services, agreed to provide ICE officials with direct access to a Medicaid database that includes enrollees’ addresses and citizenship status. This decision prompted 22 states, predominantly led by Democratic governors, to file a lawsuit to block the data-sharing agreement. A federal judge ruled in December that ICE could only access information about individuals unlawfully residing in the country from the Medicaid database in those states.

Despite the ruling, many hospitals contacted by KFF Health News declined to comment on whether they have updated their disclosure policies regarding the potential sharing of patient information with ICE. None of the responding hospitals indicated that they are directly warning patients about the risks associated with applying for Medicaid coverage.

Aimee Jordon, a spokesperson for M Health Fairview, a hospital system in Minneapolis, stated, “We do not provide legal advice about federal government data-sharing between agencies. We encourage patients with questions about benefits or immigration-related concerns to seek guidance from appropriate state resources and qualified legal counsel.”

Some states’ Emergency Medicaid applications still ask for a patient’s immigration status while assuring applicants that their information will be kept confidential. For instance, California’s application, as of February 3, included language stating that immigration information is “confidential” and used solely to determine eligibility for health insurance.

California Department of Health Care Services spokesperson Anthony Cava confirmed that the agency will ensure that Californians receive accurate information regarding the privacy of their data. In contrast, Utah’s Medicaid website previously claimed that its Emergency Medicaid program did not share information with immigration officials. Following inquiries from KFF Health News, the state agency promptly removed this misleading language.

Oregon Health & Science University, a hospital system in Portland, provides immigrant patients with a Q&A document developed by the state Medicaid program, addressing concerns about the use of their information. However, this document does not explicitly state that Medicaid enrollees’ information is shared with ICE.

Emergency Medicaid is crucial for hospitals, as it allows them to receive reimbursement for treating individuals who would qualify for Medicaid if not for their citizenship status. This includes both undocumented immigrants and those with legal status, such as students or work visa holders. The coverage is limited to emergency medical and pregnancy care, and hospitals typically assist patients in applying while they are still receiving care.

The main Medicaid program, which serves over 77 million low-income and disabled individuals, does not cover those living in the country illegally. Consequently, Emergency Medicaid enrollment becomes a key avenue for deportation officials to identify immigrants, including those who may not be lawfully present in the U.S.

Rich Danker, a spokesperson for HHS, confirmed that CMS is sharing data with ICE following the judge’s ruling but did not clarify how the agency is ensuring compliance with the requirement to limit information sharing to individuals unlawfully present in the country.

With ICE now having direct access to the personal information of millions of Medicaid enrollees, hospitals face a challenging dilemma. Sarah Grusin, an attorney at the National Health Law Program, emphasized the need for transparency regarding these changes. “They need to be telling people that the judge has permitted sharing of information, including their address, for people who are not lawfully residing,” she stated. “Once this information is submitted, you can’t protect it from disclosure at this point.”

Grusin advised families to carefully weigh the importance of seeking medical care against the risk of having their information shared with ICE. “We want to give candid, honest information even if it means the decision people have to make is really hard,” she said.

Emergency Medicaid coverage was established in the mid-1980s, following a federal law requiring hospitals to treat and stabilize all patients presenting with life-threatening conditions. In 2023, federal spending on Emergency Medicaid reached nearly $4 billion, representing about 0.4% of total federal Medicaid spending.

States are required to report detailed information about Medicaid enrollment and services to the federal government monthly. The December ruling limited the information CMS can share with ICE to basic details, including addresses, for Medicaid enrollees in the states that sued over the data-sharing arrangement. ICE officials are prohibited from accessing information about the medical services received by individuals in those states, as well as data pertaining to U.S. citizens or lawfully present immigrants.

However, deportation officials still have access to the personal Medicaid information of all enrollees in the remaining 28 states. Medicaid experts have raised concerns about the feasibility of separating data to comply with the judge’s order, leading to questions about the Trump administration’s adherence to the ruling.

The implications of these policies on immigrant families seeking healthcare are significant. A recent KFF/New York Times poll revealed that approximately one-third of adult immigrants reported postponing or skipping healthcare in the past year due to fears related to their immigration status. Bethany Pray, chief legal and policy officer at the Colorado Center on Law and Policy, expressed alarm over the potential consequences of sharing Medicaid data with deportation officials. “This is very concerning,” she said. “People should not have to choose between giving birth in a hospital and wondering if that means they risk deportation.”

KFF Health News is a national newsroom dedicated to producing in-depth journalism on health issues and is part of KFF, an independent source for health policy research, polling, and journalism.

Dhireesha Kudithipudi Leads First U.S. Open-Access Neuromorphic Computing Hub

Dhireesha Kudithipudi is spearheading the first open-access neuromorphic computing hub in the U.S. at the University of Texas at San Antonio, aiming to democratize artificial intelligence research.

Indian American computer scientist Dhireesha Kudithipudi is transforming the landscape of artificial intelligence (AI) in the United States. As the founding director of the MATRIX AI Consortium at the University of Texas at San Antonio (UTSA), she is at the forefront of launching THOR: The Neuromorphic Commons, the first open-access hub of its kind in the country.

Funded by the National Science Foundation, the THOR project seeks to democratize access to neuromorphic computing, a field that emulates the architecture of the human brain to process information. Unlike traditional silicon chips, which consume significant amounts of electricity regardless of the task, neuromorphic systems operate on an “event-based” model, activating only when new data is detected.

“THOR is the U.S. national hub for neuromorphic computing,” Kudithipudi stated. She also holds the Robert F. McDermott Chair in Engineering at UTSA. “We are democratizing the technology, expanding industry-academia partnerships, and serving as a catalyst for bringing neuromorphic computing closer to real-world applications.”

Historically, access to such advanced hardware has been limited to elite corporate laboratories or well-funded academic institutions. In contrast, UTSA’s new initiative functions similarly to a public library, allowing researchers and students nationwide to apply for free access to run experiments. This approach significantly lowers the barrier to entry for the next generation of engineers.

At the core of the hub is the SpiNNaker2 system, a substantial platform featuring approximately 400,000 processing elements. Developed in collaboration with SpiNNcloud, this hardware utilizes energy-efficient ARM-based cores, akin to those found in smartphones, to simulate the pulsing signals of biological neurons and synapses.

The practical implications of this energy efficiency are profound. According to the research team, neuromorphic chips have the potential to revolutionize medical devices. For instance, they could enable pacemakers to adapt in real-time to a patient’s physical distress or allow hearing aids to intelligently filter background noise without quickly draining their batteries.

In addition to energy savings, Kudithipudi and her colleagues are addressing the issue of “catastrophic forgetting,” a common flaw in AI systems where machines lose previously acquired knowledge when learning new information. By mimicking the brain’s “lifelong learning” capabilities, THOR could facilitate the development of AI that evolves continuously.

This initiative involves a nationwide collaboration, with contributions from experts at UT Knoxville, UC San Diego, and Harvard University. The official launch of THOR is scheduled for February 23, marking a significant milestone for UTSA’s newly established College of AI, Cyber and Computing.

For Kudithipudi, the overarching goal is to ensure that the future of computing is not only more powerful but also more accessible and sustainable for all.

The information for this article was sourced from The American Bazaar.

Simple Food Combination May Be More Effective Than Omega-3 Supplements

A recent study indicates that a combination of kefir and prebiotic fiber may be more effective in reducing inflammation than omega-3 supplements alone, highlighting the importance of gut health.

A new study from the University of Nottingham has revealed that a simple dietary combination could provide greater immune benefits than omega-3 supplements on their own. Researchers found that pairing kefir, a fermented milk drink, with a mix of prebiotic fibers led to more significant reductions in inflammation markers compared to omega-3 supplements or fiber alone.

The findings, published in the Journal of Translational Medicine, underscore the potential role of gut bacteria in supporting immune and metabolic functions. Kefir, which is similar to yogurt and contains live bacteria and yeast, appears to enhance the effects of prebiotic fiber. This type of fiber nourishes healthy gut bacteria, enabling them to grow and function more effectively.

As these beneficial bacteria flourish, they produce natural substances that help to alleviate inflammation in the body. In a six-week study, participants who consumed the kefir and fiber combination experienced the most significant decrease in markers associated with whole-body inflammation. While those taking omega-3 supplements or fiber alone also saw improvements, the results were not as pronounced.

“Our study shows that while all three dietary approaches reduced inflammation, the synbiotic — combining fermented kefir with a diverse prebiotic fiber mix — had the most powerful and wide-ranging effects,” said Amrita Vijay, a gut microbiome scientist who led the research.

The researchers focused on measuring systemic inflammatory markers, which indicate inflammation occurring throughout the body. While inflammation is a normal immune response, chronic low-level inflammation that persists over time has been linked to various health issues, including heart disease and metabolic disorders, according to the Cleveland Clinic.

The study’s findings suggest that combining probiotics and prebiotics may offer broader support for health than relying on a single supplement. “This suggests that the interaction between gut microbes and dietary fiber may be key to supporting immune balance and metabolic health,” Vijay noted.

Looking ahead, the research team plans to further investigate how synbiotic supplementation could impact individuals with chronic inflammatory disorders, potentially paving the way for new dietary strategies in managing inflammation.

These insights into the benefits of kefir and prebiotic fiber highlight the importance of gut health in overall well-being, suggesting that dietary choices can play a crucial role in managing inflammation and supporting immune function.

According to Fox News, the implications of this research could lead to more effective dietary recommendations for those seeking to reduce inflammation and improve their health.

Sreedhareeyam Ayurvedic Eye Hospital Offers Leading Ayurvedic Eye Treatments in India

Sreedhareeyam Ayurvedic Eye Hospital is recognized for providing exceptional Ayurvedic eye treatments in India, focusing on holistic healing and patient care.

Sreedhareeyam Ayurvedic Eye Hospital has established itself as a leading institution for Ayurvedic eye treatments in India. With a commitment to holistic healing, the hospital offers a range of services aimed at improving eye health and overall well-being.

Located in Kerala, Sreedhareeyam combines traditional Ayurvedic practices with modern medical techniques to provide comprehensive eye care. The hospital’s approach emphasizes the importance of treating not just the symptoms but also the underlying causes of eye ailments.

Patients at Sreedhareeyam benefit from personalized treatment plans tailored to their specific needs. The hospital employs a team of experienced Ayurvedic practitioners and ophthalmologists who work together to ensure the best possible outcomes for their patients.

In addition to its treatment offerings, Sreedhareeyam also focuses on patient education, helping individuals understand the importance of eye health and the role of Ayurveda in maintaining it. This educational component is a vital part of their holistic approach, empowering patients to take charge of their health.

As a pioneer in Ayurvedic eye care, Sreedhareeyam Ayurvedic Eye Hospital continues to attract patients not only from India but also from around the world, seeking effective and natural solutions for their eye conditions.

According to GlobalNetNews, the hospital’s dedication to quality care and patient satisfaction has made it a trusted name in the field of Ayurvedic medicine.

Certain Bitter Foods May Trigger Brain Response Similar to Exercise

New research indicates that certain bitter foods, such as dark chocolate and red wine, may enhance memory and attention by activating brain responses similar to those triggered by exercise.

Recent studies in sensory nutrition have uncovered intriguing links between bitter foods and cognitive function. Foods like dark chocolate, red wine, tea, and berries may boost memory and attention through a unique brain activation process triggered by their bitter taste.

Research conducted in Japan suggests that flavanols—plant compounds present in these foods—stimulate the brain not by entering the bloodstream but by activating sensory responses associated with their bitterness. Professor Naomi Osakabe from the Shibaura Institute of Technology explained, “The key finding of this experiment is that it first demonstrated how flavanol intake stimulation—likely the bitter taste—is transmitted to the central nervous system, triggering a stress response reaction that enhances short-term memory and produces beneficial effects on the circulatory system.”

Osakabe noted that the brain activity-enhancing effects of flavanols were observed even at low doses. In experiments involving mice, a single dose of flavanols was found to increase spontaneous activity and improve performance on memory tests. The study, published in Current Research in Food Science, also revealed rapid activation of brain regions responsible for attention, arousal, and stress regulation.

This research aligns with findings from other studies that suggest certain foods may offer protective benefits for heart health, particularly for those who lead sedentary lifestyles.

The researchers propose that the minimal absorption of flavanols into the bloodstream may mean they influence the brain and heart by stimulating sensory nerves. This concept falls under the emerging field of sensory nutrition, which posits that the taste and physical sensations of food can directly regulate biological functions. Such insights could pave the way for new food products that combine appealing flavors with beneficial physiological effects.

The brain’s response to these foods resembles the effects of mild exercise, which activates the sympathetic nervous system and can enhance focus and alertness. “While it is clear that healthy foods contribute to maintaining and enhancing homeostasis, the mechanisms remain largely unclear,” Osakabe said. “Notably, this study identified the potential for the taste of food components to regulate biological functions.”

However, the study does have limitations, as it was conducted on animals. The complexity of food, which consists of various compounds that may interact with one another, necessitates further research. Larger human studies are required to determine whether the effects observed in mice are applicable to people.

Dr. Johnson Moon, a neurologist at Providence St. Jude Medical Center in California, emphasized the need for caution. He remarked, “I do not believe people, including most doctors, are aware that a taste of a specific molecule or compound can rapidly trigger major changes in the brain.” He also pointed out that more data is needed before recommending foods like dark chocolate, especially since factors such as calories, sugar, and fat could negate potential benefits.

Despite these concerns, Osakabe highlighted that previous long-term studies on cocoa flavanols have indicated cardiovascular and cognitive benefits. She advocates for a balanced, plant-forward diet, stating, “I believe consuming plant-based foods like cocoa, berries, and red wine, along with fruits and vegetables, can help maintain health.”

Major health organizations advise that if adults choose to consume alcohol, it should be done in moderation—up to one drink per day for women and two for men—and emphasize that no amount of alcohol is entirely risk-free.

As research in this area continues to evolve, the potential for bitter foods to enhance cognitive function presents an exciting avenue for future exploration.

According to Fox News Digital, the findings underscore the importance of understanding how the sensory experiences of food can influence our health.

Android Malware Disguised as Fake Antivirus App Targets Users

Cybersecurity experts warn that a fake antivirus app named TrustBastion is using Hugging Face to distribute Android malware that can steal sensitive information from users’ devices.

Android users should be on high alert as cybersecurity researchers have identified a new threat involving a fake antivirus application called TrustBastion. This malicious app exploits Hugging Face, a widely used platform for sharing artificial intelligence (AI) tools, to deliver dangerous malware that can capture screenshots, steal personal identification numbers (PINs), and display fraudulent login screens.

The TrustBastion app initially presents itself as a helpful security tool, claiming to offer virus protection, phishing defense, and malware blocking. However, once installed, it quickly reveals its true nature. The app falsely alerts users that their device is infected, prompting them to install an update that actually delivers the malware. This tactic, known as scareware, preys on users’ fears and encourages them to act without thinking.

According to Bitdefender, a global cybersecurity firm, the campaign surrounding TrustBastion is particularly concerning due to its deceptive nature. Victims are often misled by ads or warnings suggesting their devices are compromised, leading them to manually download the app. The attackers cleverly hosted TrustBastion’s APK files on Hugging Face, embedding them within seemingly legitimate public datasets, which allowed the malicious code to go unnoticed.

Once installed, TrustBastion immediately prompts users to download a “required update,” which is when the actual malware is introduced. Despite researchers reporting the malicious repository, Bitdefender noted that similar repositories quickly reemerged, often with minor cosmetic changes but maintaining the same harmful functionality. This rapid re-creation complicates efforts to fully eliminate the threat.

The malware associated with TrustBastion is invasive and poses significant risks. Bitdefender reports that it can take screenshots, display fake login screens for financial services, and capture users’ lock screen PINs. The stolen data is then transmitted to a third-party server, allowing attackers to drain bank accounts or lock users out of their devices.

Google has reassured users that those who stick to official app stores are generally protected against this type of malware. A Google spokesperson stated, “Based on our current detection, no apps containing this malware are found on Google Play.” Google Play Protect, which is enabled by default on Android devices with Google Play Services, helps safeguard users by warning them about or blocking apps known to exhibit malicious behavior, even if they originate from outside the Play Store.

This incident serves as a stark reminder of the importance of cautious app downloading practices. Users are advised to only download applications from reputable sources, such as the Google Play Store or the Samsung Galaxy Store, which have moderation and scanning processes in place. It is also crucial to scrutinize app ratings, download counts, and recent reviews, as fake security apps often garner vague feedback or experience sudden rating spikes.

Even the most vigilant users can fall victim to data exposure. Utilizing a data removal service can help eliminate personal information, such as phone numbers and email addresses, from data broker sites that criminals exploit. While no service can guarantee complete data removal from the internet, these services actively monitor and systematically erase personal information from numerous websites, providing peace of mind and reducing the risk of follow-up scams and account takeovers.

To further enhance security, users should regularly scan their devices with Google Play Protect and consider backing up their protection with robust antivirus software. Although Google Play Protect automatically removes known malware, it is not infallible. Historically, it has not always been 100% effective in eliminating all malware from Android devices.

To safeguard against malicious links that could install malware and compromise personal information, users should ensure they have strong antivirus software installed across all devices. This software can also help detect phishing emails and ransomware, protecting personal information and digital assets.

Additionally, users should avoid installing apps from websites outside of official app stores, as these apps bypass essential security checks. It is vital to verify the publisher name and URL before downloading any application. Enabling two-step verification (2FA) and using strong, unique passwords stored in a password manager can also help prevent account takeovers.

Finally, users should remain cautious about granting accessibility permissions, as malware often exploits these to gain control over devices. This incident illustrates how quickly trust can be weaponized, with a platform designed for advancing AI research being repurposed to distribute malware. A fake antivirus app has become the very threat it claims to protect against, underscoring the need for users to scrutinize even seemingly trustworthy applications.

For those who have encountered suspicious activity on their devices, sharing experiences can help raise awareness. Users are encouraged to report their findings and concerns to relevant platforms.

According to Bitdefender, staying informed and cautious is the best defense against evolving cyber threats.

Astronauts Arrive at ISS for Eight-Month Mission Following Medical Emergency

Four astronauts arrived at the International Space Station for an eight-month mission, following an early evacuation due to a medical emergency last month.

Four new astronauts arrived at the International Space Station (ISS) on Saturday, restoring the lab to full capacity after a medical emergency forced an early evacuation of several crew members last month. The international crew, which includes NASA Commander Jessica Meir, launched from Cape Canaveral in a SpaceX rocket on Friday, embarking on a journey that lasted approximately 34 hours.

“That was quite the ride,” Meir remarked shortly after the launch, as reported by BBC News. “We have left the Earth, but the Earth has not left us.” The launch had faced delays due to weather concerns prior to takeoff.

Joining Meir for the next eight to nine months aboard the ISS are NASA astronaut Jack Hathaway, France’s Sophie Adenot, and Russian cosmonaut Andrei Fedyaev. Both Meir and Fedyaev have previous experience aboard the ISS, with Meir notably participating in the first all-female spacewalk in 2019. Adenot, a military helicopter pilot, is only the second French woman to travel to space, while Hathaway serves as a captain in the U.S. Navy.

NASA reported that the spacecraft is set to autonomously dock with the space station’s Harmony module at 3:15 p.m. CT on Saturday, traveling at a speed of 17,000 mph in Earth orbit. “What an absolutely wonderful start to the day,” said NASA Administrator Jared Isaacman following the launch. “This mission has shown in many ways what it means to be mission-focused at NASA.”

Isaacman also highlighted the recent adjustments made by NASA, including the early return of Crew-11 and the expedited launch of Crew-12, all while preparing for the upcoming Artemis 2 mission, which is scheduled to begin in early March.

This mission marks the 12th crew rotation with SpaceX as part of NASA’s Commercial Crew Program. Crew-12 will engage in scientific investigations and technology demonstrations aimed at preparing humans for future exploration missions to the Moon and Mars, as well as providing benefits for people on Earth.

After docking, the capsule’s hatch opened at 4:14 p.m. CT, allowing the crew to enter the space station. “We are so excited to be here and get to work,” Meir expressed upon arrival. Adenot added, “The first time we looked at the Earth was mind-blowing. … We saw no lines, no borders.”

Prior to the arrival of the new crew, only one American and two Russians remained at the space station, ensuring its continued operation. The medical evacuation that took place in January was the first of its kind in 65 years, as NASA reported that a crew member experienced a serious health issue. The agency has not disclosed the nature of the medical condition or the identity of the astronaut involved, citing medical privacy.

The astronaut who faced the medical emergency, along with three other crew members who had launched with them, returned to Earth more than a month earlier than planned after the decision was made to bring them home.

According to the Associated Press, the successful arrival of the new crew marks a significant step forward for ongoing research and exploration efforts aboard the ISS.

ATS Breathe Easy: Thakur Challenges Trump Administration’s Science Funding Cuts

Neeta Thakur, MD, discusses the impact of abrupt research grant terminations on scientific studies and health outcomes, as she joins a lawsuit to restore funding for critical research.

In 2025, scientific research grants were unexpectedly terminated for hundreds of researchers, including many within the American Thoracic Society (ATS) community. This abrupt decision has left numerous important studies, some in their final stages, at risk of being discarded. The implications of these cuts extend beyond individual projects, threatening collaborative research efforts that are vital for community health.

One researcher affected by these funding cuts is Neeta Thakur, MD, from the University of California, San Francisco. Dr. Thakur was working on a significant project funded by the Environmental Protection Agency (EPA) that aimed to study the effects of wildfire smoke on vulnerable communities. The termination of her grant has not only halted her research but also raised concerns about the broader impact on public health.

In a recent episode of the ATS Breathe Easy podcast, Dr. Thakur shared her experience with the funding cuts and discussed the collaborative efforts among researchers to challenge these decisions in court. The lawsuit seeks to restore the necessary funding to complete critical research that could inform health policies and improve patient outcomes.

Dr. Thakur emphasized the importance of her research, which aims to understand how wildfire smoke affects populations that are already at risk due to various health disparities. The sudden loss of funding has not only disrupted her work but has also jeopardized the potential benefits that could arise from her findings.

During her conversation with Air Health Our Health host Erika Moseson, MD, MA, Dr. Thakur outlined the broader implications of these funding cuts for scientific research and public health. She expressed concern that the termination of grants could lead to a significant setback in understanding environmental health issues, particularly as climate change continues to exacerbate conditions like wildfires.

The lawsuit filed by Dr. Thakur and her colleagues aims to highlight the detrimental effects of these funding cuts on scientific progress. They argue that such abrupt terminations undermine years of collaborative research efforts and threaten the health of communities that rely on this vital information.

As the legal battle unfolds, Dr. Thakur remains hopeful that the courts will recognize the importance of restoring funding for scientific research. She believes that the outcome of this case could set a precedent for how future funding decisions are made and could help safeguard the integrity of scientific inquiry.

For those interested in the ongoing discussion about funding cuts and their implications, previous episodes of the ATS Breathe Easy podcast delve into related topics. These include the real costs of federal budget cuts and the human impact of reductions in National Institutes of Health (NIH) funding.

The challenges faced by researchers like Dr. Thakur underscore the critical need for sustained investment in scientific research. As the landscape of funding continues to evolve, the commitment to supporting research that addresses pressing health issues remains paramount.

According to Newswise, the outcome of this lawsuit could have far-reaching consequences for the future of health research and the communities that depend on it.

Indian-American Family Legacy Transforms Operating Rooms into Living Classrooms

Medical students from UC Irvine gain invaluable insights into healthcare and community through a transformative clinical exchange program in Rajkot, India, supported by a family legacy of education and perseverance.

IRVINE, CA – Alicia Wells, a fourth-year medical student at the University of California, Irvine, embarked on a transformative journey when she entered the bustling wards of a government hospital in Rajkot, India. While she anticipated differences in healthcare systems, she did not expect how profoundly this experience would shape her understanding of medicine, care, and her own identity as a future physician.

Wells traveled to Gujarat as part of a short clinical exchange program, applying for residency in Child Neurology. Within days, her experience began to redefine not only her approach to medicine but also her perspective on community and personal responsibility.

“I thought I was going there to observe another healthcare system,” Wells said. “Instead, it made me reflect on the kind of doctor I want to become.”

During her rotation at Zanana Hospital, where she worked in obstetrics and gynecology, Wells was struck by the scale and efficiency of care. The hospital manages nearly 10,000 births annually and handles hundreds of outpatient visits each day. Procedures such as tubal ligations were completed in five to ten minutes, a stark contrast to the hours such procedures can take in the United States. Wells was impressed not only by the speed but also by the calm coordination among physicians, residents, and interns, who adapted to limited resources while meeting overwhelming demand.

“The efficiency was incredible,” she noted. “But what stood out even more was how composed everyone remained despite the volume and resource limitations.”

Wells’ time in the pediatric and neonatal intensive care units further deepened her understanding of healthcare. She encountered clinical conditions she had previously only read about, such as congenital CMV, cobra bites, and Guillain-Barré syndrome. However, what resonated most with her was the role of families in the care process. Parents and relatives were consistently present, providing bedside care that would typically be the responsibility of nursing staff in American hospitals. Across various departments, families acted as integral members of the care team, united by a sense of responsibility and resilience.

“In the U.S., we talk about family-centered care,” Wells reflected. “In Rajkot, I saw it lived out every day.”

The learning experience extended beyond the hospital environment. A visit to Gondal High School became one of the most emotional highlights of her trip. Hundreds of students welcomed the visiting medical students with enthusiasm, teaching them traditional Garba dance, playing games, and proudly showcasing their classrooms. As Wells hugged a long line of girls goodbye, she felt a mix of gratitude and humility, acutely aware of the privilege that brought her there and the responsibility she would carry forward.

Equally impactful were the friendships Wells formed with interns at Pandit Deendayal Upadhyay Medical College. After long days in the hospital, these interns made time to show the visitors around Rajkot, navigating busy streets on mopeds, sharing meals at local restaurants, and introducing them to the local culture. What began as hospitality quickly blossomed into meaningful connections.

A small yet significant moment encapsulated this spirit of camaraderie. When Wells realized she might miss the closing time for a required yellow fever vaccine, one intern immediately dropped everything to ensure she made it on time, racing through traffic to get her there just minutes before closing. By the end of her two-week rotation, her colleagues felt like family.

Mihir Solanki, an intern at the medical college, described hosting the UCI students as both academically enriching and personally meaningful. “Their curiosity during ward rounds and the way they engaged with our professors made discussions more dynamic,” Solanki said. “It pushed us to think more deeply about our own approaches.”

Solanki reflected on how observing medical education in another country prompted him to reconsider his own training while reinforcing the shared values that transcend borders. “Despite differences in infrastructure, our core values were the same,” he noted. “Empathy, service, and commitment to patients do not change with geography.”

Outside the hospital, Solanki appreciated the informal time spent together, riding mopeds, trying local cuisine, visiting temples, shopping in markets, and playing sports. “Those moments made the exchange feel natural rather than formal,” he added. The experience left him eager for more global exchanges and hopeful for an opportunity to visit UCI in the future.

The India Summer Travel Program, which facilitates these exchanges, is rooted in the belief that medicine is best learned through exposure and humility. This philosophy is embodied by Dr. Rimal Bera, Clinical Professor of Psychiatry and Human Behavior at the UC Irvine School of Medicine, whose family played a pivotal role in establishing the program.

In 2020, the Bera family donated $100,000 to UCI to permanently support medical student travel to Rajkot. This generous gift reflects a family history shaped by education and perseverance. Dr. Bera’s parents, Kanta and Babulal Bera, grew up in modest circumstances in Gujarat before immigrating to the United States in the late 1950s. They worked multiple jobs, pursued higher education, and raised three sons, instilling in them the belief that education is both an opportunity and a responsibility.

This philosophy has now carried two generations of the Bera family to the UC Irvine School of Medicine and back to India, creating a bridge between personal history and global learning. For Dr. Bera, the program is not merely an act of charity but a continuation of a legacy, preparing future physicians for a world where medicine is practiced under vastly different conditions yet guided by shared values.

For students like Wells and interns like Solanki, this exchange offers something increasingly rare in modern medical training: the time and space to view medicine through a different lens. They return with sharper clinical instincts, deeper cultural awareness, and a renewed respect for collaboration with families and colleagues alike.

Across crowded wards, school courtyards, and bustling hospital corridors, the program quietly accomplishes what education does best. It builds understanding, forges connections, and reminds future doctors on both sides of the world why they chose this path in the first place.

According to India-West, the impact of such exchanges is profound, fostering a sense of global citizenship among future healthcare professionals.

James Van Der Beek’s Death Raises Awareness of Colon Cancer in Young Adults

James Van Der Beek’s death underscores a troubling rise in colon cancer cases among younger adults, prompting urgent calls for increased awareness and earlier screening.

Following the death of actor James Van Der Beek after a two-and-a-half-year battle with colon cancer, health experts are sounding the alarm about the increasing prevalence of this disease among younger individuals. The star of “Dawson’s Creek” publicly shared his stage 3 colon cancer diagnosis in November 2024, although he was officially diagnosed in August 2023 after undergoing a colonoscopy.

In an August 2025 interview with Healthline, Van Der Beek revealed that the first warning sign of his colon cancer was a change in his bowel movements, which he initially attributed to his coffee consumption. “Before my diagnosis, I didn’t know much about colorectal cancer,” he admitted. “I didn’t even realize the screening age had dropped to 45; I thought it was still 50.”

Recent research has highlighted a concerning trend: colorectal cancer (CRC) has become the leading cause of cancer-related death among men and women aged 50 and younger, according to the American Cancer Society. This marks a significant shift from the 1990s, when CRC was the fifth deadliest cancer in this age group. While overall cancer deaths have declined by approximately 44% since 1990, CRC is the only major cancer that has seen an increase in mortality rates for those under 50 during this time.

Dr. Aparna Parikh, medical director of the Center for Young Adult Colorectal Cancer at the Mass General Cancer Center, noted that the reasons behind this rise remain unclear. “Experts don’t entirely understand why cases are on the rise,” she explained. “But it seems to be an interplay of a person’s risk factors, overall makeup, and early exposures.” These exposures may include dietary habits, environmental factors, and even antibiotic use, along with lifestyle choices.

A recent study by the American Cancer Society found that long-term heavy drinking is associated with an increased risk of developing colorectal cancer. Other significant risk factors include family history of the disease, obesity, smoking, a diet high in red and processed meats, inflammatory bowel disease, and a personal or family history of polyps.

In a recent appearance on “America’s Newsroom,” Fox News senior medical analyst Dr. Marc Siegel discussed the rising incidence of CRC among younger adults. He highlighted the role of genetics and the consumption of ultraprocessed foods, citing a study from Mass General that indicates a diet high in such foods increases the likelihood of colon cancer by 45%. Additionally, a diet rich in processed meats, such as hot dogs, raises the risk by 30%, while a diet high in red meat increases the risk by 20%.

Experts emphasize that while colorectal cancer may not present symptoms in its early stages, certain signs should not be ignored. Dr. Eitan Friedman, Ph.D., an oncologist and founder of The Suzanne Levy-Gertner Oncogenetics Unit at the Sheba Medical Center in Israel, confirmed that changes in bowel habits are a primary red flag for colorectal cancer. Other symptoms include fatigue due to anemia, abdominal pain or discomfort, rectal bleeding, weakness, and unexplained weight loss.

Dr. Erica Barnell, Ph.D., a physician-scientist at Washington University School of Medicine and co-founder of Geneoscopy, noted that Van Der Beek’s experience of having no obvious symptoms is not uncommon. “Many colorectal cancers develop silently, without obvious symptoms,” she explained. “By the time symptoms appear, the disease may already be advanced.”

Early detection is crucial for improving outcomes in colorectal cancer cases. “Colonoscopy at age 45 onwards, at five- to ten-year intervals, has been shown to lead to early detection of polyps that have the potential to become malignant,” Dr. Friedman stated. “Removing these polyps can significantly minimize the risk of malignant transformation.”

Unfortunately, Dr. Barnell pointed out that screening compliance in the United States remains below national targets, with the most significant gaps found in rural, low-income, and minority communities. “Most people don’t like talking about bowel habits, but paying attention to changes can save your life,” she urged. “Screening gives us the chance to find problems early—often before you feel sick—and that can make all the difference.”

Dr. Siegel reiterated the importance of colonoscopies as the most effective method for screening CRC, especially when polyps are detected and removed before they can develop into cancer. The rising incidence of colorectal cancer among younger adults, as exemplified by Van Der Beek’s tragic story, serves as a stark reminder of the need for increased awareness and proactive health measures.

As the conversation around colorectal cancer continues to evolve, it is essential for individuals to stay informed about their health and the importance of early screening. According to the American Cancer Society, understanding risk factors and recognizing warning signs can be life-saving.

Psychologists Recognize Sensory Processing Sensitivity as a Human Behavior Strength

Recent research highlights sensory processing sensitivity as a valuable human trait, challenging traditional views of emotional intensity in social and professional settings.

The landscape of human psychology is evolving, particularly in how emotional intensity is understood in both social and professional settings. For many years, individuals who exhibit a high degree of emotional depth were often labeled as overly sensitive or ill-suited for the demands of a fast-paced, efficiency-driven world. However, recent studies on sensory processing sensitivity reveal that this trait, once considered a personal shortcoming, is actually a sophisticated cognitive style.

Sensory processing sensitivity is characterized by a heightened responsiveness to emotional, social, and sensory stimuli. Approximately 15 to 20 percent of the global population is believed to score high on this spectrum. Individuals with this trait often report an uncanny ability to sense emotional shifts in a room before any words are spoken. They experience feelings such as joy, disappointment, grief, and rejection with a depth that sets them apart from the general population.

While societal norms often value composure and emotional neutrality, psychologists argue that the struggles faced by sensitive individuals do not stem from a lack of resilience. Instead, these challenges frequently arise from existing in environments that undervalue emotional awareness and prioritize the suppression of feelings over their integration. This cultural narrative can lead to significant emotional tension for those who are naturally sensitive.

Neurological studies provide a biological basis for these experiences, showing that highly sensitive individuals exhibit increased activation in brain regions associated with emotional awareness, empathy, and meaning-making. These areas are responsible for integrating complex emotional signals with conscious awareness, suggesting that some people are biologically predisposed to notice and process a greater volume of emotional data than others.

From an evolutionary standpoint, this trait likely served a protective function within early human communities. Groups benefited from members who could detect subtle threats, recognize early signs of social friction, or sense environmental changes. This heightened attunement contributed to better group cohesion and the navigation of complex social systems.

In modern times, however, many professional and social structures reward emotional minimization. In corporate settings, leadership and competence are often equated with calm detachment and cold efficiency. Individuals who can suppress their emotional responses may be perceived as more capable in the short term, but the long-term consequences of such behavior are rarely reflected in performance evaluations. Chronic emotional suppression is linked to increased physiological stress, impaired memory, and heightened anxiety.

For those with naturally high sensitivity, the effort required to suppress their emotional responses can be immense, as their baseline reactions are stronger than average. Over time, the constant demand for emotional regulation can lead to exhaustion or even emotional shutdown. Additionally, the psychological impact of repeated emotional invalidation is a critical concern for sensitive individuals. When they are frequently told they are overreacting or being too sensitive, they may begin to distrust their own internal signals, leading to a cycle of shame and emotional distress.

This internalized shame can manifest as rumination or hypervigilance. Paradoxically, the effort to feel less often results in emotional experiences that are more overwhelming, as individuals lack the tools to process the emotional data they receive. Physiologically, emotional intensity is closely tied to nervous system reactivity. Some individuals enter a heightened state of arousal more quickly in response to social stimuli, which does not indicate a failure of character but rather a nervous system that is exceptionally adept at detecting information.

In environments where emotions are ignored, sensitive individuals may remain in a state of physiological activation without a clear path to resolution. Their bodies continue to process information that the surrounding environment refuses to acknowledge, leading to chronic stress and emotional fatigue.

The cultural myth equating emotional intensity with weakness is being challenged by resilience research. A 2021 study published in the journal *Frontiers in Psychology* found that emotional openness is associated with post-traumatic growth, creativity, and deeper meaning-making. This research suggests that true resilience is not defined by emotional numbness but rather by the ability to process complex feelings within a supportive context. Sensitive individuals often struggle not because they cannot handle their emotions, but because they are expected to manage them in isolation, without the benefit of a validating environment.

The mismatch in emotional processing styles can also have significant implications for personal relationships. Research from 2024 indicates that emotional responsiveness is one of the most accurate predictors of relationship satisfaction. When one partner experiences emotions with significantly more intensity than the other, misattunement can occur. The more sensitive partner may feel unseen or overwhelmed, while the less expressive partner may feel burdened by the depth of the interaction. Without a shared vocabulary to discuss these neurological differences, both parties may interpret the mismatch as a personal or relational failure.

Psychologists emphasize that the resolution to these challenges lies in emotional translation and mutual understanding rather than suppression. Techniques such as emotional labeling, cognitive reappraisal, and co-regulation through trusted relationships have been shown to improve mental health outcomes. By framing sensitivity as a source of information rather than a liability, individuals can diminish the shame associated with their traits and enhance their psychological flexibility.

Ultimately, the ability to remain attuned to others is a sophisticated tool for fostering meaningful connections. In a world that often favors emotional detachment, this level of attunement is increasingly recognized as a misunderstood form of intelligence. When supported by the right skills and environments, emotional depth can fuel empathy, moral awareness, and intimacy. Rather than viewing high emotional sensitivity as a flaw, it can be seen as a powerful means of connecting with the people and experiences that matter most, transforming what is often perceived as vulnerability into a definitive human strength.

According to GlobalNetNews, embracing sensory processing sensitivity can lead to a more nuanced understanding of emotional intelligence and its role in human interactions.

James Van Der Beek Raises Awareness of Colorectal Cancer Symptoms

James Van Der Beek highlighted a critical warning sign of colorectal cancer months before his passing, emphasizing the importance of early screening at age 45.

James Van Der Beek, the actor best known for his role in “Dawson’s Creek,” shared an important warning sign of his stage 3 colon cancer prior to his death at the age of 48. His wife, Kimberly Van Der Beek, confirmed his passing in a heartfelt social media post on Wednesday.

In November 2024, Van Der Beek received a diagnosis of colorectal cancer, but he had previously expressed to Healthline in August that he had not experienced any alarming symptoms. “There wasn’t any red flag or something glaring,” he stated. Despite maintaining a healthy lifestyle, including cold plunges and excellent cardiovascular fitness, he was unaware of his cancer diagnosis.

The only symptom he did notice was a change in his bowel movements, which he initially attributed to his coffee consumption. “Before my diagnosis, I didn’t know much about colorectal cancer,” Van Der Beek admitted. He was surprised to learn that the recommended screening age had been lowered to 45, believing it was still set at 50.

Ultimately, a colonoscopy revealed that he had stage 3 colon cancer. Professor Eitan Friedman, M.D., Ph.D., an oncologist at the Sheba Medical Center in Israel, confirmed that changes in bowel habits are a primary indicator that should raise suspicion for colorectal cancer. Other symptoms can include fatigue linked to anemia, blood in the stool, weight loss, loss of appetite, and abdominal discomfort.

Dr. Erica Barnell, M.D., Ph.D., a physician-scientist at Washington University School of Medicine and co-founder of Geneoscopy, noted that Van Der Beek’s experience of having no obvious symptoms is not uncommon. “Many colorectal cancers develop silently, without obvious symptoms,” she explained. “By the time symptoms appear, the disease may already be advanced.”

Friedman highlighted that symptoms are particularly concerning for individuals aged 45 and older who have at least one first-degree relative with colon cancer or other gastrointestinal malignancies, as well as those with active inflammatory bowel diseases like ulcerative colitis or Crohn’s disease.

The lifetime risk of developing colorectal cancer for an average-risk individual is estimated to be between 4% and 5%. Friedman emphasized the importance of colonoscopies starting at age 45, recommending them every five to ten years. This approach has been shown to facilitate early detection of polyps that could become malignant, allowing for their removal and significantly reducing the risk of cancer.

Despite the clear benefits of screening, Barnell pointed out that compliance in the U.S. remains below national targets, with the largest gaps found in rural, low-income, and minority communities. To address these disparities, she advocates for improved access to accurate, noninvasive screening technologies and increased public awareness.

“Most people don’t like talking about bowel habits, but paying attention to changes can save your life,” Barnell stressed. “Screening gives us the chance to find problems early — often before you feel sick — and that can make all the difference.”

For more health-related articles, visit www.foxnews.com/health. Fox News Digital previously reached out to Van Der Beek’s representative for comment.

Posture-Driven Retinal Signals May Predict Diabetic Retinopathy Progression

Researchers have found that posture-driven retinal signals can predict the progression of diabetic retinopathy in individuals with type 2 diabetes, offering a new approach to early disease detection.

Diabetic retinopathy is a complex condition characterized by microvascular damage resulting from chronic hyperglycemia. Traditional risk factors, such as the duration of diabetes and glycemic control, only partially account for individual risk levels. The retina provides a unique, non-invasive perspective on microvascular health, where early functional abnormalities may manifest before visible retinal lesions appear.

Under normal circumstances, retinal vessels automatically constrict or dilate to maintain stable blood flow when a person’s body position changes. However, in individuals with diabetes, this autoregulatory function is often compromised, indicating underlying endothelial and neurovascular dysfunction. Evaluating these dynamic vascular responses has been challenging due to the limitations of bulky imaging systems, prompting researchers to investigate whether posture-induced changes in retinal vascular behavior could serve as early indicators of disease progression.

A team from The Chinese University of Hong Kong conducted a study published in January 2026 in the journal Eye and Vision, exploring the relationship between retinal vascular responses to postural changes and the progression of diabetic retinopathy in people with type 2 diabetes. Utilizing smartphone-based fundus imaging, the researchers captured retinal images of participants in both sitting and supine positions and monitored them over a five-year period.

The study revealed that abnormal posture-related changes in specific retinal vascular parameters were strongly associated with the future worsening of diabetic retinopathy, independent of established clinical risk factors. The researchers compared retinal vascular responses among three groups: healthy individuals, patients with diabetes but no retinopathy, and patients with existing diabetic retinopathy.

In healthy eyes, transitioning from a sitting to a supine position triggered a normal constriction of both arterioles and venules, indicating intact autoregulatory control. Conversely, participants with diabetes exhibited blunted or even paradoxical vascular responses, suggesting impaired microvascular regulation.

Long-term follow-up indicated that two posture-dependent vascular features were particularly predictive. Greater increases in retinal arteriolar tortuosity during postural changes were associated with more than a two-fold higher risk of retinopathy progression. This exaggerated vascular bending likely reflects structural fragility and endothelial dysfunction stemming from chronic hyperglycemia. In contrast, wider venular branching angles during posture changes correlated with a significantly lower risk of disease progression, suggesting preserved vascular adaptability.

Importantly, incorporating these dynamic vascular measures enhanced predictive accuracy beyond conventional factors such as HbA1c levels, diabetes duration, and baseline retinopathy severity. The findings imply that the response of retinal vessels to everyday physiological stressors may reveal subclinical disease activity that static imaging techniques cannot detect.

“Our findings suggest that the retina’s ability to adapt to routine physiological changes carries meaningful information about future disease risk,” said the study’s senior investigator. “By observing how retinal vessels respond to a simple change in body position, we can detect early microvascular dysfunction that may otherwise go unnoticed. This dynamic approach moves beyond traditional snapshot imaging and highlights the potential of functional vascular biomarkers to support more personalized monitoring strategies for people with diabetes.”

This research underscores a practical pathway toward more accessible and individualized risk assessment for diabetic retinopathy. Smartphone-based retinal imaging is portable, cost-effective, and well-suited for primary care or resource-limited settings where conventional ophthalmic equipment may not be available. Integrating posture-responsive vascular metrics into screening programs could facilitate the early identification of high-risk patients and allow for more precise tailoring of follow-up intervals.

Combined with telemedicine platforms and automated image analysis, this innovative approach could transform diabetic eye care from a reactive treatment model to a proactive prevention strategy. This shift has the potential to reduce unnecessary screenings while ensuring timely interventions for those most at risk, ultimately improving patient outcomes.

According to Eye and Vision, this study highlights the importance of dynamic assessments in understanding diabetic retinopathy progression and emphasizes the need for further research in this area.

Superhealth Launches SuperOS, Claims First Agentic AI Hospital

Superhealth has introduced SuperOS, touted as the world’s first agentic AI operating system designed to manage hospital operations entirely, marking a significant advancement in healthcare automation in India.

Superhealth has launched what it claims to be the world’s first agentic AI operating system, named SuperOS, designed to manage a hospital from end to end. This initiative positions India as a potential leader in large-scale healthcare automation.

SuperOS is crafted as a comprehensive system that integrates nearly every aspect of hospital operations. According to the company, it encompasses everything from outpatient consultations and diagnostics to surgical workflows and discharge summaries. Varun Dubey, the founder of Superhealth, emphasized the platform’s capabilities, stating, “SuperOS is the world’s first agentic AI operating system built to actually run a hospital, from clinical decisions to operations, from labs to discharge, from OT assignments to auto prescriptions, it does it all.”

Dubey further explained that SuperOS understands the needs of doctors, nurses, and patients, as well as 15 Indian languages. The system orchestrates outcomes by facilitating real-time interactions between human staff and AI agents. “Only Superhealth could build this, because we are the only full-stack provider that designs, builds, and operates hospitals while also developing all the technology that runs them,” he added. “This is not software that merely assists healthcare. This is technology that operates healthcare.”

The introduction of SuperOS places Superhealth in the midst of global discussions about integrating AI into hospital systems. While many healthcare facilities are exploring AI tools for specific tasks, Superhealth is marketing SuperOS as a unified operating layer that connects clinical and administrative functions in real time.

According to the company, SuperOS serves as an intelligent framework across the hospital, coordinating tasks between AI agents and human teams. In outpatient departments, it acts as an ambient clinical co-pilot, providing patient history, assisting with differential diagnoses, drafting prescriptions for physician approval, and coordinating with lab technicians and pharmacists directly in the consultation room. The aim is to reduce wait times and enhance meaningful interactions between doctors and patients.

SuperOS is also integrated into radiology and pathology workflows. The platform replaces traditional Picture Archiving and Communication Systems (PACS) with cloud-based imaging systems and employs instant 3D volumetric analysis to aid in the detection of conditions in neurology, orthopaedics, chest trauma, and oncology. Superhealth claims that this integration reduces reporting time by 30 percent and effectively triples the capacity of specialists.

For inpatient and surgical care, SuperOS coordinates operating rooms, surgeons, and recovery workflows. It continuously monitors patients in both regular and intensive care units, utilizing personalized alerts, automating discharge summaries through a feature dubbed “Magic Discharge,” and conducting real-time audits of all clinical interactions to enhance medical quality.

Dubey framed the launch of SuperOS as part of a broader national ambition, stating, “India has a unique opportunity to show the world what real, meaningful healthcare AI looks like. SuperOS is built in India, for India, using Indian clinical data. It is also deployed in India and is focused on solving problems that matter to our country and our people.”

Superhealth is working to establish a network of 100 hospitals, supported by full-time senior clinicians, advanced infrastructure, and a zero-commission business model aimed at transparency and simplicity. Central to this expansion is SuperOS, which the company describes as operating seamlessly alongside healthcare professionals while enhancing efficiency across consultations, diagnostics, surgery, pharmacy, and recovery.

As hospitals worldwide face challenges such as staffing shortages, rising costs, and burnout, Superhealth is making a bold assertion that an AI-native operating system can transition from merely assisting care to actively managing it. The scalability of this model beyond India will be closely monitored by healthcare systems in the United States and other countries.

According to The American Bazaar, the implications of SuperOS could reshape the landscape of hospital management and patient care, setting a precedent for future innovations in healthcare technology.

Instagram Chief Defends App Design Amid Youth Mental Health Lawsuit

Adam Mosseri, head of Instagram, testified in a California trial addressing the platform’s impact on youth mental health, defending its design against claims of addiction and negligence.

Adam Mosseri, the head of Instagram, took the witness stand on Wednesday in a pivotal trial in Los Angeles that could significantly influence how Silicon Valley addresses the mental health of its youngest users.

During his testimony, Mosseri defended Instagram against allegations that the platform was intentionally designed to be addictive, particularly among young users, contributing to a mental health crisis among adolescents. The case was brought forth by a 20-year-old woman from California, identified as Kayle, who argued that the app’s “endless scroll” feature and instant gratification elements led to years of depression and body dysmorphia from an early age.

In response to the term “addiction,” Mosseri reframed the discussion, describing it as “problematic use” that varies from individual to individual. He also addressed internal communications from 2019 concerning face-altering “plastic surgery” filters. While some teams within the company raised concerns that these tools could harm the self-esteem of teenage girls, Mosseri and Meta CEO Mark Zuckerberg initially considered lifting a ban on such filters to promote user growth. Ultimately, the company decided to maintain the ban on filters that overtly promote cosmetic surgery.

“I was trying to balance all the different considerations,” Mosseri told the jury, according to reports from the courtroom.

Several parents who have lost children to the adverse effects of social media were present in the courtroom, sharing their grief as part of the ongoing case. Victoria Hinks, whose daughter died by suicide at the age of 16, stated that their children had become “collateral damage” in Silicon Valley’s “move fast and break things” culture. Outside the courthouse, she remarked, “Our children were the first guinea pigs,” a sentiment that Mosseri countered during his testimony by asserting that the “move fast and break things” motto, originally coined by Zuckerberg, is no longer applicable.

The plaintiff’s attorney, Mark Lanier, argued that the platform operates like a “slot machine in a child’s pocket,” designed to exploit developing brains for profit. He contended that Meta was aware of the psychological toll its platform could take but prioritized user engagement over the well-being of its young audience.

This trial serves as a critical “bellwether” for over 1,500 similar lawsuits filed across the country. It also tests the boundaries of Section 230, the federal law that typically protects platforms from liability for user-generated content. If the jury finds Meta negligent in its product design, it could lead to significant financial repercussions and compel substantial changes to social media algorithms.

Meta maintains that it has implemented numerous safety features for teens, including parental controls and time limits. Zuckerberg is expected to testify later this month as the trial continues to explore the complex relationship between technology profits and the vulnerability of the teenage mind, according to American Bazaar.

FDA Declines to Review Moderna’s mRNA Flu Vaccine Application

The FDA has declined to review Moderna’s application for an mRNA flu vaccine, citing study design issues, while the company disputes the decision, claiming it contradicts previous guidance.

The U.S. Food and Drug Administration (FDA) has refused to review Moderna’s application for a new flu vaccine utilizing mRNA technology, a decision that may postpone the rollout of a vaccine aimed at providing enhanced protection for older adults. The company announced this development on Tuesday, revealing that it received a “refusal-to-file” (RTF) letter from the FDA’s Center for Biologics Evaluation and Research (CBER).

The FDA’s refusal was based on concerns regarding the study design, specifically the lack of an “adequate and well-controlled” study that included a comparator arm not representative of the best-available standard of care. Stéphane Bancel, Moderna’s chief executive officer, expressed disappointment over the FDA’s decision, emphasizing that it did not cite any safety or efficacy issues with the vaccine.

Bancel stated, “It should not be controversial to conduct a comprehensive review of a flu vaccine submission that uses an FDA-approved vaccine as a comparator in a study that was discussed and agreed on with CBER prior to starting.” He added that the company is eager to engage with CBER to clarify the path forward, ensuring that seniors and individuals with underlying conditions have access to innovative American-made solutions.

This unusual decision from the FDA comes amid heightened scrutiny over vaccine approvals under Health Secretary Robert F. Kennedy Jr., who has publicly criticized mRNA vaccines and has made changes to COVID-19 vaccination recommendations over the past year. Kennedy has previously removed members from the federal vaccine advisory panel, appointed new members, and sought to cancel $500 million in mRNA vaccine contracts.

Recently, the FDA authorized COVID-19 vaccines for high-risk groups only, and in May, Kennedy announced that these vaccines would be removed from the CDC’s routine immunization schedule for healthy children and pregnant women.

Moderna contends that the refusal-to-file decision stemmed from its choice of comparator in the Phase 3 trial, which involved a licensed standard-dose seasonal flu vaccine. The FDA argued that this choice did not reflect the “best-available standard of care.” However, Moderna maintains that this decision contradicts previous written communications from the FDA, including guidance issued in 2024 that indicated a standard-dose comparator would be acceptable, although a higher-dose vaccine was recommended for participants aged 65 and older.

According to Moderna, the FDA did not raise any objections or clinical hold comments regarding the adequacy of the Phase 3 trial after the submission of the protocol in April 2024 or at any point before the study began in September 2024.

In August 2025, following the completion of the Phase 3 efficacy trial, Moderna held a pre-submission meeting with CBER, during which the agency requested additional analyses regarding the comparator to be included in the submission. CBER indicated that this data would be a “significant issue” during the review of the Biologics License Application (BLA). Moderna asserts that it provided the requested analyses and that CBER did not indicate any intention to refuse to review the file during the pre-submission feedback or meeting.

The company has requested a Type A meeting with CBER to better understand the rationale behind the RTF letter, noting that regulatory reviews are still ongoing in the European Union, Canada, and Australia.

Fox News has reached out to the Department of Health and Human Services for further comment on this matter.

According to Fox News, the situation underscores the complexities surrounding vaccine approvals and the ongoing debates within the health sector regarding mRNA technology.

Common Vision Issue May Cause Missed Cancer Warnings, Study Finds

A recent Stanford Medicine study indicates that colorblind men are at a significantly higher risk of dying from bladder cancer due to difficulties in recognizing early warning signs.

A new study from Stanford Medicine has revealed that men with colorblindness face a 52% higher risk of mortality from bladder cancer, primarily because they may not notice critical early warning signs.

Color vision deficiency (CVD), which predominantly affects men, is estimated to impact about 8% of the male population compared to only 0.5% of women. This condition alters the way individuals perceive and identify colors, potentially causing them to overlook blood in their urine—a crucial indicator of bladder cancer.

According to researchers, blood in the urine is the most common initial symptom of bladder cancer and often prompts further medical investigation. The study, published in the journal Nature Health, analyzed health records and found that colorblind bladder cancer patients had a significantly higher mortality rate over a 20-year period compared to those with normal vision.

Individuals with colorblindness typically struggle to differentiate between red and green hues, which can lead to everyday challenges, including the inability to recognize blood in their urine. This oversight may result in delayed medical attention, ultimately leading to poorer health outcomes.

Dr. Ehsan Rahimy, the senior author of the study and an adjunct clinical associate professor of ophthalmology at Stanford Medicine, expressed hope that the findings will raise awareness among both patients with colorblindness and healthcare providers. “This study highlights the importance of recognizing the challenges faced by colorblind patients,” he stated in a press release.

Dr. Douglas Lazzaro, a professor in the Department of Ophthalmology at NYU Langone, emphasized the real risk associated with the inability to recognize the color red in this context. “It is crucial for patients, their families, and medical professionals to be aware of this potential gap in diagnosis,” he noted, adding that many doctors may overlook color vision issues in medical records, which can delay diagnosis.

While the challenges posed by colorblindness may not be entirely preventable, Lazzaro suggested that awareness could mitigate risks. He encouraged colorblind patients to inform their healthcare providers about their vision limitations.

Dr. Don Railsback, an optometrist and CEO of Vision Care Direct in Kansas, echoed this sentiment, stating that both patients with known CVD and their clinicians should pay close attention to the implications of color vision deficiency. “This small detail in a medical history can significantly influence how we counsel patients regarding symptoms they should never ignore,” he remarked.

Railsback further advised that patients should not rely solely on color to identify health issues. “Bladder cancer can manifest as painless bleeding, and if you suspect blood in your urine, it is essential to alert your doctor,” he said. He also recommended that colorblind individuals request a urine test during their annual check-ups, especially if they notice any unusual changes in the color of their urine, such as a tea-colored or unusually dark appearance.

“Colorblindness does not cause bladder cancer, but it may make the earliest warning signs easier to miss,” Railsback concluded. “The solution lies in awareness and simple testing, not fear.” The study serves as a vital reminder to tailor health guidance to account for variations in color vision.

For more information on this study, please refer to Fox News Digital.

India Launches SHAKTI Initiative to Enhance Biotechnology Manufacturing

The Indian government has launched the Biopharma SHAKTI initiative, committing ten thousand crore rupees to enhance domestic biotechnology manufacturing and position India as a global biopharma hub.

The Indian government has officially unveiled the Biopharma SHAKTI initiative as part of the 2026-27 Union Budget. This initiative allocates ten thousand crore rupees over the next five years, aiming to transform India into a global biopharma manufacturing hub.

This significant financial commitment comes at a critical time for the domestic healthcare sector, which is facing a dramatic shift in public health challenges. Government data indicates that non-communicable lifestyle diseases, including diabetes, various forms of cancer, and chronic heart conditions, now account for nearly two-thirds of all deaths in the country. This marks a staggering increase from 1990, when such diseases were responsible for just over a third of the national mortality rate.

To address this growing crisis, the medical community has increasingly relied on advanced biologic drugs, which are complex medicines derived from living organisms. However, the vast majority of these treatments are currently imported from international pharmaceutical companies, resulting in prohibitively high costs for a significant portion of the Indian population.

The introduction of Biopharma SHAKTI is designed to bridge the gap between India’s established expertise in chemical generics and the emerging field of biologics. Industry analysts suggest that the timing is strategically aligned with a major shift in the global pharmaceutical landscape. Several blockbuster biologic drugs, some generating annual revenues exceeding ten billion dollars each, are set to lose their patent protections in the coming years. India has long held a dominant position as a world leader in producing affordable near-copy versions of traditional medicines once their patents expire. By focusing on biopharma manufacturing, the government aims to replicate this success in the realm of biosimilars, potentially capturing a significant share of the international market while simultaneously lowering treatment costs for domestic patients.

Despite the substantial financial commitment, the current structure of the Biopharma SHAKTI program has sparked intense debate within the scientific and entrepreneurial communities regarding resource allocation. The designated funds are primarily directed toward large-scale infrastructure projects, including the establishment of new research institutes, the modernization of existing laboratories, and the creation of a thousand new clinical trial sites. Additionally, a portion of the budget is intended to expand the workforce at the national drug regulatory body, providing more specialists to manage the increasing volume of applications.

While these investments are welcomed by established manufacturing giants that already operate at a factory scale, critics argue that the funding model overlooks the most vulnerable segment of the ecosystem: innovative startups. The central challenge facing Indian biotechnology is often described as a “valley of death” that exists between laboratory discovery and the final delivery of a treatment to patients. In the current landscape, a scientist may discover a promising new molecule or therapeutic approach and form a startup to bring that vision to life. However, once the initial research phase is complete, the enterprise frequently encounters formidable obstacles.

There is currently a severe shortage of specialized pilot facilities where these startups can test whether their discoveries can be manufactured effectively at a larger scale. Without access to such mid-sized production environments, many promising innovations remain trapped in a theoretical state, unable to demonstrate their commercial or clinical viability to potential investors.

Moreover, the regulatory environment presents a secondary hurdle that often proves insurmountable for true innovators. Many of these new products involve cutting-edge science that frequently falls outside the traditional categories used by regulators. This lack of a clear approval pathway creates a state of bureaucratic limbo where regulators are uncertain how to classify or evaluate the safety and efficacy of a novel biologic. This uncertainty, combined with the exorbitant costs associated with conducting independent clinical trials, creates a high-pressure environment for small firms. Consequently, many Indian startups are faced with a difficult choice: they must either sell their intellectual property to a larger corporation for a fraction of its potential value or shut down operations entirely, wasting years of research and development.

The fundamental issue is that the current funding strategy under Biopharma SHAKTI appears to strengthen the two ends of the development spectrum while leaving the center neglected. By reinforcing the research side and the mass-manufacturing side, the government is providing support to those who have already achieved success or those who are in the earliest stages of academic inquiry. However, the bridge across the valley remains unbuilt.

For a startup with a genuinely original drug candidate, the need is not for more basic research labs or larger factories, but for the specialized intermediate infrastructure that allows a concept to transition into a product. This includes affordable access to specialized manufacturing equipment and a regulatory framework that is agile enough to handle unprecedented biotechnological advancements.

If the goal of the initiative is to move India beyond being a mere pharmacy of the world that copies existing formulas and toward becoming a global leader in original drug discovery, many experts believe the funding priorities must be re-evaluated. The current focus on infrastructure for existing large-scale manufacturers primarily benefits the production of biosimilars. While this is a lucrative business opportunity, it does not necessarily foster an environment where homegrown Indian innovations can thrive.

To truly capitalize on the intellectual capital of Indian scientists, the ecosystem requires dedicated support for the translation of research. This means creating government-backed pilot plants that startups can rent, establishing fast-track regulatory sandboxes for novel therapies, and providing targeted subsidies for clinical trials focused on original Indian intellectual property.

The economic implications of successfully bridging this gap are substantial. Beyond the immediate health benefits of making advanced biologics more accessible to the Indian public, a thriving domestic biotech innovation sector would create high-value jobs and retain scientific talent that often migrates to more supportive environments in the West.

As it stands, the Biopharma SHAKTI initiative represents a historic investment in the future of Indian healthcare, but its ultimate success will depend on whether the government can address the structural deficiencies that currently stifle innovation. Without a focused effort to support the transition from the lab to the market, the valley of death will continue to claim promising Indian ideas, regardless of how much capital is poured into the surrounding landscape.

As the program rolls out over the next five years, the pharmaceutical industry will be watching closely to see if any adjustments are made to support small-scale innovators. The global demand for biologics is only expected to grow as the world grapples with an aging population and the continued rise of chronic diseases. For India, the opportunity is not just to manufacture the world’s medicine, but to invent it. Accomplishing this will require more than just funding; it will necessitate a strategic vision that recognizes that a discovery only becomes a treatment when there is a clear and supported path for it to travel. The current budget marks a bold first step, but the construction of the bridge that will carry Indian biotech from the laboratory to the patient remains the most critical task ahead for policymakers and industry leaders alike, according to GlobalNetNews.

Family Dinners May Reduce Substance Use Among Teenagers, Research Finds

Regular family dinners may help reduce substance use among teenagers through improved communication and parental involvement, according to new research published in a leading journal.

Regular family meals may play a significant role in discouraging substance use among teenagers, according to a recent study published in the Journal of Aggression, Maltreatment and Trauma. The research suggests that sharing meals as a family can help reduce the likelihood of adolescents engaging in alcohol, drug, and vaping use.

The study found a correlation between higher-quality family meals and lower rates of alcohol, cannabis, and e-cigarette use among teenagers. However, for those with more severe adverse childhood experiences, simply sharing meals did not provide the same protective benefits.

To reach these conclusions, researchers analyzed online survey data from 2,090 adolescents aged 12 to 17 and their parents across the United States. Participants were asked about the quality of their family meals, focusing on aspects such as communication, enjoyment, digital distractions, and logistical challenges.

Teenagers were also surveyed regarding their alcohol, vaping, and cannabis use over the previous six months. The researchers examined the effectiveness of family meals in relation to the levels of household stress and traumatic experiences reported by both parents and teens.

Rather than treating all adverse experiences uniformly, the research team weighted each factor based on its established links to substance use in previous studies. Among adolescents with lower levels of childhood adversity, higher-quality family meals were associated with a 22% to 34% reduction in reported substance use.

Margie Skeer, the study’s lead author and a professor at Tufts University, emphasized the importance of routine family connection. “These findings build on what we already knew about the value of family meals as a practical and widely accessible way to reduce the risk of adolescent substance use,” Skeer stated.

She explained that regular family dinners can create opportunities for consistent communication and parental involvement, which may help mitigate risky behaviors over time. However, the study also revealed that family meals offered limited benefits for adolescents who had experienced four or more adverse childhood experiences.

“While our research suggests that adolescents who have experienced more severe stressors may not see the same benefits from family meals, they may benefit from more targeted and trauma-informed approaches, such as mental health support and alternative forms of family engagement,” Skeer noted.

The researchers acknowledged potential limitations in their study, including its cross-sectional design, which prevents establishing a direct cause-and-effect relationship between family meals and substance use. Additionally, the reliance on online recruitment may limit the generalizability of the findings to all families.

Overall, the study highlights the potential of family dinners as a simple yet effective strategy for promoting healthier behaviors among teenagers, particularly in environments with lower levels of childhood adversity. As families navigate the challenges of modern life, the importance of shared meals and open communication remains a valuable tool in fostering resilience and reducing the risk of substance use.

These findings underscore the need for families to prioritize mealtime togetherness as a means of strengthening bonds and encouraging positive behaviors among adolescents, according to SWNS.

Trump Administration Introduces TrumpRx Program to Reduce Prescription Drug Costs

President Donald Trump has launched the TrumpRx program, aimed at reducing prescription drug costs significantly, but experts raise concerns about its practical impact on American consumers.

President Donald Trump officially introduced a new healthcare initiative called TrumpRx on Thursday, framing it as a pivotal change in the U.S. pharmaceutical landscape. During the announcement, the president described the program as a transformative effort intended to deliver the most substantial reduction in prescription drug prices in American history. The administration aims to address the escalating costs of medications through specific pricing agreements and direct consumer incentives.

The TrumpRx program primarily operates through a series of coupons applicable to 43 branded medications. Discounts offered through these coupons range from 33 percent to 93 percent off the standard list prices for various conditions. The initial list of covered medications includes treatments for obesity, respiratory illnesses, infertility, bladder issues, and menopause. While the administration has hailed these discounts as unprecedented, health policy experts and consumer advocates are beginning to assess the program’s actual impact on average American consumers.

Despite the significant discounts advertised, some policy analysts express skepticism regarding the extent of the savings. Observations from healthcare researchers suggest that the prices achieved via TrumpRx coupons may still be higher than the out-of-pocket costs typically incurred by individuals with comprehensive private insurance. Juliette Cubanski, deputy director of the Program on Medicare Policy at KFF, noted that insured patients often find that their existing coverage offers better value than the discounted prices featured on the new government website.

However, the program may address specific gaps for medications that are often excluded from standard insurance formularies. Treatments for weight loss and in vitro fertilization, for instance, are frequently poorly covered by private plans, meaning a broader segment of the population might benefit from the TrumpRx discounts in these specific areas. For individuals lacking robust coverage for lifestyle or specialty drugs, the platform provides a centralized means to access manufacturer-backed pricing that was previously challenging to navigate.

A notable aspect of TrumpRx is that its current offerings consist exclusively of branded versions of drugs. These prices result from Most Favored Nation pricing agreements established between the administration and pharmaceutical manufacturers. Under these agreements, drugmakers commit to providing certain medications at rates comparable to the lowest prices offered in other developed nations. While this marks a shift in federal procurement strategy, it also means the platform currently emphasizes more expensive brand-name products rather than lower-cost generics.

The focus on branded drugs has drawn criticism from consumer advocacy groups, who point out that generic alternatives are already widely available at significantly lower prices. For example, the branded medication Protonix, used for stomach acid reduction, is listed on the platform with a 55 percent discount, bringing the cost to approximately $200 for a 30-day supply. Market data indicates that the generic equivalent, pantoprazole, can be purchased for around $10 using existing market-based discount tools. Similar price disparities exist for heart medications like Tikosyn, where the generic version remains substantially cheaper than the discounted brand-name price offered through the new initiative.

The prevalence of generic medications in the United States is a crucial factor in the potential reach of TrumpRx. Data from the Food and Drug Administration suggests that over 90 percent of all prescriptions in the country are filled as generics. Since the new platform targets the branded segment of the market, its utility may be limited to patients who require specific medications without generic counterparts or those who prefer brand-name products for clinical reasons.

Advocates for healthcare reform have characterized the initiative as a reorganization of existing pharmaceutical assistance programs rather than a fundamental restructuring of the market. Anthony Wright, executive director of FamiliesUSA, suggested that the program acts more as a catalog for programs that have long existed to assist uninsured patients. From this perspective, the benefits may be limited in scope regarding the number of drugs offered and the population eligible to receive them.

Conversely, some former health officials have expressed a more optimistic view of the platform. Ashish Jha, who previously coordinated federal pandemic responses, described the initiative as a positive development for the uninsured population. For the millions of Americans without any form of health coverage, a centralized government-verified portal for drug coupons provides a layer of accessibility and cost certainty that was previously absent from the cash-pay market.

The eligibility requirements for TrumpRx include specific legal restrictions that exclude certain groups. The platform explicitly states that individuals enrolled in government-funded health plans, such as Medicaid, are ineligible to use the coupons. This exclusion is largely rooted in the federal anti-kickback statute, which prevents the exchange of items of value in connection with items or services reimbursable by federal healthcare programs. Consequently, the program is primarily tailored toward the uninsured and those with private insurance plans.

The current scale of the program is another point of discussion among academic observers. Yunan Ji, an assistant professor at Georgetown’s McDonough School of Business, noted that the scope appears limited as it currently stands. With roughly 8 percent of the American population remaining uninsured, and the platform only covering 43 medications, the immediate impact is expected to be felt by a relatively small subset of the total patient population. Administration officials have countered this by asserting that the inventory of available medications will expand in the coming months.

There are also long-term economic considerations regarding the use of Most Favored Nation pricing. Economic theory suggests that when large markets like the United States demand the lowest available global price, it can create upward pressure on initial launch prices. Manufacturers may set higher starting prices for new drugs to protect their global margins, knowing that those prices will serve as the benchmark for various international agreements. Additionally, this policy could lead to delays in drug launches in other countries with strict price controls, as companies weigh the impact of those prices on their American revenue.

During the launch event, the president acknowledged that the strategy could have international ramifications. He noted that while costs are expected to decrease for American consumers, pricing structures in other nations may see an increase as manufacturers adjust to the new domestic requirements. This shift aims to rebalance the global pharmaceutical market, where Americans have historically paid significantly higher prices than their counterparts in Europe and Asia for the same medications.

As the program rolls out, the administration will likely face ongoing questions regarding its interaction with private insurance and the potential for the platform to include generic options in the future. For now, the success of TrumpRx will be measured by its ability to provide tangible relief to the cash-pay segment of the healthcare market and whether it can effectively scale its offerings to encompass a more diverse range of therapeutic classes, according to Source Name.

Protecting a Loved One’s Identity After Death: Essential Steps

Protecting a deceased loved one’s identity is crucial to prevent scams and identity theft, requiring proactive steps during an emotionally challenging time.

When a loved one passes away, families often find themselves overwhelmed with a multitude of tasks, including legal obligations, financial paperwork, and the emotional toll of loss. Amid this chaos, one critical aspect that often gets overlooked is the protection of the deceased’s identity. Scammers frequently target the identities of those who have died, exploiting delays, data gaps, and the assumption that someone else is managing the situation.

Janet from Indiana recently reached out with a question that resonates with many families: how can one effectively safeguard a loved one’s identity after death? Her concerns are valid, as the systems in place do not always function as seamlessly as one might expect.

Typically, when someone dies, the funeral home notifies Social Security, which is an important first step. However, this notification alone does not automatically secure the deceased’s financial identity. Relying solely on automation can leave significant vulnerabilities.

Janet took an important first step by understanding the urgency of the situation. For immediate protection, credit locks—distinct from freezes—allow for instant control over access to credit files. This proactive measure can place families ahead of the curve in safeguarding their loved one’s identity.

Once the initial paperwork is underway, there are several practical steps that can help close the gaps that scammers often exploit. While none of these steps are overly complicated, together they create a robust layer of protection.

Even with a credit freeze in place, it is advisable to contact the three major credit bureaus—Equifax, Experian, and TransUnion—to request that the deceased’s credit file be marked as such. Each bureau may require a copy of the death certificate. Once this flag is added, it becomes significantly more difficult for fraudsters to process fraudulent applications, as lenders are alerted upfront. A credit lock offers similar protection but with real-time control, which can be crucial when managing a deceased estate or responding to lender inquiries.

Unfortunately, many checklists fall short in addressing the full scope of identity protection. While credit freezes and deceased flags are helpful, identity theft can still manifest in various ways. Ongoing monitoring is essential to detect any fraudulent attempts early.

Identity theft protection services can be particularly beneficial during this time, as they focus on safeguarding personal and financial information beyond just credit scores. One of the top-rated identity theft services offers an all-in-one approach that includes identity theft insurance of up to $1 million per adult, covering eligible losses and legal fees. Additionally, it provides 24/7 U.S.-based fraud resolution support with dedicated case managers ready to assist in restoring identity swiftly. This service also combines three-bureau credit monitoring with an instant credit lock feature, allowing users to secure their Experian file directly from the app.

During estate administration, sharing paperwork is often necessary, but it can also lead to identity leaks. It is crucial to limit access to sensitive documents and only share what is absolutely required. Keeping track of where documents are sent can help mitigate risks.

Small signals can often indicate early fraud attempts. Families should remain vigilant and pay close attention to any irregularities. If something seems off, it is wise to pause and verify the source independently before responding.

Protecting a loved one’s identity after death is an additional responsibility that few are prepared for. It is not about mistrusting the system; rather, it is about taking proactive measures during a time of grief when the system may not respond as quickly as needed. Janet’s inquiry reflects a common concern among families navigating this challenging process. Identity protection does not cease with life, and scammers are aware that grief can create vulnerabilities. By taking a few extra steps now, families can prevent months or even years of stress later on.

Have you taken steps to protect a loved one’s identity after death, or is this information new to you? Share your experiences with us at Cyberguy.com.

According to CyberGuy.com, understanding and implementing these protective measures can make a significant difference in safeguarding a loved one’s identity.

Scientists Identify Gene Associated with the Development of Spoken Language

A new study links a specific gene variant to the origins of spoken language, suggesting it may have played a crucial role in the development of human communication.

A recent study has established a connection between a particular gene and the emergence of spoken language, proposing that a unique protein variant found only in humans may have facilitated our ability to communicate verbally. This research highlights the significant role genetics may have played in the evolution of speech, which was vital for our survival as a species.

Speech enabled early humans to share information, coordinate activities, and pass down knowledge, providing a competitive advantage over extinct relatives such as Neanderthals and Denisovans. Liza Finestack, a researcher at the University of Minnesota who was not involved in the study, described the research as “a good first step to start looking at the specific genes” that may influence speech and language development.

The genetic variant under investigation is part of a broader set of genes that contributed to the rise of Homo sapiens as the dominant species. Dr. Robert Darnell, a co-author of the study published in the journal Nature Communications, has been researching the protein known as NOVA1, which is crucial for brain development, since the early 1990s. In this latest study, Darnell’s team at Rockefeller University in New York utilized CRISPR gene editing technology to replace the NOVA1 protein in mice with the human variant to observe its effects on vocalization.

To their surprise, the results revealed that the mice vocalized differently when they possessed the human variant. Baby mice with the human NOVA1 variant emitted distinct squeaks compared to their normal littermates when their mother approached. Similarly, adult male mice with the variant produced different chirps than their typical counterparts when they encountered a female in heat. Darnell noted that both scenarios involved motivation to communicate, demonstrating how the human variant influenced vocalization.

This study is not the first to link genetics to speech. In 2001, British scientists identified the FOXP2 gene, which was associated with language and speech disorders and dubbed the “human language gene.” However, while FOXP2 plays a role in human language, later research indicated that the variant present in modern humans is not exclusive to our species, as it was also found in Neanderthals. In contrast, the NOVA1 variant identified in this study is unique to modern humans, according to Darnell.

While the presence of a specific gene variant is significant, it is not the sole factor that enables speech. The ability to communicate verbally also relies on anatomical features of the human throat and the collaboration of various brain regions responsible for language comprehension and production.

Darnell expressed hope that this research will not only enhance our understanding of human origins but may also pave the way for innovative treatments for speech-related challenges. Finestack added that the genetic findings could potentially allow for early identification of individuals who may require speech and language interventions, a possibility that could have profound implications for early childhood development.

As scientists continue to explore the genetic underpinnings of language, this study marks a significant step toward unraveling the complex relationship between our biology and the unique ability to communicate through spoken language, according to Fox News.

Global Leaders Commemorate 49 Years of Eye Foundation of America

Global leaders gathered at the House of Lords to commemorate the International Day for a World Without Childhood Blindness and celebrate 49 years of the Eye Foundation of America’s impactful work.

House of Lords, London | January 31, 2026: On January 31, 2026, global leaders, parliamentarians, healthcare pioneers, philanthropists, and representatives from various community and professional organizations convened at the Cholmondeley Room and Terrace in the House of Lords. The gathering commemorated the International Day for a World Without Childhood Blindness (IDWWCB) and celebrated 49 years of dedicated service by the Eye Foundation of America (EFA), an organization committed to restoring sight and safeguarding children’s futures since its inception in 1977.

The event marked a significant moment in the global effort to address childhood blindness, emphasizing the urgent need to eliminate preventable visual impairments among children worldwide. Lord Rami Ranger, a member of the House of Lords, chaired the event, bringing together a distinguished group of voices dedicated to prioritizing child eye health as a public health and development issue.

In his welcome address, Lord Ranger expressed his gratitude for the attendees, stating, “This is indeed a privilege and pleasure to welcome you to the House of Lords, a place where decisions are made that will touch the lives of almost everyone in the world.” He underscored the importance of the mission to eradicate childhood blindness, asserting, “A world without childhood blindness is not an aspiration—it is an achievable goal if governments, philanthropy, and civil society act together.”

Dr. V. K. Raju, the Founder and Visionary Leader of EFA, reflected on the organization’s journey since its founding. He stated, “Forty-nine years ago, this mission began with one simple belief—that no child should go blind because of poverty or lack of access. Today, that belief has become a global responsibility. Childhood blindness is preventable, and together, we have the power to end it.”

The Eye Foundation of America was established following Dr. Raju’s first eye camp in Vijayawada, India, in 1977. This initiative sparked a movement that has since expanded across India, Africa, the United States, and the United Kingdom.

Dr. Raju recounted the challenges he faced in bringing modern medical equipment to India, including the introduction of vitrectomy instruments in 1979. Despite obstacles at customs, he remained committed to making advanced treatments accessible to children in need. Over the past nearly five decades, EFA has implemented impactful programs focused on prevention, early detection, treatment, and strengthening healthcare systems for underserved and vulnerable children.

Dr. Raju highlighted the profound consequences of childhood blindness, noting that three-fourths of visually impaired children never attend school, and blindness reduces employability by 50%. He pointed out that of the 3.5 million premature babies born in India, nearly one in six are at risk of developing Retinopathy of Prematurity, a condition that can lead to blindness.

Describing his work as “God’s work,” Dr. Raju called for collective action to eradicate childhood blindness, emphasizing that every child deserves to see the world clearly. “Let’s join hands to eradicate childhood blindness and unlock a brighter future for generations to come,” he urged.

Throughout the event, senior parliamentarians, healthcare leaders, Rotarians, policy advocates, diplomats, and global media representatives underscored the importance of institutional partnerships and the integration of childhood eye health into public health systems. EFA’s model, which combines clinical excellence with local capacity building and global partnerships, was recognized as a benchmark for sustainable impact.

Among the notable speakers was Siddharth Chatterjee, United Nations Chief in China, who emphasized the connection between child vision, education, and sustainable development. He urged for leadership that recognizes the consequences of inaction and the need for momentum in driving change.

Dr. Sam Maddula, a Board Member and Major Donor of EFA, shared his personal story of transformation through the Eye Foundation’s initiatives, highlighting the importance of long-term investment in childhood blindness prevention. He stated, “Restoring sight is not charity—it is one of the most powerful investments we can make in a child’s future and in a nation’s human capital.”

Padma Shri Dr. Mukesh Batra, a global ambassador for homeopathy, emphasized the importance of measurable impact, stating, “History will remember not how many conferences we held, but how many children we helped see.”

Rotarian Sandeep Saxena noted the significance of collaboration among public policy, private capital, and civil society in achieving true transformation. He paid tribute to Dr. Raju for his lifelong dedication to the cause.

Dr. Leela Raju, President of EFA, concluded the event by emphasizing the collective responsibility to ensure that every child has access to eye care. She expressed gratitude to donors, benefactors, and partners, urging everyone to work together to make eye health a priority in public health systems.

The International Day for a World Without Childhood Blindness serves as a reminder that over 90% of a child’s learning occurs through vision. Yet, millions of children continue to face avoidable blindness, which undermines education and economic mobility.

As EFA approaches its 50th year, it calls on governments to integrate child eye health into national strategies, corporates to prioritize sight restoration in their corporate social responsibility initiatives, and global citizens to advocate for sight as a fundamental right.

Dr. Raju concluded with a call to action for world leaders, stating, “Let this gathering not be another discussion. Let it be a point of convergence where policy meets medicine, philosophy meets need, and intention meets action.”

The Eye Foundation of America, founded by Dr. V.K. Raju in 1977, is a global non-profit organization dedicated to preventing blindness through service, education, and research. EFA has impacted millions across India, Africa, the UK, and the U.S. by providing high-quality eye care in underserved regions. For more information, visit www.eyefoundationofamerica.org.

According to GlobalNetNews.

Measles Outbreak Raises Concerns Over Potential Brain Damage Risks

Health officials in South Carolina are warning of the potential for “irreversible” neurological damage amid a measles outbreak that has resulted in numerous hospitalizations and complications.

South Carolina health officials have issued a stark warning regarding the risks associated with a measles outbreak that has led to an increase in hospitalizations. With 876 confirmed cases reported in the state’s upstate region, at least 19 patients have been hospitalized due to serious complications.

During a briefing on February 4, state epidemiologist Linda Bell highlighted the dangers of complications arising from measles, particularly in children. “Some of these complications include measles encephalitis, or inflammation of the brain, in children and pneumonia,” she stated.

Bell underscored that encephalitis is especially perilous for young patients. “Any time you have inflammation of the brain, there can be long-term consequences, things like developmental delays and impacts on the neurologic system that can be irreversible,” she cautioned.

While the state does not systematically track every medical complication, data from the Centers for Disease Control and Prevention (CDC) indicates that pneumonia is the leading cause of measles-related death among young children, affecting approximately one in every 20 infected minors.

In response to the outbreak, a total of 147 students have been quarantined across 10 K-12 schools in the area. The outbreak also poses a significant risk to expectant mothers, as the MMR (measles, mumps, and rubella) vaccine cannot be administered during pregnancy. Several women who were exposed to the virus have recently required emergency treatment with immune globulin to provide “passive immunity.”

Bell emphasized the importance of this treatment to “protect them against the high risk of complications during pregnancy and to protect their newborn babies.” The measles virus is known for its high contagion rate, capable of lingering in the air for up to two hours after an infected person has left a room, according to experts.

In light of the outbreak, South Carolina has experienced a historic surge in vaccinations. In January alone, Spartanburg County reported a 162% increase in MMR vaccinations compared to the previous year. “I’m hoping that what we can attribute [the vaccine surge] to is a wider recognition of the threat of this disease circulating in our communities and the desire for people to be protected against the complications,” Bell noted during the briefing.

Health officials continue to urge the public to seek vaccinations, especially as a new case in the Pee Dee region suggests that the virus may be spreading beyond the initial upstate clusters through “unrecognized community transmission.” Bell reiterated the importance of increasing vaccination coverage, stating, “These are complications we hope to prevent. Increasing vaccination coverage protects those who cannot be vaccinated, like young infants, pregnant women, and those with weakened immune systems.”

According to Source Name, the ongoing outbreak highlights the critical need for public awareness and proactive health measures to combat the spread of measles and protect vulnerable populations.

Small Steps Toward Lasting Change in 2026 Wellness Reset

As 2026 begins, mental health takes center stage for many Americans, with over one-third planning resolutions focused on well-being, according to therapist Geetha Narayan.

As we step into 2026, mental health has emerged as a significant concern for millions of Americans. A recent survey indicates that more than one in three individuals are setting New Year’s resolutions centered on mental wellness. During a Chai & Chat session with India Currents, licensed marriage and family therapist Geetha Narayan highlighted the importance of recognizing what we can and cannot control. She emphasized that establishing a sense of predictability through manageable actions can serve as a powerful strategy for maintaining mental stability.

Narayan advocates for a “gentle approach” to self-care, prioritizing self-advocacy and cultural awareness as essential components for sustaining a balanced year.

Redefining Productivity and Cultural Identity

For many in the South Asian community, mental health is often deeply intertwined with a cultural legacy of immigration and survival. Those who arrived in the United States with limited resources frequently developed a mindset focused on productivity and provision.

This cultural backdrop can lead to what Narayan describes as the “Identity Trap,” where individuals define themselves solely through their work or familial roles, such as being a daughter, spouse, or provider. This can evolve into the “Martyr Syndrome,” where people immerse themselves in these roles to the point of burnout, resulting in feelings of resentment, victimhood, and depression.

Narayan encourages individuals to grant themselves permission to simply “be.” Taking breaks to explore one’s identity outside of work is not only acceptable but often necessary for mental health.

Practical Strategies for Sustaining Habits

The excitement of a new year can provide a sense of hope and an opportunity to reset from rigid patterns. However, that energy may fade as life’s demands take over. To maintain momentum, Narayan offers several practical strategies:

First, consider making a financial commitment by enrolling in a class or joining a gym. When individuals invest money in an activity, they are often more likely to follow through.

Next, break down overwhelming tasks into smaller, manageable chunks. Instead of a daunting list of 20 tasks, categorize them into morning, afternoon, and evening segments.

Narayan also highlights the psychological benefit of “striking” items off a list. This simple act can provide a sense of accomplishment and help prioritize the next steps.

Additionally, she advocates for normalizing “low days” where individuals may not feel up to getting out of bed. Allowing oneself guilt-free rest, including naps, can create the necessary space for a mental reset.

Navigating Uncertainty: Focus on What You Can Control

In a world filled with professional and political uncertainty, it is crucial to anchor oneself in daily routines. Narayan points out that while individuals cannot control external factors like workplace politics or global events, they have complete agency over their personal routines.

Engaging in small, controllable actions—such as brushing your teeth or preparing a meal—can foster a sense of agency and accomplishment. Acknowledging these small victories is vital; instead of self-criticism, individuals should celebrate their efforts, reinforcing their well-being.

Setting Boundaries in a High-Pressure Culture

In the high-pressure environment of Silicon Valley, a “heroic” narrative often glorifies working excessively long hours. The COVID-19 pandemic has further blurred the lines between personal and professional time, making it essential to establish boundaries.

Narayan recommends setting a “hard stop” for work hours, especially in a global context where work can extend from early morning to late evening. It is also important to engage in open conversations with managers about workload, as many companies are beginning to recognize the detrimental effects of overwork on employee mental health.

Self-advocacy is key; if you feel overwhelmed, don’t hesitate to reach out to family or supervisors to discuss ways to alleviate the pressure.

Navigating Trauma, Loneliness, and Conflict

Loneliness is a universal human experience, yet it often carries a stigma. Narayan encourages individuals to embrace loneliness as an opportunity to reassess relationships and determine which connections are worth nurturing.

In times of conflict, especially when living with others, it is crucial to respond thoughtfully rather than react impulsively. Taking time to process emotions can help individuals articulate their feelings calmly and assertively.

When dealing with trauma, the first step is to express how another person’s actions affect you. This can lead to collaborative problem-solving or, if necessary, taking steps to ensure personal safety and well-being. Recognizing when to seek professional help is also vital.

Digital Wellness and Social Media

Social media often exacerbates anxiety through the “comparison trap.” Narayan warns that individuals frequently compare their inner experiences to the curated lives of others, forgetting that social media typically showcases only highlights, not struggles.

To protect mental peace, she suggests scheduling regular disconnection from screens and social media.

Support for Specialized Challenges

For caregivers of aging parents, the demands can be overwhelming. Narayan advises seeking external support, utilizing community resources, and joining support groups to alleviate the burden.

For parents of children with ADHD, creating predictability and structure is essential. Collaborating with schools for accommodations and fostering community connections can provide valuable support.

The “Best Friend” Philosophy

The most important takeaway for 2026 is to become your own best friend. Many individuals are their harshest critics, often treating themselves with less kindness than they would offer a loved one. Narayan encourages practicing self-compassion and using gentle language with oneself.

Wellness is not a singular solution but rather the accumulation of small, kind, and manageable choices made throughout the day.

For more insights, watch the full episode of Chai & Chat.

This article was edited for clarity and accuracy by India Currents.

Nearly 40% of Cancers Preventable Through Three Lifestyle Changes

New research indicates that nearly 40% of global cancer cases could be prevented by addressing three major lifestyle risk factors: tobacco use, infections, and alcohol consumption.

Recent findings published in Nature Medicine reveal that nearly half of all cancer cases worldwide could be prevented by eliminating three significant risk factors: tobacco, infections, and alcohol consumption. The study, conducted by the World Health Organization (WHO) and its International Agency for Research on Cancer (IARC), highlights that approximately 40% of global cancer cases are linked to these factors, which account for 15%, 10%, and 3% of new cases, respectively.

In 2022, around 7.1 million cancer diagnoses were attributed to 30 modifiable risk factors, according to the research. Dr. Marc Siegel, a senior medical analyst for Fox News Digital, emphasized the importance of behavioral changes in cancer prevention, stating, “The key here is that almost half of all cancers could be prevented by behavioral changes.”

The study analyzed cancer data from 185 countries, correlating it with exposure data for the 30 identified risk factors. Among these, lung, stomach, and cervical cancers accounted for nearly half of the cases linked to modifiable risks. Many of these cases were associated with viruses and bacteria, including the human papillomavirus (HPV), hepatitis B and C, and Helicobacter pylori, a bacterium that infects the stomach lining.

Dr. Siegel noted the potential for prevention, particularly for cervical and throat cancers, which are directly linked to the HPV virus and can be mitigated through vaccination. “Preventable cancers of the cervix and throat are directly linked to the HPV virus and can be prevented by the HPV vaccine,” he explained.

The study also identified a range of cancers associated with cigarette smoking and alcohol consumption. Lung cancer, throat cancer, and gastrointestinal cancers were notably linked to smoking, while alcohol consumption was associated with breast, liver, colon, and throat cancers.

Environmental factors play a crucial role in cancer risk, with variations observed by geography. The study indicated that 45% of new cancers could be prevented in men, compared to 30% in women. Hanna Fink, a study author from the Cancer Surveillance Branch at IARC/WHO, emphasized the significance of the findings, stating, “Almost four in 10 new cancer cases worldwide, which represent 7.1 million lives that don’t need to be changed by a cancer diagnosis, were linked to things we can change or modify through awareness and public-health action.”

Fink pointed out that modifiable factors include tobacco smoking, infections, alcohol consumption, excess body weight, air pollution, and ultraviolet radiation. The researchers advocate for stronger prevention strategies targeting these areas, suggesting that effective public health policies could significantly reduce global cancer cases.

“The study reinforces that cancer prevention works, and action is most effective at the population level,” Fink added. She highlighted the role of governments and communities in facilitating healthier choices, such as implementing higher taxes on tobacco and alcohol, enforcing smoke-free policies, providing clear health warnings, ensuring safer workplaces, improving air quality, and making vaccinations and screenings more accessible.

Dr. Chris Scuderi, a family physician and cancer survivor, emphasized the importance of daily habits in reducing cancer risk. He advocates for regular exercise, restorative sleep, a Mediterranean-style diet, routine medical check-ups, and adequate rest as key prevention strategies. “Small daily wins add up to make a powerful difference over time,” Scuderi stated, underscoring the importance of routine screenings that can be coordinated with a family physician.

While the study presents compelling evidence, it does have limitations. Researchers often relied on data from around 2012 due to the long latency period between exposure and cancer diagnosis, which may not accurately reflect current behaviors or environments. Fink acknowledged this, stating, “This is a necessary simplification, because in reality, latency can be longer or shorter depending on the cancer and the exposure.”

Siegel noted that cancer types vary by geographic region, with stomach cancer being more prevalent in Asia, and the relationships between risk factors and cancer prevalence can differ across countries and populations. “We rely on the best available data on how common each risk factor is in different countries and how strongly it is linked to cancer, but these data are not perfect and are weaker in some low- and middle-income countries,” Fink explained.

Finally, the study focused on 30 risk factors with the strongest evidence and global data. Fink remarked that the estimate of “almost 40% of cancers are preventable” is likely conservative, as other suspected causes, such as certain dietary aspects, could not be included due to insufficient scientific data at a global level. “Our estimate is very likely conservative,” she concluded.

These findings underscore the critical importance of lifestyle choices in cancer prevention and the need for continued public health efforts to mitigate risk factors associated with this disease, according to Fox News Digital.

New Mexico Newborn Dies from Listeria After Mother Consumed Raw Milk

A newborn in New Mexico has died from a Listeria infection likely linked to the mother’s consumption of raw milk during pregnancy, prompting health officials to issue renewed warnings.

A newborn baby in New Mexico has died from a Listeria infection that state health officials believe is likely connected to the mother’s consumption of raw milk during her pregnancy. In response to this tragic incident, the New Mexico Department of Health issued a warning urging residents to avoid raw dairy products.

Health officials indicated that while they could not definitively identify the source of the infection, they consider the mother’s intake of unpasteurized milk during pregnancy to be the “most likely” cause. They emphasized that this unfortunate death highlights the serious risks that raw dairy products pose to vulnerable populations, including pregnant women, young children, the elderly, and individuals with weakened immune systems.

The consumption of raw milk has gained popularity in recent years, partly fueled by movements advocating for natural and unprocessed foods. This trend has been notably supported by figures such as Health and Human Services Secretary Robert F. Kennedy Jr.

Despite the popularity of raw milk, the U.S. Food and Drug Administration (FDA) has prohibited the interstate sale of unpasteurized milk for decades. However, there is no federal ban on raw milk, which allows individual states to determine its safety for human consumption.

Dr. Chad Smelser, deputy state epidemiologist for the New Mexico Department of Health, stressed the importance of consuming only pasteurized milk products during pregnancy to prevent potential illnesses and fatalities in newborns. Pasteurization is a process that heats milk to eliminate harmful germs.

The Centers for Disease Control and Prevention (CDC) warns that consuming raw milk or products made from it can expose individuals to various pathogens, including Campylobacter, Cryptosporidium, E. coli, Listeria, Brucella, and Salmonella. Listeria is particularly concerning, as it is the third leading cause of death from foodborne illnesses in the United States, with approximately 1,250 infections and 172 deaths reported each year.

Certain groups, including children under five, adults over 65, pregnant women, and those with weakened immune systems, are at a heightened risk of severe illness from Listeria and other foodborne pathogens.

Jeff M. Witte, New Mexico’s secretary of agriculture, reiterated the commitment of the state’s dairy producers to provide safe and wholesome products, emphasizing that pasteurization is a critical component of food safety. He encouraged consumers, especially those in high-risk categories, to choose pasteurized dairy products to mitigate the risk of serious foodborne illnesses.

This incident follows a previous outbreak last August, when raw milk from a Florida farm was linked to E. coli and Campylobacter infections that sickened 21 people, including six children.

As health officials continue to investigate the circumstances surrounding the newborn’s death, they stress the importance of awareness regarding the risks associated with raw milk consumption, particularly for vulnerable populations.

According to Fox News, the ongoing discussions surrounding raw milk safety highlight the need for informed choices regarding dairy consumption, especially for pregnant women and those with compromised immune systems.

Measles Exposure Risk Reported at Airport and Theme Park

Health officials have issued a warning about potential measles exposure at Los Angeles International Airport and Disneyland following an international traveler’s visit.

Health officials are alerting the public to a potential risk of measles exposure after an international traveler visited several busy locations in Southern California, including Los Angeles International Airport (LAX) and the Disneyland Resort.

The traveler arrived on January 26 aboard Viva Aerobus Flight 518, landing at Tom Bradley International Terminal B, Gate 201A. According to a statement from the Los Angeles County Department of Public Health (LADPH), individuals who were in Terminal B between 10:45 p.m. on January 26 and 1 a.m. on January 27 may have been exposed to the virus.

Following their arrival, the individual traveled to Orange County, where the Orange County Health Care Agency identified additional exposure windows on January 28. A subsequent exposure was reported on January 30 at a Dunkin’ Donuts in Woodland Hills, as noted by the LADPH.

“People who were at these locations during these times may be at risk of developing measles from seven to 21 days after exposure,” the Orange County Health Care Agency stated.

Health officials recommend that anyone who visited these locations during the specified windows check their immunization status and monitor for symptoms for 21 days following their potential exposure.

Public health departments in both Los Angeles and Orange County will continue to track potential exposure sites and notify individuals deemed to be at high risk. Experts advise that individuals contact a healthcare provider by phone before visiting a clinic if symptoms develop, in order to prevent further spread of the virus.

Measles is a highly contagious viral disease. According to the Centers for Disease Control and Prevention (CDC), if one person is infected, up to 90% of nearby individuals who are not immune may also contract the disease.

“Measles doesn’t only affect people who travel internationally — everyone is at risk if they’re not protected,” said Dr. Anissa Davis, deputy county health officer for Long Beach, California. “The best way to protect yourself and your loved ones is to get vaccinated before exposure occurs.”

Symptoms of measles typically include fever, cough, runny nose, and red eyes, followed by a characteristic rash that begins on the face and spreads downward. An infected person is contagious for four days before and four days after the rash appears.

As of January 30, there have been 588 confirmed cases of measles in the U.S. so far in 2026, according to the CDC. This follows a significant surge in 2025, which saw 2,267 cases — the highest annual count in more than three decades.

For more information, visit the CDC’s website or consult your local health department.

According to Fox News Digital, health officials continue to monitor the situation closely.

US Researchers Validate First Hindi Tool for Diagnosing Prolonged Grief

The first clinical tool in Hindi for diagnosing prolonged grief disorder has been validated by researchers, addressing a critical gap in mental health care for Hindi-speaking communities.

A team of researchers from the City University of New York (CUNY) and Weill Cornell Medicine has successfully validated the first clinical tool in Hindi designed to diagnose prolonged grief disorder (PGD), a condition that is now recognized in leading psychiatric manuals.

This significant milestone addresses a long-standing gap in culturally and linguistically appropriate mental health care for Hindi-speaking communities in the United States and beyond, according to a release from CUNY.

Prolonged grief disorder refers to an intense and persistent form of grief that disrupts daily functioning long after the death of a loved one. It is classified as a distinct mental health condition in both the Diagnostic and Statistical Manual of Mental Disorders and the International Classification of Diseases.

The absence of a validated assessment tool in Hindi—one of the world’s most widely spoken languages—has left many bereaved individuals without reliable pathways to diagnosis and support.

To address this issue, the research team translated, culturally adapted, and tested the Prolonged Grief Disorder-13 Revised Scale (PG-13-R), resulting in what is now known as the PG-13-R-H (Hindi version). This scale measures symptoms such as intense yearning and emotional pain, helping clinicians differentiate between normal grief and disordered grief.

The project was led by CUNY researchers, including Dr. Apeksha Mewani of Lehman College and Dr. Vincent Jones II of York College, along with collaborators Sungwoo (Justin) Kim, Dr. Kim Glickman, and scale originator Dr. Holly G. Prigerson of Weill Cornell Medicine. This cross-institutional effort was born out of a community need for better mental health resources.

The validation study surveyed 527 Hindi-speaking adults living in the United States, who were recruited online and through community outreach in culturally diverse Queens, New York. The results demonstrated that the Hindi scale is both reliable and valid, with a Cronbach’s alpha of 0.75, indicating consistent performance across items.

Approximately 15.6% of participants met the diagnostic criteria for PGD. Notably, 41.7% reported a death related to COVID-19, and 88.6% experienced an unexpected loss, both of which are recognized risk factors associated with prolonged grief.

For many participants, grieving in a diasporic context—where traditional rituals and extended family support structures may be lacking—may have compounded their distress.

The researchers emphasize that culturally tailored tools like the PG-13-R-H not only improve detection but also connect individuals with care that respects their linguistic and cultural frameworks. Dr. Mewani expressed hope that this tool would ensure that Hindi speakers can have their mental illness clinically diagnosed and receive the necessary mental health support.

Dr. Jones highlighted the importance of culturally grounded care, stating, “Language should never be a barrier to healing.” Dr. Prigerson, whose work laid the foundation for modern PGD research, noted that making the scale available in Hindi furthers the goal of “helping those who are mourning, who never found a name for what they were experiencing.”

The study, titled “Psychometric Properties, Stability, and Predictive Validity of the Hindi Version of the Prolonged Grief Disorder Scale (PG-13-R-H),” has been published in the Indian Journal of Psychological Medicine.

Researchers believe that the scale will be beneficial not only in clinical settings but also for community health workers, counselors, and researchers aiming to improve mental health equity for Hindi-speaking populations, according to CUNY.

-+=